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ACC – acetylCoA carboxylase  
ACP – acyl carrier protein 
ACT – actinorhodin 
AMP – antimicrobial peptide 
AMR – antimicrobial resistance 
CAMP(s) – cyclic antimicrobial peptides 
CFU – colony forming units 
CL – cardiolipin 
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The glycopeptide antibiotics vancomycin and teicoplanin are clinically important as a second-
line therapy to treat nosocomial infections caused by Gram-positive pathogens. Glycopeptide 
antibiotics universally target the terminal residues, D-Alanyl-D-Alanine on the cell wall 
peptidoglycan intermediate lipid II, interfering with peptidoglycan biosynthesis and weakening 
the cell wall. A general resistance mechanism to these antibiotics requires a core set of genes, 
vanRSHAX, that detect a glycopeptide (VanS) and upregulate genes (VanR) which orchestrate 
the remodelling of D-Ala-D-Ala on lipid II to D-Ala-D-Lactate (VanHAX), reducing 
glyopeptide affinity by 1000-fold. Our previous study demonstrated that altering the termini of 
lipid II by VanHAX action is insufficient for providing resistance to teicoplanin in S. 
coelicolor, which is instead mediated mainly by the elusive membrane protein, VanJ.  
This study further characterised VanJ by comparing the transcriptomes of a wt S. coelicolor 
A3(2) M600 strain and an isogenic ΔvanJ knock-out mutant after exposing cells to teicoplanin, 
identifying that ΔvanJ exhibited increased signs of cellular stress that were attributed to a 
delayed induction of genes involved in the osmotic, redox, and cell envelope stress responses. 
This dataset led to the functional characterisation of a group of genes with phosphatidic acid 
phosphatase activity which affected the sensitivity of S. coelicolor to a broad range of cell wall 
targeting antibiotics. One of these genes, SCO6355, significantly counteracted the intrinsic 
vanRSHAX resistance system of S. coelicolor, lowering its high-level vancomycin resistance 
(80 µg/mL) by four fold, to intermediate levels (20 µg/mL). This work demonstrates a novel 
mechanism which can antagonise the function of intrinsic van resistance clusters that will be 
important in the development of strategies that can circumvent glycopeptide resistance in 








1.1 Antimicrobial resistance  
1.1.1 The origins of antibiotics and the problem of antimicrobial resistance 
Many infections easily treated today were rampant at the turn of the 20th century, leading 
scientists to look for what they coined a ‘magic bullet’, that would kill pathogens while leaving 
the host relatively unharmed 1. In 1928, Alexander Fleming found a Staphylococcal petri dish 
that had been contaminated with a fungus that showed bacteriolytic properties 2. This was the 
first discovery of a natural product produced by an organism with antibacterial properties. Later 
work, carried out in the 40s by a team led by Howard Florey and Ernst Chain, resulted in the 
mass production of the natural product which was named penicillin (Figure 1.1) 3,4. The 
introduction of penicillin revolutionised modern medicine by not only making it easier to treat 
infections but also making complex procedures safer by reducing the rate of nosocomial 
infection. 
The two decades following the introduction of penicillin could be considered the ‘Golden era’ 
of antibiotic discovery (Table 1.1), where all the significant antibiotic classes were identified 
5. Pharmaceutical companies shifted from discovery towards the development of the antibiotics 
already available because the rate of rediscovery was too high to make it economically viable 
for further discovery initiatives. As a result, many generations of some antibiotics have been 
developed, and very few novel antibiotics have made it to the market since the 1980s (Table 
1.1). During this time, some infections became more challenging to treat, requiring higher 
doses of antibiotics or alternative drugs entirely. Bacteria producing enzymes with the ability 
to cleave the β-lactam ring in penicillin were identified as one example reducing the biological 
activity of an antibiotic 2,6,7. In other cases, some bacteria were innately resistance to antibiotics 
or acquired resistance through beneficial mutations or horizontal gene transfer.  
With, approximately 1,000 tonnes of antibiotics used in the UK in 2013, antibiotic use is 
increasing globally 8,9. Use of antibiotics in farms and within the community has been 
demonstrated to produce large amounts of antibiotic pollution which can contaminate the 
ecosystem and exacerbates antimicrobial resistance (AMR) by selecting for organisms with 
beneficial AMR genes 10–13. As demonstrated in Figure 1.2, if these organisms get back into 
the human population, in some instances they can prove challenging to treat, increasing the rate 






















Figure 1.1 The core structure of Penicillin derived from Penicillium spp. The characteristic β-





Table 1.1 A list of clinically available antibiotics and when they were introduced. The first 
instance where antibiotic resistance was identified is also shown in the third column. Adapted 

























Antibiotic Year introduced Resistance observed 
Sulfonamidesa 1930s 1940s 
Penicillin 1943 1946 
Streptomycin 1943 1959 
Chloramphenicol 1947 1959 
Tetracycline 1948 1953 
Erythromycin 1952 1988 
Vancomycin 1956 1988 
Methicillinb 1960 1961 
Ampicillin 1961 1973 
Cephalosporins 1960s Late 1960s 
Nalidixic acida 1962 1962 
Teicoplanin 1980s 1988 
Fluoroquinolonesa 1980s 1980s 
Linezolida 1999 1999 
Daptomycin 2003 2003 
Retapumulinb 2007 2007 
Fidaxomicin 2011 2011 
Telavancinb,c 2011 ? 
Bedaquiline 2013 2009 
Dalbavancinb,c 2015 ? 
Oritavancinb,c 2015 ? 
a Synthetic antibiotics 
bSemi-synthetic antibiotics 





















Figure 1.2 Image shows how AMR is believed to be selected for and introduced back into 
human populations through the use of antibiotics in both hospital and agricultural settings.   
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1.2 Antibiotics and their targets 
1.2.1 General mechanisms of antibiotics 
Effective antibiotics target unique bacterial components with minimal cross-reactivity with 
eukaryotic cells. This makes bacterial cells incredibly target poor, with all antibiotics 
interfering with the normal homeostasis of the cell. For example, penicillin belongs to a group 
of antibiotics called the β-lactam antibiotics which target penicillin-binding proteins (PBP). 
These enzymes are involved in maintaining the integrity of the unique peptidoglycan (PG) 
layer surrounding bacterial cells. By inhibiting these enzymes, the cell struggles to maintain 
the integrity of the PG, increasing susceptibility to rupturing due to the high osmotic pressure 
inside of the cell. This is just one example of how antibiotics can affect the homeostasis of a 
bacterial cell, but all antibiotics within a class of antibiotic broadly share the same cellular 
target. There are six general targets within bacterial cells. This includes antibiotics that target 
the steps involved in PG biosynthesis, which include β-lactams, lipopeptides and glycopeptide 
antibiotics. Others target either DNA replication, transcription or translation slowing the rate 
of growth of a cell. Antibiotics such as the sulpha drugs target the bacterial specific folate 
metabolic pathway. Finally, antimicrobial peptides (AMPs) and antibiotics such as daptomycin 
interact with the negatively charged bacterial membrane surface and associate to form 
membrane pores, resulting in membrane depolarisation as ions leak out of the cell 5,16. A more 
detailed list of the classes and targets of common antibiotics can be found in Table 1.2.  
1.2.2 The bacterial cell envelope and its importance for survival 
As previously mentioned, bacterial cells are surrounded by a protective layer of PG which is 
unique to bacteria. Its function is to provide the cell shape and counteract the high intracellular 
pressure of several atmospheres 17,18. PG and all the components embedded within this structure 
make up the bacterial cell wall, which along with the cell membrane and outer membrane (only 
Gram-negative bacteria), make up the cell envelope. The cell envelope acts as a barrier to the 
hostile and unpredictable exogenous environment, protecting internal cellular components. 
Due to its constant interaction with the external environment, it has become the principal target 
of many different antibiotics, which interfere with one or multiple components involved in the 
normal function of this structure. This structure is still an attractive target for drug development 
because many of the enzymes and intermediates involved in its maturation do not have 
eukaryotic counterparts 19,20.  
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Antibiotic 
Class Cellular Target Mechanism Reference 
β-lactam Irreversibly bind to penicillin binding 
proteins (PBPs) 
Inhibits cell wall biosynthesis 7 
Sulfonamides dihydropteroate synthase Inhibits folate synthesis 21 
Aminoglycosides Disturbs peptide elongation at the 
ribosome 
Interferes with protein synthesis 22 
Tetracyclines Block loading of aminoacyl-tRNA in 
the ribosome 
Interferes with protein synthesis 23 
Chloramphenicol Inhibits protein chain elongation Interferes with protein synthesis 24 
Macrolides Prevents peptidyltransferase from 
adding to the growing peptide chain 
Interferes with protein synthesis 25 
Glycopeptides Bind to lipid II in the bacterial 
membrane 
Inhibits cell wall biosynthesis 26 
Ansamycins Binds to RNA polymerase Prevents DNA-dependant RNA 
synthesis 
27 
Quinolones Covalently bind to DNA-gyrase Cause double-strand breaks in 
DNA during DNA replication 
28 
Streptogramin Bind the P-site of the ribosome Interferes with protein synthesis 29 
Oxazolidinones Bind the P-site of the ribosome Interferes with protein synthesis 30 
Lipopeptides Interact with the cell membrane Disrupts membrane structure 31 
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There are substantial differences in the cell envelope organisation of both Gram-positive and 
Gram-negative bacteria (Figure 1.3) even though the structure has a similar role in both. It 
serves to allow the selective passage of nutrients and expulsion of waste; acting as a site of 
biochemical reactions and segregating specific molecules into different subcellular 
compartments 32. Both Gram-positive and Gram-negative bacteria contain a cell membrane, 
consisting of a lipid bilayer studded with different proteins, lipoproteins, glycoproteins and 
lipid-linked polymers. This membrane is then surrounded by the cell wall, which has a layer of 
PG.  The thickness of this layer is only a few nanometres (several layers) in Gram-negative 
bacteria but can be anywhere between 30 and 100 nm in Gram-positive bacteria with both 
membrane-anchored and PG-anchored teichoic acids. Gram-negative bacteria also have a 
secondary membrane called the outer membrane (OM) which surrounds the inner membrane 
and peptidoglycan layer. The inner leaflet of the OM membrane consists of a phospholipid 
monolayer and a glycolipid outer leaflet mostly consisting of lipopolysaccharide (LPS). This 
secondary membrane provides greater resistance to a broad range of harmful compounds, 
including some bulkier antimicrobial compounds such as the glycopeptide antibiotics 32.  
1.3 The bacterial cell envelope  
1.3.1 The PG layer and the processes that are involved in its biosynthesis 
1.3.1.1 Cytoplasmic steps in PG biosynthesis  
In the following sections, there will be more emphasis put into the Gram-positive cell envelope 
as this project focuses on the interactions of the Streptomyces coelicolor cell envelope with 
different antibiotics, some of which are specific for Gram-positive bacteria. However, much of 
the work that elucidated the processes that synthesise PG and the cell envelope have been 
studied primarily in Escherichia coli. The need for these processes for bacterial survival means 
that they are fairly well conserved across bacteria, and some generalisations can be applied to 
most bacterial species and where gaps in our current knowledge exist, predictions can be 
applied from knowledge of model systems such as E. coli.  
The major component of the cell envelope in Gram-positive bacteria is the thick PG layer which 














Figure 1.3 Diagrams showing comparisons of the Gram-positive and Gram-negative cell 
envelopes. Abbreviations: IMP, inner membrane protein; LTA, lipoteichoic acid; WTA, wall 
teichoic acid; CAP, covalently attached protein; LP, lipoprotein; OMP, outer membrane 




The sugars are covalently linked by β1-4 glycosidic bonds to make long-chain polymers with 
a pentapeptide stem attached to each murNAc. Interglycan cross-linking occurs through the 
transpeptidation of the pentapeptide chain between neighbouring glycans, strengthening the 
structure 33. PG biosynthesis has been the focus of many studies over the past 50 years, and the 
following sections will summarise what is currently known about this process. The cytoplasmic 
steps of PG biosynthesis first produce the sugar-peptide moiety in PG (Figure 1.4). The first 
step in this process converts fructose-6-phosphate to glucosamine-6-P through the action of 
GlmS. The second reaction, catalysed by GlmM, produces glucosamine-1-P. The same 
bifunctional enzyme, GlmU, catalyses the third and fourth reactions in this pathway, producing 
N-acetylglucosamine-1-P and then uridine diphosphate (UDP)-GlcNAc. MurA and MurB then 
convert UDP-GlcNAc to UDP-murNAc, and the MurCDEF ligases are then responsible for 
sequentially adding amino acid residues to UDP-MurNAc, catalysing the formation of the stem 
peptide. Typically, the peptide starts with a D-Alanine (D-Ala) which is ligated to a D-glutamic 
(D-Glu) acid by MurD. Gram-positive bacteria generally follow this with L-lysine which is 
added by MurE. Finally, a D-alanyl-D-alanine (D-Ala-D- 
Ala) motif caps the end of the pentapeptide; however, alternative terminal residues such as D-
alanyl-D-lactate (D-Ala-D-Lac) are seen under certain circumstances 34.  
1.3.1.2 Membrane-bound steps of peptidoglycan biosynthesis  
The UDP-MurNAc-pentapeptide is then transferred to a membrane-bound C55-lipid carrier, 
undecaprenyl phosphate (UP). This is a vital lipid carrier not just for PG but for several lipid-
bound structures in bacteria, such as teichoic acids and LPS in Gram-negative bacteria 18. It is 
an essential molecule that is synthesised from the isoprenoid, isopentenyl diphosphate (IPP). 
IPP is first converted to dimethylallyl diphosphate (DMAPP) where it is condensed with IPP 
to produce farnesyl diphosphate (FPP). FPP acts as the building block for most isoprenoids 
found in bacteria, including UP (Figure 1.5). UppS then generates undecaprenyl 
pyrophosphate (UPP) from FPP within the membrane. UPP has to be dephosphorylated before 
it can be used for PG biosynthesis, and this is mostly carried out by the UPP-phosphatase 
(UppP) 18,35. The UDP-MurNAc-pentapeptide is then transferred to a UP molecule by MurX, 
releasing uridine monophosphate, generating lipid I. A GlcNAc moiety is then transferred to 
Lipid I by the glycosyltransferase MurG on the C4 hydroxyl group to produce the C55-P-
























Figure 1.5 Biosynthetic steps for making the isoprenoid lipids, undecaprenyl phosphate (UP) 
and hopanoids from farnesyl diphosphate (FPP). Isopentenyl diphosphate (IPP), dimethylallyl 
diphosphate (DMAPP), farnesyl diphosphate synthase (FPPS), undecaprenyl pyrophosphate 













































































































Most bacteria also contain additional interglycan cross-links between pentapeptide chains of 
neighbouring glycans (Figure 1.7). These cross-links are made between residues that branch 
off the stem pentapeptide and vary in structure between species. In S. coelicolor, only one 
glycine is present in the cross-bridge; but, in Staphylococcus aureus, there are five (Figure 
1.8). The first residue is added by the non-ribosomal peptidyltransferase, FemX (Figure 1.6), 
which recognises the terminal D-Ala-D-Ala motif 36. Two other proteins FemA and FemB are 
required for the additional glycine residues in S. aureus but are absent in species like S. 
coelicolor 37. 
 
The next step in this process is the transfer of lipid II from the inner leaflet to the outer leaflet 
of the lipid bilayer. As lipid II is a highly polar molecule, the rate that this would occur 
spontaneously would be too slow to be biologically useful, so it has long been hypothesised 
that there must be a transporter or flippase that fulfils this role. Although several candidates 
have been suggested, MurJ has the most substantial evidence to support its role in this cellular 
function 38. MurJ belongs to a superfamily of multidrug/oligosaccharidyl-lipid/polysaccharide 
(MOP) exporters, and members of this protein family are involved in the excretion of LPS. As 
both PG and LPS use UP as a lipid carrier for their intermediates, it seems logical that MOP 
transporters could be involved in both processes. However, MurJ has also been found to be 
redundant in Bacillus subtilis, suggesting that several proteins may have lipid II flippase 
activity 39–41. 
1.3.1.3 Late stages of peptidoglycan biosynthesis  
Once flipped to the external surface of the membrane, lipid II needs to deliver the PG monomer 
to the nascent glycan termini (Figure 1.6). PBPs are responsible for catalysing these reactions 
and modifying mature PG to cope with the needs of the cell. These enzymes can be grouped 
broadly into three classes which each have different roles in the cell wall. Class A PBPs possess 
an N-terminal glycosyltransferase which catalyses the formation of glycosidic bonds between 
the disaccharide and the PG polymer. They also contain a C-terminal transpeptidase domain 
which can cross-link the amino acid branches between neighbouring glycans. Class B PBPs 
only have a C-terminal transpeptidase domain and when studied in Escherichia coli, are 
typically involved in cell division and PG maturation/recycling. The role of class C PBPs is 
less clear, but they contain a DD-carboxypeptidase and can remove the terminal D-ala from a 
















Figure 1.7 Diagram showing an example of the lattice structure of crosslinked peptidoglycan 


















Figure 1.8 Diagrams of the interpeptide bridges in the stem peptides of three different bacteria. 
E. coli forms bridges directly between its stem peptides, whereas both S. aureus and the 
Streptomyces spp. bridge their stem peptides with differing numbers of glycine residues. 
Adapted from Vollmer et al., 2008.  
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So far, all bacteria with PG have been discovered to have at least one of each class although 
the number may vary. E. coli has 12 PBP while the sporulating bacteria Bacillus subtilis and 
S. coelicolor have 16 and 21 respectively. It has been proposed that the higher number of PBPs 
in the latter organisms may help with the more complicated developmental processes that occur 
during sporulation 17. 
The final stage of PG biosynthesis involves the dephosphorylation of UPP to reconstitute UP 
for further rounds of PG cycling. Although the flippase that transports the C55-carrier lipid back 
to the inner leaflet of the membrane remains elusive, there is strong evidence to suggest that 
the BacA membrane protein is the main UPP phosphatase in E. coli. Although not essential, 
BacA has been shown to dephosphorylate UPP in vitro and when deleted, causes 
hypersensitivity to the UPP targeting antibiotic bacitracin, 42,43. Other studies have 
demonstrated that other proteins are also able to fulfil some of the UPP-phosphatase activity in 
the membrane, including Yeiw and PgpB from E. coli and BcrC from B. subtilis 44,45. All belong 
to the type 2 phosphatidic acid phosphatase (PAP2) superfamily which includes various other 
membrane phosphatases. It is likely that because of the importance of maintaining the 
homeostasis of the cell envelope, membrane phosphatases exhibit multi-functionality to ensure 
that cells can still function in case one enzyme fails 46. 
1.3.2 The bacterial cell membrane  
1.3.2.1 Architecture and composition of bacterial cell membranes  
This section will discuss the current understanding of the structure and function of the cellular 
membranes and how they relate to the function of the bacterial cell envelope. This mostly 
lamellar phospholipid bilayer confers spatial separation between the intra- and extracellular 
environments 47,48 and early models proposed that this structure existed as a lipid matrix with 
globular proteins embedded into the structure. 49. Based on this model, components can diffuse 
freely in the plane of the membrane while smaller, less-polar molecules can spontaneously flip 
between the leaflets of the membrane (Figure 1.9). Flippases such as MurJ, are required to flip 
bulkier molecules across the membrane creating a heterogeneous composition 50–52, but there 
is now compelling evidence to demonstrate that bacteria augment the composition of their 
membranes to adapt to their environments 53–55. In doing so, they maintain the integrity of the 
cell envelope 56, resist against high osmolarity 57; increase thermotolerance 58,59; and to adapt 












Figure 1.9 Diagram depicting the movement of lipids in biological membranes. Lipids can 
diffuse through the plane of both the inner and outer leaflets of the lipid bilayer, and some 
smaller lipids can spontaneously flip-flop between the leaflets. For larger, more polar 




C55-P lipids have already been discussed concerning PG biosynthesis. However, the primary 
lipids in bacterial membranes are the amphiphilic phospholipids. They consist of an acylated 
glycerol-3-phosphate (G3P) molecule that may be loaded with several different polar head 
groups. The composition of these structures can vary between species 61, but common 
phospholipids include phosphatidic acid (PA), phosphatidylglycerol (PpG), cardiolipin (CL), 
phosphatidylinositol mannosides (PIM) and phosphatidylethanolamine (PE) (Figure 1.10). To 
understand how the bacterial membrane protects the broad range of environments, the 
metabolic processes that generate these phospholipids must be understood. Like PG, the initial 
stages in the biosynthesis of each phospholipid occur in the cytoplasm and are then loaded into 
the membrane.   
The mechanisms that go into creating phospholipids are relatively conserved amongst bacteria 
and start with the generation of G3P through the phosphorylation of glycerol by GlpK 62. 
Simultaneously, fatty acids are produced through the fatty acid biosynthetic pathway. This 
pathway begins with the conversion of acetyl-CoA to malonyl-CoA by acetyl-CoA carboxylase 
(ACC). Chain elongation requires the action of four enzymes working cyclically to increase 
the length of the nascent acyl chain. The malonyl group is transferred to the acyl carrier protein 
(ACP) by FabD, and the intermediate is condensed with another acetyl-CoA by FabH to form 
β-ketoacyl-ACP. Branched acyl chains can also be incorporated into this metabolic pathway as 
is typically the case in Gram-positive bacteria, and bacteria that are undergoing temperature-
related stress. FabA then dehydrates the β-ketoacyl-ACP to trans-2-enoyl-ACP, which is 
finally reduced by FabI to produce an acyl-ACP (Figure 1.11).  
The membrane phospholipid intermediate, lysophosphatidic acid (LPA), is generated at the 
membrane surface from the acylation of a G3P by an acyl-transferase such as PlsX/PlsY or 
sometimes PlsC 58. A second acyl-chain is then added by PlsB, producing PA. Its small size 
and neutral charge allow it to spontaneously flip-flop across the membrane, serving as a lipid 
carrier on either side of the membrane (Figure 1.11). PA is then condensed with a cytidine 
diphosphate to produce cytidine diphosphate-diacylglycerol (CDP-DAG)61,63. Bacterial 
membranes differ in their phospholipid composition, but PE and CL are two of the more 
common lipids 64. PE is synthesised from CDP-DAG through the action of two enzymes: 
phosphatidylserine synthase (Pss) and phosphatidylethanolamine decarboxylase (Psd) which 













Figure 1.10 Structure of the main bacterial phospholipids as well as the phosphate-free, 
ornithine lipid. Each lipid has been grouped based on their overall charge, showing that most 




Alternatively, a G3P can be added to CDP-DAG by a PpG phosphate synthase (PgsA) to form 
PGP. PGP can then be dephosphorylated by a PpG phosphate phosphatase (PgpA, PgpB or 
PgpC in E. coli) to produce PG. CL is then synthesised from the condensation of a PG and a 
CDP-DAG via a CL synthase (Figure 1.11) 61. Further modifications of PGP with lysine or 
alanine have been recognised in some bacteria, providing resistance to cyclic antimicrobial 
peptides (CAMPs), osmotic stress and bile salts 53,54,65,66. 
Other phospholipids seen in bacteria include phosphatidylinositol (PI). PI is more commonly 
found in eukaryotes, but PI is also widespread throughout the Actinobacteria and δ-
proteobacteria. PI is essential for the synthesis of lipoglycans in mycobacteria, but its role in 
other bacteria has yet to be elucidated 60,67. Myoinositol-1-phosphate is first added to CDP-
DAG by PisA to produce PI-phosphate (PIP). The mechanism by which this molecule is 
dephosphorylated is unknown, but a membrane phosphatase likely catalyses the reaction 61,67. 
In the Streptomyces spp., PimA adds a mannose to position-2 of PI to produce PI 
monomannoside (PIM1). PIM1 can then either have an additional mannose added to its structure 
by PimB’ to produce PIM2, or undergo further acylation, producing acyl-PIM1 (Ac-PIM1). Ac-
PIM2 is then generated from either of these intermediates using the converse enzyme (Figure 
1.11) 67.  
1.3.2.2 The enzymes involved in recycling phospholipids 
Although we have a good understanding of the enzymes and biochemical reactions involved in 
the recycling of the C55-P in peptidoglycan biosynthesis, there is still a poor understanding of 
the processes that are involved in the degradation and recycling of phospholipids. The PAP 
family are known to be one group of enzymes involved. These enzymes can be grouped based 
on whether they are Mg2+-dependant (PAP1) or Mg2+-independent (PAP2), with the former 
only found in eukaryotes and the latter predominant in bacteria. PAP2 enzymes show a broader 
specificity for their targets. The phosphatidic acid phosphatase, PgpB from E. coli is known to 
hydrolyse many pyrophosphate phospholipid derivatives other than phosphatidic acid, 
including including the PG intermediate, UPP 68. This also includes BcrC from Bacillus sp., 
which expresses UPP-phosphatase activity in the bacterial membrane increasing resistance to 
the antibiotic bacitracin by competing for its target, UPP 45,69. The widespread distribution of 
predicted membrane phosphatases suggests that these enzymes could also have a diverse and 
essential role in modifying and recycling phospholipids, although their role in these processes 








Figure 1.11 Cytoplasmic and membrane reactions that produce membrane phospholipids that 
have so far been identified in bacteria. Solid arrows indicate reactions that have been 
experimentally observed, while dotted arrows have yet to have their mechanisms elucidated. 
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1.3.2.3 Other important bacterial membrane lipids 
Some bacteria have also been found to produce phosphate-free lipids such as ornithine lipid 
(OL). They have been well characterised in the α-, β-, γ-proteobacteria as well as in the 
actinomycetes. Recent work on S. coelicolor has shown that OL is produced during later stages 
of development and during phosphate-limited conditions 60. The pathway is well conserved in 
the Streptomyces and is carried out by two enzymes that acylate one molecule of ornithine. 
OlsB carries out the first acylation step, producing lyso-OL (LOL). OlsB then carries out a 
second acylation step to produce OL (Figure 1.12).  
Unlike eukaryotic membranes, bacterial membranes lack the isoprenoid lipid, cholesterol. 
Instead, they produce hopanoids which carry out a similar function in bacteria (Figure 1.5). 
These molecules can interact with the acyl chains of phospholipids, reducing their fluidity in 
the plane of the bilayer. In some bacteria, such as B. subtilis and S. coelicolor, they become 
abundant during development, particularly at the point of sporulation 48,70. More recently these 
molecules have been found to coalesce with flotillin proteins to form microdomains within 
bacterial membranes. Although not well understood in bacterial membranes, flotillins can 
recruit many different proteins to the site of the microdomain, possibly localising particular 
functions to specific locations within the membrane 48,71.  
1.4 The glycopeptide antibiotics 
1.4.1 Glycopeptide antibiotics and their structure 
Glycopeptide antibiotics constitute roughly 0.3% of all antibiotics used in the UK yet, they 
have become instrumental in the second-line treatment of multidrug-resistant, Gram-positive 
bacteria 9. All known naturally derived glycopeptide antibiotics originated from the soil-
dwelling Gram-positive actinomycetes. Vancomycin (Figure 1.13A) was the first glycopeptide 
to be introduced and was first purified from Amycolatopsis orientalis (previously Streptomyces 
orientalis) in 1953 72. After its introduction in 1958, it became the drug of choice for penicillin-
resistant staphylococcal infections but fell out of favour due to several of its undesirable side 
effects including; ototoxicity, nephrotoxicity and a characteristic upper-body rash referred to 
as ‘red-man syndrome’ 73. Because they were generally safer and easier to administer, newer 
generations of β-lactam antibiotics became the preferred line of treatment for Gram-positive 
infections, and vancomycin fell out of favour. A second glycopeptide antibiotic, teicoplanin 




























Figure 1.13 The structures of clinically approved glycopeptide antibiotics. (A) Vancomycin 
binds to D-Ala-D-Ala with five hydrogen bonds in a glycopeptide sensitive phenotype. The 
structure of the D-Ala-D-Lac in resistant phenotype is shown underneath. (B) The structure of 
teicoplanin A2-2. (C) Three semi-synthetic lipoglycopeptide antibiotics that have been 
approved recently for the use in the EU. Red circles indicate shared hydrogen bonding groups.  
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It was first purified as a natural product in 1977 from the bacterium Actinoplanes 
teichomyceticus 75. Like vancomycin, this novel drug was a potent inhibitor of Gram-positive 
organisms but had a longer half-life within the body while presenting far fewer adverse side 
effects associated with vancomycin treatments 76,77. 
The glycopeptides can be divided into Types I-V depending on the amino acid sequence in 
their heptapeptide backbone. Depending on the residues, they form either di-, tri- or tetracyclic 
cores and are synthesised non-ribosomally. Vancomycin belongs to the Type I glycopeptides, 
which have tricyclic structures with aliphatic residues at positions AA-1 and AA-3 (Figure 
1.13A), while Types II, III and IV all have aromatic residues in these positions. Type III and 
IV (which includes teicoplanin) glycopeptides have an additional aryl ester (Figure 1.13B) 
creating tetracyclic structures 78.  
The glycopeptide aglycone may also display several structural variations which include 
different glycosylation patterns, the presence of chlorine atoms to provide rotational stability, 
and the presence of a fatty-acid chain substituted into a sugar moiety on AA-4 78. Teicoplanin 
is an interesting glycopeptide because it is produced as a mixture of five structurally related 
compounds (TA2-1 – TA2-5) that all have the same core but have variable alkyl sidechains. It 
is believed that the improved clinical properties of teicoplanin are attributed to these lipophilic 
sidechains, and it should be no surprise that many semi-synthetic glycopeptide derivatives have 
similar modifications. The second-generation of glycopeptides which have been introduced 
over the past ten years (Figure 1.11C) all contain lipophilic side chains and include the 
chloroeremomycin derivative, oritavancin 79,80; the vancomycin derivative, telavancin 81,82; and 
a derivative of A40926, dalbavancin 83,84. 
1.4.2 Mechanisms of glycopeptide antibiotics; modes of action and resistance 
mechanisms 
The high molecular weight of glycopeptide antibiotics means that they are unable to pass 
through the outer membrane of Gram-negative bacteria, making Gram-negatives innately 
resistant to these drugs. However, they can diffuse through the thick PG layer of Gram-positive 
bacteria, to reach the membrane surface where they target, the D-Ala-D-Ala motif of lipid II 
85. This interaction is mediated by five hydrogen bonds that are stabilised by many hydrophobic 
van der Waals contacts 86, allowing them to sterically occlude the enzymes involved in the later 
stages of PG biosynthesis (Figure 1.13A) 87,88. 
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Glycopeptides are unusual antibiotics in that they target a substrate rather than the enzymes 
within a biochemical process. This means that the chance of spontaneous resistance to 
glycopeptides is low as several enzymes would have to develop mutations in unison to produce 
a modified lipid II.  However, reports of glycopeptide resistance were first documented in the 
1980s when the first isolates were identified in the enterococci 89,90. These organisms form part 
of the healthy microbiota but can become opportunistic pathogens in immunocompromised 
individuals, leading to urinary tract infections, endocarditis and sepsis. It was found that 
vancomycin-resistant enterococci (VRE) had acquired mobile elements with gene clusters that 
allowed them to modify the D-Ala-D-Ala motif in lipid II to produce pentapeptides terminating 
in D-Ala-D-Lactate. In doing so, the number of hydrogen bonds that could form between lipid 
II and the glycopeptide was reduced by one, resulting in a 1000-fold decrease in affinity, and 
significant reduction of biological activity (Figure 1.13A) 72. The health crisis caused by VRE 
continued during the following decade where nine subtypes of VRE (VanA, -B, -C, -D, -E, -
G, -L, -M and -N) were identified based on the genetic organisation of their resistance clusters 
72,91. For a full review of the subtypes of VRE, see Ahmed and Baptise (2017), but the most 
common types, VanA and -B will be discussed here.  
Both VRE VanA and B show high levels of inducible resistance to vancomycin, but only VanA 
also exhibits high-level teicoplanin resistance. Genetic differences in the resistance clusters are 
what cause this difference in phenotype. Both have a core set of genes, vanRSHAX, that are 
essential for modifying D-Ala-D-Ala. Additionally, they also both have several accessory 
genes that are not essential for glycopeptide resistance (Figure 1.14A). The enzymatic 
functions converting D-Ala-D-Ala to D-Ala-D-Lac are encoded for by the genes vanHAX, and 
their induction causes high-level resistance to both vancomycin and teicoplanin. VanH is 
responsible for converting pyruvate to lactate which is then used by the D-Ala-D-Lac ligase, 
VanA (denoted VanB in VanB-type). VanX cleaves any remaining D-Ala-D-Ala to prevent 
any further incorporation into lipid II (Figure 1.14B) 91.  
vanRS encode a two-component system (TCS) which are the primary system of signal 
transduction in bacteria and are essential in the regulation of transcription in response to a wide 
variety of environmental conditions. The classic TCS involves a sensory kinase (SK), usually 
located in the membrane that is responsible for recognising an environmental signal. Once 
activated, the SK subsequently phosphorylates its cognate response regulator (RR), which then 












Figure 1.14 Glycopeptide resistance gene cluster (A) and the proposed function of VanH, 
VanA and VanX proteins (B).   
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The TCSs from VanA and B enterococci are distinctly different with evidence suggesting that 
the ligand for VanA-type enterococci is a teicoplanin-D-Ala-D-Ala complex. It is unclear what 
the ligand is for in VanB-type but the SK is more truncated than the VanA SK 94. There is now 
strong evidence to suggest that the differences observed between the two types is down to the 
induction of vanHAX by the two different SKs and the reduced resistance to teicoplanin in 
VanB-type enterococci is due to poor induction of the SK 95.  
1.4.3 Evidence of a dual target for lipoglycopeptide antibiotics 
Teicoplanin is empirically more effective than vancomycin even in VanA-type VRE 77,81,83,96–
99. The major structural difference between the two is the lipophilic sidechain of teicoplanin 
which classifies teicoplanin as a lipoglycopeptide antibiotic. It is known that the structural 
differences between teicoplanin and vancomycin can affect the induction of van genes 100,101, 
but the role of these structural difference remains controversial. Studies have indicated that 
vancomycin preferentially blocks the transglycosylation step of PG biosynthesis at the 
membrane surface 102, but early studies on teicoplanin suggested that it was also able to 
interfere with membrane integrity, causing depolarisation or lysis, similar to the biological 
effects seen with the lipopeptide daptomycin 88,103,104.  
Challenging evidence has emerged in the past decade where in vivo studies using rotational-
echo double resonance (REDOR) NMR on live cells have indicated that the lipophilic side 
chains of oritavancin analogues contact the branch amino acids on the pentapeptide of unlinked 
PG. This suggests, like vancomycin, lipoglycopeptides can block transglycosylases from 
polymerising nascent glycan strands nearer the membrane during transglycosylation. But, 
additionally they can also occlude class II PBPs from accessing unlinked bridge peptides during 
transpeptidation (Figure 1.15). The secondary binding site also means that lipoglycopeptides 
have a greater affinity for lipid II even in cells expressing the D-Ala-D-Lac phenotype, 
explaining why these drugs are more active against vancomycin-resistant organisms 88,105,106. 
It is also likely that due to the secondary binding site, lipoglycopeptides are more difficult to 
recognise by certain SKs, leading to reduced induction of the van genes by VanRS.  
1.4.4 Glycopeptide resistance in S. coelicolor 
Most of the research on glycopeptide resistance has been carried out on VRE, nonetheless, 
several problems arise when studying clinical isolates. Firstly, they require special handling 




Figure 1.15 Model to show the proposed dual mechanism of lipoglycopeptides in the cell wall of S. aureus. PG pentapeptides are represented as 
dotted lines, with mature cross-links between glycan chains shown as connected light grey hexagons. Lipoglycopeptides are represented in red 
with the hydrophobic side chain making the secondary contact site shown in dark red. By binding both D-Ala-D-Ala and the terminal branch 
amino acids that make up the crossbridge in the stem peptide, both transglycosylases (TG) and transpeptidases (TP) are inhibited, and PG 




Secondly, their phenotypes can vary drastically between strains, making them challenging to 
study. Heterologous expression in a non-pathogenic model organism can be used to address 
the first issue, but heterologous expression can produce spurious phenotypes that may not be a 
true representation of the parental organism107. One comprehensive solution is to use a non-
pathogenic organism with an endogenous van resistance system. S. coelicolor makes a good 
candidate for this role. It is a member of the actinomycetes, which are soil-dwelling organisms 
that collectively make approximately two-thirds of all clinically relevant antibiotics and can 
have up to 15 intrinsic AMR systems 5,108. S. coelicolor does not produce any glycopeptide 
antibiotics, but it is genetically well-characterised and possesses an inducible glycopeptide 
resistance system similar to VRE 37(Figure 1.13A).  
The S. coelicolor van cluster is organised into four transcriptional units (vanRS, vanJ, vanK, 
vanHAX) which are all under the control of the VanS/VanR TCS. Our current model for the 
TCS in S. coelicolor indicates that in the absence of vancomycin, the small molecule 
phosphodonor, acetyl phosphate, phosphorylates VanR, while VanS acts as a phosphatase to 
deplete the intracellular pool of phospho-VanR (Figure 1.16). After exposure to vancomycin, 
VanS acts as a kinase, instead phosphorylating VanR and increasing the concentration of 
VanR-P. As a result, there is an increase in expression from each of the four van promoters and 
an increase in resistance to vancomycin (Figure 1.16) 109. The van gene cluster in S. coelicolor 
confers high-level resistance to vancomycin and related glycopeptides 110, but like VanB-type 
enterococci, VanS is poorly induced in the presence of teicoplanin (Figure 1.17). S. coelicolor 
is therefore highly resistant to vancomycin but remains susceptible to teicoplanin. Studies have 
demonstrated that vancomycin directly binds purified VanS sensor proteins 111,112 and that in 
the case of the VanS from S. coelicolor, vancomycin has to be bound to its ligand to induce the 
resistance system 113. Work carried out on both VanB-type VRE and S. coelicolor has 
demonstrated that although the core aglycones of both teicoplanin and vancomycin induce the 
resistance cluster, the presence of a lipophilic side-chain on the former reduces the 
transcriptomic response 100,114. This information is important for understanding how 
glycopeptide antibiotics interact with the bacterial cell-surface. The function of lipophilic side 
chains in shielding lipoglycopeptide antibiotics from some VanS SK variants in VRE and S. 
coelicolor demonstrates the importance of these secondary modifications and how they can 
counteract high-level glycopeptide resistance.  This information is important for understanding 













Figure 1.16 A model illustrating the function and regulation of vancomycin resistance via the 











Figure 1.17 Plates showing the resistant phenotype of S. coelicolor A3(2) M600 wt and S. 
coelicolor A3(2) ΔvanJ strains on MMCGT with vancomycin (30µg) and teicoplanin (30µg) 
antibiotic disks. In M600 the characteristic D shape in the inhibitory zone is seen because vanJ 
is induced in the presence of vancomycin, increasing resistance to teicoplanin, allowing cells 
to grow. In the ΔvanJ mutant, the zone of inhibition remains circular because the cells remain 




1.4.5 The novel vanJ gene from S. coelicolor mediates specific resistance to 
teicoplanin 
The S. coelicolor van cluster has two additional accessory genes, vanK and vanJ. The function 
of vanK has been elucidated and has no counterpart in other resistance clusters in pathogenic 
organisms, but is essential for vancomycin resistance in S. coelicolor 110. It belongs to the Fem 
family of enzymes which add the branch amino acids to the pentapeptide in PG precursors 
(Figure 1.8). The native FemX enzyme adds a single glycine to pentapeptides terminating in 
D-Ala-D-Ala but cannot recognise precursors terminating in D-Ala-D-Lac. VanK can 
recognise D-Ala-D-Lac terminating precursors and therefore can add a single glycine to the 
pentapeptide when vanHAX are expressed.  
Work also carried out by Hong’s group has demonstrated that the other gene, vanJ, is not 
involved in resistance to vancomycin but provides resistance to teicoplanin-like glycopeptide 
antibiotics when overexpressed 115. The gene encodes a membrane protein oriented with its C-
terminal predicted active site exposed to the extracytoplasmic space. Over-expression of vanJ 
in a ∆vanHAX mutant strain of S. coelicolor produces the same increase in teicoplanin 
resistance as overexpressing vanJ in the wild-type strain, indicating that this phenotype is 
independent of the reprogramming of cell wall precursors encoded by the VanHAX proteins 
115.  
VanJ belongs to a family of genes with a predicted endonuclease/exonuclease/phosphatase 
(EEP) domain. Other proteins with this domain have diverse roles in other bacteria including 
SpnA from Streptococcus pyogenes, which acts as a DNase to degrade neutrophil extracellular 
traps during infections 116. Others, such as REX1 and REX2, are involved in mRNA maturation 
within the mitochondria of trypanosomes 117,118. This superfamily of proteins is heavily 
implicated in numerous processes in both eukaryotic and prokaryotic cells involving the 
cleavage of phosphodiesters, but the particular role of VanJ remains elusive. This protein has 
been shown to be localised to the membrane with an externally facing catalytic domain that 
does not inactivate teicoplanin or modify PG precursors. One suggestion for the role of VanJ 
has been the cleavage of the phosphodiester bond of lipid II in the presence of teicoplanin to 
alleviate the effects of teicoplanin on the cell wall 115.  But this fails to explain why VanJ 




Homologues of vanJ are found ubiquitously in actinomycetes, including staP from the A47934 
producer, Streptomyces toyocaensis (Figure 1.17). With a high amino acid sequence similarity 
between VanJ and StaP (>70%), they appear to represent a subset of a larger protein family 
which have acquired specialist roles in teicoplanin resistance. In comparison, other 
homologous genes such as SCO2255 and SCO7017 encoding putative membrane proteins with 
much lower amino acid identity to VanJ (50-60%) are found in S. coelicolor and other 
actinomycetes, but are not involved in teicoplanin resistance 115. Further understanding of the 
functional role of VanJ and its homologues will improve our understanding of the mechanisms 
necessary for teicoplanin resistance, and consequently also provide information on its activity 
why this drug is more biologically effective.  
1.5 Aims and objectives 
This project combines transcriptomics with functional analysis to identify the possible role of 
the teicoplanin-resistance gene, vanJ, by comparing the transcriptomes of a wt S. coelicolor 
A3(2) M600 strain and an isogenic ΔvanJ knock-out mutant. The specific teicoplanin stress 
response will also be analysed using the current knowledge on the S. coelicolor stress response 
to other cell wall targeting antibiotics in order to identify possible novel teicoplanin resistance 
genes. Each proposed gene will be validated for their possible role in altering the resistance of 
S. coelicolor against a library of antibiotics because resistance systems can show cross-
reactivity between similarly related drugs. In doing so, this project aims to improve our 
understanding of how vanJ alters resistance to teicoplanin by identifying which systems are 
affected in the vanJ null mutant. This project also aims to identify novel resistance markers that 













Figure 1.17 VanJ homologues in S. coelicolor and other Streptomyces strains (adapted from 








2.1 Bioinformatic analysis of RNA-sequencing data 
2.1.1 Extraction of RNA from S. coelicolor wild type and ∆vanJ strains  
RNA was prepared and sequenced prior to the start of this project. RNA was prepared as 
previously described 100, by growing both S. coelicolor M600 and S. coelicolor ∆vanJ null-
mutant strains to mid-log phase in NNMP media (~0.5 at OD600). Immediately after the first 
sample was taken (time 0 min), teicoplanin was added to cultures  to make a final concentration 
of 10µg/mL and samples were taken at 30 and 90 minutes using the RNeasy Midi kit (Qiagen). 
rRNA was depleted from samples using Ribo-Zero (Illumina), and S. coelicolor mRNA was 
then randomly primed to create a strand-specific cDNA library. The cDNA was checked using 
gel electrophoresis and sample concentration was measured using a ThermoScientific 
NanoDrop 2000c spectrophotometer. Approximately between 1.5 and 3 mg/mL of cDNA was 
sent to GATC (acquired by Eurofins in 2017) to be sequenced using an Illumina HiSeq 
sequencer. 
2.1.2 Upstream processing of RNA-seq data using the Tuxedo package 
FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) was used to assess the 
quality of the raw read data. We employed the pipeline outlined in Pertea et al. (2016), which 
used the HISAT2 (hierarchical indexing for spliced alignments of transcripts) package to align 
raw sequencing reads to the S. coelicolor reference genome 
(ftp://ftp.ncbi.nih.gov/genomes/refseq/bacteria/Streptomyces_coelicolor/latest_assembly_ver
sions/GCF_000203835.1_ASM20383v1/GCF_000203835.1_*). The reads were then 
assembled into full and partial transcripts with StringTie, which was also used to identify novel 
RNA isoforms. The Integrative Genomics Viewer (IGV) was then used to check for coverage 
119–121, and the number of reads was quantified using the Rsubread 3.5 Bioconductor package 
for R 122.  
2.1.3 Downstream processing of RNA-seq data using the EdgeR and Limma 
packages for R 
Downstream data analysis was carried out in R studio v3.3.2 (R v3.3.2) using the protocols 
previously laid out by Chen et al. (2016) and Law et al. (2016). The EdgeR package was used 
to filter out lowly expressed transcripts from the data which was then normalised using the 
trimmed mean of M-values method (TMM), to remove any bias created by differences in 
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library size. The pcaMethods package for R was used to cluster the data to create an 
unsupervised principle component analysis (PCA) plot. The voom function in Limma was used 
to calculate the mean-variance relationship in the data, which was then rescaled to remove this 
relationship. A linear model of the data was then created using the empirical Bayes method in 
order for us to estimate the gene-wise variability 122,123. 12 pairwise comparisons were created, 
which are listed in Table 2.1. An adjusted P-value was calculated by applying the t-tests 
relative to a threshold (TREAT) method to our data to create a stricter definition of significance 
124. TREAT combines empirical Bayes statistics with a fold-change cut-off set by the user (FC 
= 2) in order for genes to be classified as differentially expressed (DE) 123,124. All pairwise 
comparisons can be accessed at https://doi.org/10.24384/4z3s-4x55.  
2.1.4 Data clustering and functional enrichment analysis 
DEGs were hierarchically clustered based on their expression profiles using Pearson’s 
correlation algorithm. Seven clusters of similarly expressed genes were created and plotted 
onto separate graphs using ggplot2. GO analysis was carried out as previously described using 
an annotation file from the EBI website 
(ftp://ftp.ebi.ac.uk/pub/databases/GO/goa/proteomes/84.S_coelicolor.goa) 125. The Goseq 
package was used to identify any significantly enriched gene categories within each cluster 
whilst accounting for length bias. The Wallenius approximation was then used to calculate the 
number of under- and over-expressed GO categories within each cluster 125,126. All data tables 
and plots generated from this dataset can be accessed at https://doi.org/10.24384/4z3s-4x55. 
2.2 E. coli strains and culture methods 
2.2.1 Making competent E. coli cells for bacterial transformations 
Competent cells were made for DH5α and ETpUZ strains of E. coli for subsequent 
transformation steps. A modified version of the standard CaCl2 method 127 with a wash step in 
MgCl2 (100 mM) followed by suspending the cells in 2 mL of a CaCl2 (85 mM), 15% (w/v) 
glycerol buffer solution. Cells were distributed into 100 μL aliquots and flash frozen in dry ice 
for storage at -80oC. 
2.2.2 Growth conditions and storage for E. coli cells 
Stocks of E. coli were first created by streaking out the bacteria on LB agar (Table 2.2) with 
any required antibiotics (Table 2.3) and left to grow overnight at 37oC.  
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Table 2.1 Table describes the list of pairwise comparisons used in this study to identify DEGs. 
M600 represents S. coelicolor M600 wild type and VANJ represents S. coelicolor ∆vanJ 
mutant. T denotes the time in minutes after exposure to teicoplanin. 
 
Sample Comparison RNA Datasets compared 
   
M600_T90-M600_T0 A M600 T90 against T0 
M600_T90-M600_T30 B M600 T90 against T30 
M600_T30-M600_T0 C M600T30 against T0 
VANJ_T90-VANJ_T0 D ΔvanJ T90 against T0 
VANJ_T90-VANJ_T30 E ΔvanJ T90 against T30 
VANJ_T30-VANJ_T0 F ΔvanJ T30 against T0 
VANJ_T90-M600_T90 G ΔvanJ T90 against M600 T90 
VANJ_T30-M600_T30 H ΔvanJ T30 against M600 T30 
VANJ_T0-M600_T0 I ΔvanJ T0 against M600 T0 
(VANJ_T90-VANJ_T0)-(M600_T90-
M600_T0) J 








(ΔvanJ T90 against T30) against (M600T90 against 
T30) 





Table 2.2 Growth media for E. coli. 









Up to 1 L 
LB agar Agar 













Table 2.3 E. coli strains used in this study. Chloramphenicol (Chl) and kanamycin (Kan). 









F- Φ80 lacZΔM15Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17(rk-, 
mk+) phoA supE44 thi-
1 gyrA96 relA1 λ- 































Bacteria remained viable for up to a month if plates were properly sealed and stored at 4oC. 
Single colonies were picked and inoculated into LB with any required antibiotics (Table 2.3). 
Samples were grown overnight at 37oC in glass universal tubes whilst shaking at 250 rpm. No 
more than 10 mL of LB was used for each culture, ensuring sufficient aeration. Cultures were 
pelleted at 4,000 x g in an Eppendorf 5810 R desktop centrifuge and resuspended in 20% 
glycerol. If the cells were required for DNA preparation, they were resuspended in 500 µL of 
LB and half the mixture was used for DNA extraction. The remainder diluted with 40% 
glycerol. Cells were stored at -80oC for long term storage 
2.3 Construction of plasmid DNA 
2.3.1 Cloning S. coelicolor target genes into the pIJ10257 Vector 
PCR products were amplified from purified S. coelicolor genomic DNA with synthesised oligo 
nucleotides (Table 2.4) using Q5 DNA polymerase (NEB) according to the cycle and 
specifications provided by NEB for amplifying high G+C DNA sequences. PCR fragments 
were purified using the QIAquick PCR purification kit (Qiagen) and eluted in 35 μL of TE. 20 
μL of purified DNA was then digested with the appropriate restriction enzymes overnight at 
37oC, at which time digested DNA was again purified using the QIAquick PCR purification 
kit to remove all restriction enzymes and small digested fragments of DNA. Purified DNA was 
kept in TE buffer (pH 8.0) and stored at -20oC until needed.  
Vector stocks of pre-digested DNA were made by digesting 20 μL of the pIJ10257 vector with 
either NdeI and XhoI or NdeI and PacI overnight at 37oC. DNA was purified using the 
QIAquick PCR purification kit and DNA was stored at -20oC until needed. The cut vector 
remained viable for several months of use, however when transformation efficiency decreased, 
more pIJ10257 DNA was cut and purified.  
Digested PCR fragments were ligated into the pIJ10257 vector using a standard protocol for 
T4 DNA ligase (Promega) and left at 4oC overnight. For transformation, <10% the total volume 
of the DH5α competent cells were added from the ligation mixture. After incubating cells with 
the ligated plasmid for 15 minutes, cells were heat-shocked at 42oC for 60 seconds. After 
incubating cells on ice for ~60 seconds, 1 mL of LB was added to the cells, and they were then 
allowed to incubate at 37oC whilst shaking at 250 rpm for 1 hour. Serial dilutions of DH5α 
culture were set up for 101, 10-1 and 10-2.   
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Table 2.4 Primers used in this study for genetic manipulations of pIJ10257 vector and its 
derivative plasmids. 
Primer Sequence Description Size (bp) 
pIJ10257_F TGGTCGATGTCGGACCGGAG 
 
Forward sequencing primer for 
pIJ10257 
variable 
pIJ10257_R CGTCATCTCGTTCTCCGCTC Reverse sequencing primer for pIJ10258  
    













Reverse primer with XhoI 
restriction site  
SCO2335_iF GCCGGTCGCCATCAGCCTG Internal sequencing primer - 
SCO2335_iR 
 GCATCATCTTCGCGGGCAGCGTCA 














Reverse primer with XhoI 
restriction site  
SCO2807_iF 
 TCATCGGTCTCATCGGCTTCA 




















Reverse primer with XhoI 
restriction site  
SCO6355_iF 
 GTTTGCTGATCATCGCTGTCCGC 




















Reverse primer with XhoI 
restriction site  
SCO6356_F GAGTGGACGCGGTGCTGAA Internal sequencing primer - 













Reverse primer with PacI 
restriction site  
SCO6511_iF GTCTACACCGGCGTCCACTT Internal sequencing primer - 
SCO6511_iR GCCGAGGCTGAAGGTGTTCA Internal sequencing primer  
 
    













Reverse primer with XhoI 















Reverse primer with PacI 
restriction site  
SCO1660_iF CGATCTTGTAGCCGACCGTG Internal sequencing primer - 













Reverse primer with XhoI 
restriction site  
SCO1661_iF GGGGAGGGCGAAGGTGAT Internal sequencing primer - 
SCO1661_iR 
 ACGGCGACGACCAGATGAAC 
Internal sequencing primer 
  
    













Reverse primer with XhoI 













Reverse primer with XhoI 
restriction site  
SCO3910_iF AGACAACACGGTGCCTCCT Internal sequencing primer - 
SCO3910_iR ATCATGAGGATCGCCCGCA Internal sequencing primer  





900 μL of each dilution was then plated onto LB agar supplemented with hygromycin B (150 
μg/mL) to ensure sufficient inhibition of non-successful transformants.  
2.3.2 Purification of plasmids from E. coli  
Two to three colonies for each transformant were picked and inoculated into LB with selective 
antibiotic and left to culture overnight at 37oC while shaking at 250 rpm. Plasmid DNA was 
isolated using the standard alkaline lysis and ethanol precipitation method 129. To remove 
contaminating RNA, 5 μL of RNase A (10 μg/mL) was added to each sample during the lysis 
steps of the protocol. To reduce other contaminants in each solution, a phenol:chloroform (pH 
= 7.5) step was included to remove the remaining protein and lipid cell components. The 
soluble layer was transferred to a new 1.5 mL Eppendorf tube, and two volumes of 100% 
ethanol and ¼ volume of ammonium acetate were added to the tube. After several inversions, 
samples were spun at 13,000 x g for 25 minutes at 4oC using the Eppendorf 5145 R centrifuge. 
Two wash steps using 70% ethanol were then carried out on the white precipitate formed at the 
bottom of the tube. All ethanol was removed from the tube and the pellets were allowed to dry 
between 25 - 30oC ensuring no residual ethanol contamination. The pellet was solubilised in 
30 μL of TE buffer and stored at -20oC until needed.  
The UV-spectra of each plasmid solution was measured using a ThermoScientific NanoDrop 
2000c spectrophotometer to ensure the sufficient removal of all contaminating material. Each 
plasmid was then digested with the appropriate enzymes to confirm the insertion of the 
correctly sized DNA. If the expected band was present, the gene was amplified using Q5 and 
our pIJ10257 primers flanking the 5’-upstream and 3’-downstream regions of the gene. The 
PCR product was purified using the QIAquick PCR purification kit (Qiagen) and sent for 
sequencing at Eurofins genomics. If a PCR product was >700 nt, internal sequencing primers 
were designed for sequencing contiguous stretches of DNA. Contiguous reads were assembled 
using Gene Studio Professional Edition v. 2.2.0.0, and the consensus sequence was compared 
against the StrepDB BLAST database for the S. coelicolor genome. Sequences with a 100% 
amino acid match were then carried forward for conjugation into wild type S. coelicolor M600. 
All plasmid maps were generated using ApE 10.14.6 for Windows 10. The resulting plasmids 




Table 2.5 Plasmids used in this study. Hygromycin B (Hyg) and apramycin (Apr).  
Strain Description Antibiotic working concentration 
Reference/ 
Source 
    







330 bp ermEp promoter with 
ribosome binding site and 
multicloning site from 
pIJ8723 cloned into pMS81 








Hyg (100 μg/mL) 
 





pIJ10257+SCO1659  Hyg (100 μg/mL) This study 
pIJ10257+SCO1660  Hyg (100 μg/mL) This study 
pIJ10257+SCO1661  Hyg (100 μg/mL) This study 
pIJ10257+SCO2335  Hyg (100 μg/mL) This study 
pIJ10257+SCO2472  Hyg (100 μg/mL) This study 
pIJ10257+SCO2807  Hyg (100 μg/mL) This study 
pIJ10257+SCO3910  Hyg (100 μg/mL) This study 
pIJ10257+SCO6354-
53  
Hyg (100 μg/mL) This study 
pIJ10257+SCO6355  Hyg (100 μg/mL) This study 
pIJ10257+SCO6356  Hyg (100 μg/mL) This study 
pIJ10257+SCO6357  Hyg (100 μg/mL) This study 
pIJ10257+SCO6357-
53  
Hyg (100 μg/mL) This study 
pIJ10257+SCO6357-
55  
Hyg (100 μg/mL) This study 
pIJ10257+SCO6511  Hyg (100 μg/mL) This study 
    
CRISPR plasmids    
pCRISPomyces-2 
gadhp-promoter adjacent to 
BbsI cutsite and scaffold for 
gRNA. Multiple cloning site 
in lacZ gene and Apramycinr. 
Apr (50 μg/mL) 130 
pKCcas9dO  Apr (50 μg/mL) 131 
pCRvanRS-1 pCRISPomyces-2 + HA Apr (50 μg/mL) This study 
pCRvanRS-2 pCRISPomyces-2 + gRNA1 + HA Apr (50 μg/mL) This study 
pCRvanRS-2 pCRISPomyces-2 + gRNA2 + HA Apr (50 μg/mL) This study 
  
 





2.3.3 Synthesis of CRISPR plasmids targeting the vanRS cluster 
E. coli cells harbouring the Streptomyces CRISPR plasmid pCRISPomyces-2 130 were 
purchased from Addgene (#61737) and cultured to allow for the purification of a high-purity 
plasmid. The protocol laid out in Cobb et al., 2014 was followed in order to design the required 
oligos (Table 2.6) to make the guide RNA (gRNA) and homology arms (HA). The vector was 
digested with BbsI and purified as in Section 2.3.2 and then ligated overnight with the annealed 
gRNAs. The reaction mixture was transformed into DH5α, and a blue-white screen was carried 
out on LB agar + 0.5M IPTG + 20mg/mL X-gal. White colonies were selected for overnight 
culture and in L-broth + Apramycin (50 µg/mL) at 37oC. Plasmids were purified, as stated 
previously in Section 2.3.2. 
Simultaneously, two HAs were amplified from the flanking regions of the vanRS gene cluster 
and purified to a high purity as previously described in Section 2.3.1. The two amplified HAs 
were joined using golden-gate assembly, and the reaction was confirmed by gel 
electrophoresis. The desired unified fragment was excised and purified using the Qiagen gel 
extraction kit using the manufacturer’s instructions. Both HAs and the gRNA-vector backbone 
were digested with XbaI and dephosphorylated. After one final purification step using the 
Qiagen PCR purification kit, a high ratio of digested HA DNA was ligated to the gRNA-vector 
backbone overnight as previously described, followed by a transformation step. Successful 
transformants were subcultured in L-broth + Apr 50 µg/mL overnight at 37oC, and plasmids 
were extracted and purified as described in Section 2.5.2. Plasmids were confirmed by DNA 
digest with XbaI (NEB) and BamHI (NEB) as per the manufacturer’s instructions and plasmids 




Table 2.6 Primers used to engineer pCRISPomyces-2 to knockout the vanRS genes in S. 
coelicolor.  
 
Primer Sequence Description 
vanRSspcrF ACGCTGGTTGCTCACCAACGAACG Forward spacer for the gRNA 
vanRSspcrR AAACCGTTCGTTGGTGAGCAACCA Reverse spacer for the gRNA 
vanRSspcrF2 ACGCGACACTCAGCAGCTCCAACG Forward spacer for the gRNA 
vanRSspcrR2 AAACCGTTGGAGCTGCTGAGTGTC Reverse spacer for the gRNA 
vanRS_HA1F atctctagaGCGGGAGTCCGTCCAGAA 





Homology arm 1 reverse primer with 




Homology arm 2 reverse primer with 













2.4 S. coelicolor strains and culture methods 
2.4.1 Conjugation of S. coelicolor using ETpUZ 
The conjugation protocol used in this work was mainly based off work that has been laid out 
in Kieser et al. (2000) for the transfer of replicative and integrative plasmid vectors with the 
non-methylating E. coli strain ET12567 with the pUZ8002 helper plasmid (ETpUZ).  
Successfully engineered pIJ10257 vectors (Table 2.5) were transformed into chemically 
competent ETpUZ using the same protocol as previously stated for DH5α. Cells were left to 
grow on LB agar with chloramphenicol (25 μg/mL), kanamycin (25 μg/mL) and the working 
stock of the selective antibiotic for the conjugated plasmid overnight at 37oC. 
Colonies were picked the following day and cultured overnight in LB with chloramphenicol 
(25 μg/mL), kanamycin (25 μg/mL) and the additional selective antibiotic for the specific 
plasmid pIJ10257 or pCRISPomyces-2 (See Tables 2.3 and 2.5). The following morning, 
successful cultures were serially diluted to 1:100 in fresh LB with selective antibiotics and 
grown to an OD600 of 0.4-0.6, which would take approximately 6 - 8 hours. Cells were washed 
twice with fresh LB and resuspended in 1mL of LB. 500 μL of each culture was mixed with 
500 μL of 2 x YT broth containing approximately 108 S. coelicolor spores that had been pre-
germinated by heat shock at 50oC for 10 minutes. The mixture of both species of bacteria was 
serially diluted to 10-3. Both 10-2 and 10-3 dilutions were plated on SFM media and allowed to 
dry. After 16 - 20 hours, plates were overlaid with 1 mL of water containing 0.5 mg of nalidixic 
acid to kill off any E. coli and any other necessary selective antibiotics. Some antibiotics do 
not mix well with naladixic acid due to its acidity. In these circumstances, naladixic acid was 
added first, and the plates allowed to dry. Subsequent antibiotics were then added to the plates 
in the same way and allowed to dry. The plates were then incubated for seven days at 28oC. 
Several large colonies were subcultured on SFM supplemented with 0.5 mg of nalidixic acid 
and other selective antibiotics and grown for a further 7-days. Any cultures that grew poorly 
after subculturing were discarded due to their likely loss of the appropriate selective markers.  
2.4.2 Confirming the correct insertion of plasmids into S. coelicolor strains 
Colony PCRs were carried out on S. coelicolor exconjugants to confirm the expected DNA 
fragment had been inserted into its genome. The PCR was carried out using OneTaq DNA 
polymerase (NEB) using the suggested requirements for high G+C content DNA. Nonidet-p40 
(2%) was also added to the reaction mixture to help lyse the spores. A sterile toothpick or 
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pipette tip was used to lightly brush any selected colony and inoculate spores into the reaction 
mixture. DNA was visualised on an agarose (1.2%) gel. If a colony showed the correct band, 
it was subcultured to produce a lawn of mycelia that could be harvested after incubating at 
28oC, allowing spores to develop. After incubating the plates for more than a week, 1 mL of 
20% glycerol was applied to the surface of the plate, and by using a sterile cotton pad, the 
spores were gently lifted from the plate. The cotton pad with the spore suspension was inserted 
into a 2.5mL sterile syringe and the plunger depressed, ejecting the spore inoculum. Spore 
preparations were then homogenised and distributed into 50-100 μL aliquots. Working stocks 
of spore preparations could be stored at -20oC for months without a decrease in viability, 
however master stocks of each bacterial strain were stored at -80oC. All S. coelicolor strains 
and media used in this study are listed in Table 2.7 and Table 2.8.  
2.4.3 Quantification of viable S. coelicolor spores 
The viability of spore stocks was assessed using the serial dilution method, where stocks were 
diluted to 10-8 in dH2O and plated onto SFM media. Plates were incubated at 28oC for 3 – 4 
days and the number of colony-forming units (CFU) were counted, and the CFU/mL was 
determined for each stock. The CFU/mL was used to determine the required volume of spore 
stock needed to give an approximate number of spores in a sample. 
2.4.4 Antibiotic sensitivity assays of S. coelicolor strains  
Minimum Inhibitory Concentration (MIC) testing was carried out following the EUCAST 
guidelines 132. MMCGT plates were made so that they contained the desired concentration of 
each antibiotic (Table 2.9). Each spore stock was diluted in dH2O to a concentration of 2.0 x 
103 spores/μL and vigorously homogenised. 5 μl (104 spores) of each spore solution was plated 
onto each antibiotic plate as three technical repeats and allowed to dry. Plates were stored at 
28oC and scored at approximately four days. The MIC was taken to be the minimum 
concentration of antibiotic that inhibited all growth between 3 and 4 days. Three biological 
replicates were carried out for each strain and the average MIC taken for each.  
Disc diffusion assays were set up on MMCGT plates with lawns of 107 spores and allowed to 
dry. Oxoid teicoplanin 30µg disks were applied to each plate along with vancomycin papers 
disks seeded with 100µg of antibiotic using sterile forceps. Plates were scored after 3 days and 
disk inhibitory zones (DIZ) were measured using image J. Statistical analysis were carried out 
in R studio v3.3.2 (R v3.3.2).   
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Table 2.7 S. coelicolor strains used in this study. 
    Strain             Description Re                          Reference 
   
M600 SCP1- SCP2- (Kieser et al., 2000) 
J3220 ∆vanJ::apr SCP1- SCP2- (Hong et al., 2002) 
sc10257m M600 + pIJ10257 This study 
sc10257v J3220 + pIJ10257 This study 
scSCO1659m M600 + pIJ10257 + SCO1659 This study 
scSCO1659v J3220 + pIJ10257 + SCO1659 This study 
scSCO1660m M600 + pIJ10257 + SCO1660 This study 
scSCO1660v J3220 + pIJ10257 + SCO1660 This study 
scSCO1661m M600 + pIJ10257 + SCO1661 This study 
scSCO1661v J3220 + pIJ10257 + SCO1661 This study 
scSCO2335m M600 + pIJ10257 + SCO2335 This study 
scSCO2335v J3220 + pIJ10257 + SCO2335 This study 
scSCO2472m M600 + pIJ10257 + SCO2472 This study 
scSCO2472v J3220 + pIJ10257 + SCO2472 This study 
scSCO2807m M600 + pIJ10257 + SCO2807 This study 
scSCO2807v J3220 + pIJ10257 + SCO2807 This study 
scSCO3910m M600 + pIJ10257 + SCO3910 This study 
scSCO3910v J3220 + pIJ10257 + SCO3910 This study 
scSCO6354-53m M600 + pIJ10257 + SCO6354-53 This study 
scSCO6354-53v J3220 + pIJ10257 + SCO6354-53 This study 
scSCO6355m M600 + pIJ10257 + SCO6355 This study 
scSCO6355v J3220 + pIJ10257 + SCO6355 This study 
scSCO6356m M600 + pIJ10257 + SCO6356 This study 
scSCO6356v J3220 + pIJ10257 + SCO6356 This study 
scSCO6357m M600 + pIJ10257 + SCO6357 This study 
scSCO6357v J3220 + pIJ10257 + SCO6357 This study 
scSCO6511m M600 + pIJ10257 + SCO6511 This study 
scSCO6511v J3220 + pIJ10257 + SCO6511 This study 






Table 2.8 Growth Media for S. coelicolor. 







Up to 1 L 
Soy Flour Mannitol 
medium (SFM) - also 
referred to as MS 
medium 
Agar 










Glucose and Tiger 







When ready to use, add dH2O up to 1L 
Glucose (20%) 












































Minor Elements solution2 
Distilled water 
When ready to use, add dH2O up to 1L 
NaH2PO4/K2HPO4 buffer (0.1 M / pH 6.8) 
Glucose (20%) 
Pre-germinated spore inoculum 
1 mL 





2 x YT  Tryptone 
Yeast  
NaCl 










Table 2.9 Table showing the antibiotic concentrations used for MIC testing of bacteria 





Final Antibiotic Concentration (μg/mL) 























Vancomycin Transpeptidation 5.00 10.00 20.00 40.00 80.00 160.00 
Balhimycin Transpeptidation 0.50 1.00 2.00 4.00 8.00 16.00 
Chloroeremomycin Transpeptidation 0.13 0.25 0.50 1.00 2.00 4.00 

































































Ramoplanin Transglycosylation 4.00 8.00 16.00 32.00 64.00 128.00 


























































































Novobiocin DNA-gyrase 1.00 2.00 4.00 8.00 16.00 32.00 





2.5 Phylogenetic analysis of PAP2 domains 
2.5.1 Acquisition of amino acid sequences of S. coelicolor proteins with PAP2 
domains 
S. coelicolor proteins with PAP2 domains were first identified using the Uniprot and StrepDB 
databases. The boundaries for each PAP2 domain were then determined using BLAST. The 
StrepDB database was then used to search for further PAP2 domains in genes from S. lividans 
and S. venezualae. 
2.5.2 Phylogenetic analysis of PAP2 domains 
The PAP2 domains from the three Streptomyces species plus an outgroup from Bacillus subtilis 
were aligned using MUSCLE in MEGA X. A phylogenetic relationship was generated using 
maximum likelihood and 1000 bootstrap values.  
2.6 The use of a colourimetric assay to determine the 
concentration of glycerol in the growth media of S. 
coelicolor cultures 
2.6.1 Determining a standard curve for glycerol in NMMP media 
10x stock solutions of glycerol were first established by mixing >99% pure glycerol with the 
sterile NMMP culture media. The concentrations that were found to be the most suitable for 
this assay ranged between 0.01 – 0.25 mM. The reactions were optimised for volumes in a 
single 1.5mL Eppendorf tube. Solutions of sodium periodate (10mM), potassium iodide 
(40mM) and sodium thiosulfate (80mM) were all prepared on the day from powder. 0.2M 
acetylacetone was prepared weekly, and 4.0M ammonium acetate was stored between 2 – 8oC 
for up to 2 years.  
100μL of each glycerol-NMMP solution was mixed with 100μL volume of sodium periodate 
(10mM) in 1.5mL Eppendorf tubes, and the samples were put onto a 30oC shaker for 5-minutes 
at ~400rpm to ensure complete oxidation of glycerol. Samples were then immediately put on 
ice to prevent any further oxidation of glycerol. 250μL of potassium iodide (40mM) and 250μL 
of sodium thiosulphate (80mM) were then added to quench the reaction by oxidising the 
remaining periodate ions as excess periodate ions inte rfere with colour development in the 
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final reaction. 200μL of acetylacetone (200mM) and 100μL of ammonium acetate (catalyst) 
were added to tubes, and 600μL of water was added to make a final volume of 1mL. The tubes 
were then left to develop for 10 minutes on a 50oC heat block. Tubes were then put in ice. The 
absorbance of each sample was read at 410nm on a ThermoScientific NanoDrop 2000c 
spectrophotometer using the cuvette feature. A negative baseline control with no glycerol was 
used to adjust the absorbance values for any background noise. All plots were then generated 
using the ggplot2 package in R.  
2.6.2 Establishing growth kinetics of S. coelicolor 
Growth curves were carried out on both M600, and ΔvanJ strains to identify the early to the 
mid-log phase of growth (OD540nm = ~0.4) in liquid cultures. 103 spores were first spun down 
to remove any glycerol as this can inhibit germination. Spores were then germinated in 625μL 
of 2 x YT media at 50oC for 10 minutes. Cells were then cultured in the same way as previously 
described for RNA extraction in Section 2.1.1. The OD of each culture was then read at 0, 12, 
15, 18, 24, 36 and 48h. Each culture took approximately 12.5h to read an OD540nm = ~0.4.  
2.6.3 Establishing a colourimetric test to determine the glycerol 
concentration produced by cultures of S. coelicolor after exposure to 
different antibiotics 
For each colourimetric assay, cultures were set up in the same way as previously described in 
Section 2.1.1. A negative control at 0 minutes was used before the addition of antibiotics, 
which were then added once cell densities reached an OD540nm = ~0.4 (Table 2.10). 1mL of 
each sample was taken at 2 and 4h and spun down at 4oC for 10 minutes. Three technical 
replicates were tested from each sample by taking 100µL of the supernatant forward for the 
colourimetric test described in Section 2.5.1. The absorbance at OD410nm was adjusted for the 
baseline, and the glycerol concentration was estimated using the NMMP + glycerol standard 
curve. Each experiment was repeated three times to generate an average value for three 
biological replicates and plots were generated using ggplot2 in R. 
Dosage effects from teicoplanin and kanamycin were identified in the same way as in Section 
2.5.3, but cells were treated with 0.1, 1.0 and 10 µg/mL of antibiotic instead. Each experiment 
was repeated three times to generate an average value for three biological replicates and plots 
were generated using ggplot2 in R.  
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Table 2.10 Antibiotics concentrations used in the colourimetric assay to determine the 




Teicoplanin 0.1, 1.0 and 1 0µg/mL Transglycosylation/ 
transpeptidation 
Sigma-Aldrich 
Bacitracin 50 µg/mL UPP 
dephosphorylation 
Sigma-Aldrich 
Ramoplanin 10 µg/mL Transglycosylation Sigma-Aldrich 






Chapter 3. Preparation of RNA-seq Data 







3.1 Introduction  
Understanding how organisms respond and adapt to their environment has been at the core of 
gene expression studies since the discovery that mRNA was involved in functional changes 
within cells. Advances in studying changes in RNA through the advent of probe-based 
technologies like microarray and more recently next-generation sequencing technologies have 
increased our understanding of the complexities of the regulatory networks that are involved 
in the cellular response to internal and external stimuli 133–138. Older technologies that required 
intimate prior knowledge of both the genome sequence and the organisation of gene 
transcription were inherently limited by both their dynamic range and susceptibility to signal 
noise. Next-generation sequencing (NGS) technologies involving amplification of cDNA 
libraries has revolutionised studying the transcriptional changes, as RNA-seq can be performed 
without any prior knowledge of functional sequences, has a superior dynamic range and low 
background noise 135,137,138. 
Although NGS has resolved some issues found in earlier technologies, some considerations 
still need to be addressed to ensure the quality of any RNA-seq dataset (Table 3.1). Currently, 
a consensus is building around a small number of RNA-seq methodologies for carrying out DE 
analysis. Even though this is the case, choosing the appropriate pipeline and carrying out the 
necessary quality control (QC) checks is a necessity for generating reliable data. It is also 
pertinent that RNA-seq studies be followed up with further experimental evidence from 
proteomics, metabolomics, or any other molecular technique that can give further support for 
conclusions made from a dataset 139. 
This chapter focuses on the pre-processing of an RNA-seq dataset generated from RNA 
extracted (by Dr Hee-Jeon Hong) from S. coelicolor M600 and ΔvanJ before and after exposure 
to teicoplanin. Here we discuss the quality control (QC) checks carried out on the 
transcriptomic dataset and the two methods used to identify differences in how teicoplanin 




Table 3.1 Table listing QC steps necessary to ensure quality in RNA-seq analysis. 
Limitations of RNA-seq Measures to remove bias 
Sample preparation 
Introduction of unwanted non-coding 
rRNAs 
 Deplete samples of rRNA using a 
specialised kit 
Reproducibility  Carry out >2 biological replicates for each 
sample. 
 Include technical replicates 
 Random sample prep. 
 
RNA-seq and pre-analysis 
Coverage of the whole transcriptome  Sequence to a greater depth. 
 Sequence longer reads.  
Read quality  QC checks of raw data to check for 
sequencing defects, failure to remove 
adapter sequences or contamination. 
 Filter out poorly sequenced reads. 
 
Read bias from lowly expressed 
transcripts 
 Filter out sequences that are poorly 
expressed. 
Core analysis  
Library size bias  Convert raw counts to a scale that accounts 
for differences in library size (CPM and 
log-CPM). 
 Normalise gene expression distributions. 
 
Reproducibility in data  Carry out unsupervised/supervised cluster 
analysis. 
False positives for differential 
expression analysis 
 Use an appropriate statistical method to 







Figure 3.1 Flow chart for the pipeline used in this thesis from RNA-preparation to functional 
analysis   
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3.2 Results  
3.2.1 Examination of the RNA-seq data indicated that it was high quality 
The FastQC tool was used to assess the quality of our raw data. All reports can be accessed 
online (https://doi.org/10.24384/4z3s-4x55) and all had Q-scores >30, indicating that the 
probability of incorrectly called bases for any of the reads was low (Figure 3.2B). None of the 
FastQC reports indicated any unexpected issues with the raw data, and the average library size 
contained 15,644,262 (SD = 2,886,645) reads. The average read length was 51, with no 
contamination from adapter sequences detected. There were 0 poorly detected reads and 0 
bases with Ns called (Table 3.2). Over 95% of these reads were aligned to 8,677 sites on the 
latest reference genome available for S. coelicolor. 8,298 of these were open reading frames of 
genes, 14 were unknown intergenic regions, 342 asRNAs and 23 possible polymerase run-on 
fragments.  
3.2.2 QC checks to address bias prior to DE analysis 
435 of the 8,677 annotated genomic elements were removed from the analysis as they were not 
expressed in any sample. Any transcript that was not expressed to a biologically significant 
level, which was defined as 1 count per million (cpm) in 4/12 samples, was also removed from 
the data (Figure 3.3A and B). The remaining 7,756 genes were used for differential expression 
analysis testing. Both samples VANJ_T30_A and VANJ_T30_B had a higher density of reads 
than the other libraries. To account for differences in library sizes, each sample was normalised 
using the TMM, and the differences between pre- and post-normalisation distribution can be 
seen in Figure 3.4 along with the scaling factors.  
A mean-variance relationship of log-CPM values was created to check for biological variation 
and to indicate whether poorly expressed genes had been adequately filtered in earlier steps. 
From this, a ‘variance modelling at the observational level’ (voom) plot was created. The data 
showed low biological variation as emphasised by the steep trend represented by the LOWESS 
curve in Figure 3.5A. Figure 3.5B validates that the relationship between the mean and 






Figure 3.2 An example FastQC report showing one of the QC checks that FastQC performs 
on base sequence quality. One low-quality data set taken from the FastQC manual (A) is shown 
against a report for sample M600_T0_A from the RNA-seq data used in this study (B). The 
graphs show the quality scores on the y-axis. The y-axis is divided based on quality, with red 

































Figure 3.3 Plots show the density of transcripts before (A) and after (B) filtering data for lowly 








Figure 3.4 Plots (A) and (B) show how normalising data using the TMM method brings the 
distribution of the data more in line with the median for all samples. The numbers indicate the 




Figure 3.5 Voom plot (A) showing the mean-variance relationship of RNA-seq data with the 
LOWESS trend shown as a red line. (B) shows how the trend is removed with the addition of 
voom’s precision weights. The blue line represents the average log2 residual standard 
deviation. Each black dot represents a single gene  
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An unsupervised principal component analysis (PCA) was carried out to assess the similarity 
between samples (Figure 3.6). Unsupervised clustering indicates how much differential 
expression might be detected between two samples. If two points cluster, then there is low 
biological variation 140. PC1 separated data based on strain while PC2 based on time. Together 
they show 84.5% of the variation within these data, so are likely to contribute to differences 
seen in expression 123. As expected, replicates cluster closely together, showing that they have 
little variation, giving us more confidence in our two replicates. We can see from the PCA that 
there are some differences between the two strains at 0 minutes. For the wild type M600 strain, 
both the 30 and 90 minute time points cluster closer together than the 0 minute time point. The 
90 minute data point for ∆vanJ clusters close to the 30 and 90 minute data for the M600, but 
interestingly, there is a large amount of variation between the 30 minute data points for ∆vanJ, 
strongly indicating that this time point in ∆vanJ shows more variation to the 30 and 90 minute 
time points of M600 and the 90 minute time point of ∆vanJ. In all PCAs carried out, replicates 
clustered together. 
3.2.3 The TREAT method conservatively reduces the number of genes 
classified as DE in order to identify biologically meaningful changes in 
expression 
Statistical methods that are used to define DE are good at identifying when expression is 
different from 0, but this does not always equate to a meaningful biological outcome. The 
TREAT method applied in this work allows one to assign statistical significance (P-value 
<0.05) to identify DEGs while also applying a biologically meaningful threshold which in the 
case of this work, was a fold-change of 2 124.  This extension to an earlier empirical Bayes 
moderate t-statistics method 141 is more successful at identifying DEGs with biological 
significance 124 and helps to reduce FDR.  
Pair-wise comparisons were set up between our datasets to identify any changes in expression 
between samples. We generated three groups of pairwise-comparisons between time points for 
both strains (Table 3.3 comparisons 11A-F); pair-wise comparisons of individual time points 
between the strains (Table 3.3 comparisons 11G-I); and pair-wise comparisons between the 
comparisons of time points within a strain (Table 3.3 comparisons 11J-L). The DEGs (adjusted 
P-value <0.05, fold-change cut-off = 2) from each comparison are listed in Table 3.3, along 






























Figure 3.6 A PCA where PC1 represents strain and PC2 represents time. The amount 
contributed to variation is indicated in the brackets. Time is indicated as different shapes and 
strain is represented by either pink (M600) or blue (ΔvanJ).  
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Table 3.3 Table showing each pair-wise comparison and the number of genes identified as 
either positively or negatively DE before and after the application of the TREAT method using 








Application of the TREAT method sharply reduces the number of DEGs for all comparisons. 
Comparison B drops from 3,513 DEGs to 157 or 4.3% of the DEGs called initially.  In contrast, 
the number of DEGs for comparison E is reduced from 6,899 to 3,653 or 52.9% of the DEGs 
called initially. Together these data support the conclusions made from the PCA; there is less 
variation between the 30 and 90 minutes time points in M600, but there is much variation 
between the 30 and 90 minute time points in ΔvanJ. We suggest that the two strains respond 
to teicoplanin differently when looking at comparisons G-I which compare the individual time 
points. When comparing the 0 and 90 minutes (Comparisons I and G), there are 294 DEGs 
between the 0 minute time points and 178 between the 90 minute time points. However, there 
are 4,322 DEGs between the 30 minutes time points (Comparison H), highlighting how much 
variation there is between these datasets. The gene lists created for each comparison can be 
viewed online (https://doi.org/10.24384/4z3s-4x55).  
3.2.4 Biological interpretation of DEGs using hierarchical clustering and 
functional enrichment analysis 
RNA-seq produces large amounts of data. Sorting through all this information can be 
challenging for anyone trying to identify any functional relationship with the data. Although 
considering genes significantly up- or down-regulated can reveal genes involved in a response, 
the process can be labour-intensive and fail to draw any functional relationships between data. 
A more holistic approach that takes into consideration all the genomic information generated 
in an experiment is to cluster genes based on their expression patterns. The two primary 
clustering methods include partitioning such as k-means and hierarchical clustering which 
groups genes into clusters to form a dendrogram that can be ‘cut’ at a user-determined place to 
generate the cluster groups 142–144. The later was implemented in this work, exploiting the pair-
wise relationships generated in the previous section to assess the similarity between genes over 
the time-course.  
The most significant ~1,500 DEGs were hierarchically clustered (Figure 3.7) together into 
seven distinct clusters (Figure 3.8). Replicates resembled each other, and the clusters were 
broadly grouped into four categories based on their response to teicoplanin. This included: 
M600/ΔvanJ downregulated (Cluster 1), M600/ΔvanJ upregulated (Clusters 3, 5 and 7), M600 
constitutive/ΔvanJ upregulated (Cluster 2) and M600 constitutive/ΔvanJ downregulated 











Figure 3.7 Hierarchical clustering of the 1,557 most significantly DE genes presented as a heat 
map with the strain and time indicated above. The dendrogram on the left highlights how the 
clusters were grouped. To the right of the figure are some of the most significantly enriched 
functional groups pulled out of the data during the GO analysis. GO number, adjusted P-value 





Figure 3.8 The average log2 expression for each replicate of the identified DE genes, clustered 
together based on expression profile for M600 and ΔvanJ (VANJ) strains. Each gene is plotted 
against time in minutes. Numbers above each plot indicate the cluster number and numbers in 
the bottom right indicate the number of genes in each cluster.  
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The genetic profile of genes at the 30-minute time point in ∆vanJ are more strongly 
downregulated in Clusters 1, 4 and 6 than in M600, while genes in Cluster 2 are induced 
exclusively in ΔvanJ. This confirms our hypothesis that most of the variation observed occurs 
at the 30-minute time point. It is also clear that Cluster 3 and 5 are both induced at a slower 
rate in ΔvanJ than observed in M600 (Figure 3.8). 
The main benefit of clustering data allows for the association of genes that are regulated 
similarly, as genes that are more similarly regulated are likely to have related functions within 
the cell. Therefore, if a particular cluster is enriched for specific functional groups, that 
functional group may be necessary under a particular condition depending on the expression 
level. In this work, we used a GO database to assign the current functional knowledge for S. 
coelicolor genes, or gene products to the cluster analysis to provide information about how 
genes function, where their function is located and what biological pathways they are involved 
with (http://geneontology.org/docs/go-annotations/)126.  
The DEGs from the enrichment analysis for each GO term will be discussed in more detail in 
the following chapter, but some of GO terms that were enriched for particular genes are 
displayed in Figure 3.7. Cluster 1 and 6 were highly-enriched for key pathways for active 
growth involved in the production of biomass. Cluster 2 and 4 were highly-enriched for genes 
relating to phosphopantetheine binding, fatty acid oxidation and amino acid metabolic 
processes. Clusters 3, 5 and 7 were highly-enriched for genes relating to amino acid metabolism 
for histidine, tyrosine and arginine, cell signalling including genes for sigma factors and protein 
serine/threonine kinases (STKs) and glycerol-3-phosphate metabolism. Together, data on 
Clusters 1, 6 and 7 indicate that there is possibly a shift away from processes that are involved 
in primary metabolism and the production of biomass. Simultaneously, Clusters 3 and 5 
indicate that there may be profound changes on larger parts of the transcriptome as we also 
observed changes in the expression of genes associated with cell signalling processes. 
3.3 Summary 
In the last few years, a consensus on a few effective methodologies for carrying out RNA-seq 
analysis has been established. There are several crucial steps that need to be carried out during 
any RNA-seq pipeline to ensure the reliability of the data, and this section discussed what steps 
were carried out to ensure this 123,139,145.  
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Reassuringly, the FastQC reported no problems with the raw RNA-seq data, indicating that 
there were minimal problems with RNA extraction, cDNA library preparation or sequencing. 
The average library size was 1.56 x 107 reads with VANJ_T30_A and B having the highest 
number of reads out of the 12 samples. 921 genes were removed before any analysis for either 
not being expressed at all or for not being expressed at a biologically meaningful level, reducing 
interference with statistical analysis 122. Differences in library size were accounted for by 
normalising each library using the TMM method, which brought the distributions of 
VANJ_T30_A and B in line with the other samples. The heteroscedasticity of the data was 
removed by applying voom to the data so that the mean-variance relationship was removed, 
allowing the application of Limma-based statistical analysis on the data.  
The unsupervised PCA showed that repeats clustered together, demonstrating that there was 
little variation between replicates. Most of the variation between the two strains occurred at the 
30-minute time point, immediately after the cells were exposed to teicoplanin. This indicates 
that basal levels of VanJ in the membrane of M600 was enough to influence gene expression. 
Supporting this, differential expression testing was carried out on pair-wise comparisons using 
the TREAT method in the Limma pipeline. This method required both a fold-change cut off 
(2-fold) and a P-value (<0.05) threshold for a gene to be classified as DE. This made it easier 
to focus in on the most significant changes in gene expression. Comparison H, comparing 
M600 and ΔvanJ at 30-minutes, supported this with the most significant number of DEGs 
shown in this comparison.  
The most significant DEGs were hierarchically clustered to produce seven distinct clusters 
based on the expression patterns of each gene in both strains. Genes in Cluster 1 were found to 
be downregulated more substantially in ΔvanJ than M600, while Clusters 2, 4 and 6 only 
showed changes in activity in ΔvanJ, providing an explanation as to why most of the variation 
between the two datasets occurs at 30 minutes. Genes in two of the largest clusters, Clusters 3 
and 5, were also induced more slowly in ΔvanJ demonstrating the profound effects that the 
loss of VanJ has on S. coelicolor gene expression immediately after exposure to teicoplanin.  
Higher biological functions were also assigned to genes within each cluster using a GO 
database. Some of the functionally related genes identified from the GO analysis included the 
genes relating to primary metabolism such as DNA replication, glucose metabolism and 
ribosome biogenesis which were all downregulated. Clusters enriched for genes assigned to 
ontologies relating to both phospholipid and PG biosynthesis were also found to decrease in 
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activity in response to teicoplanin. In contrast, clusters enriched for genes relating to amino 
acid metabolism, glycerol metabolism and cell signalling were all upregulated.  
In conclusion, we have demonstrated that the quality of this dataset was suitable for differential 
expression analysis. The following sections will address the conclusions made from this data 
followed with the experimental data for testing whether any of the DEGs are involved in 




Chapter 4. Interpretation of the Different 
Responses of the M600 and ΔvanJ Mutant 







The dedicated glycopeptide resistance system in S. coelicolor has been extensively studied, 
which provides high -level resistance to vancomycin-like glycopeptides when induced 110. 
Additional work has also demonstrated the importance of the regulons of genes relating to 
oxidative 146,147, osmotic 147, and nutritional stress 148 in S. coelicolor in aiding the adaptive 
responses to antibiotics, and how there is often overlap with these regulons and resistance 
systems in bacteria 149.  
Most notably, the cell envelope stress regulon is vital for normal cell envelope function. 
Although studied for nearly two decades, the regulon has only recently been published for S. 
coelicolor 150. The regulon is controlled by the global transcription factor σE, which is regulated 
at the level of transcription by the TSC, CseBC 151. Unlike VanRS, which is induced by specific 
glycopeptide antibiotics, the CseBC signal transduction system is broadly activated by a range 
of compounds that affect the integrity of the cell envelope 151. σE mutants also exhibit 
developmental defects and require high levels of magnesium for growth and disruption of any 
of these genes increases sensitivity to muramidases 152.  
Although the specific mechanism by which CseBC sensing damage to the cell envelope is 
unknown, the majority of the genes within this regulon have a predicted function targeting the 
cell envelope 150. This includes genes involved in PG assembly such as PBPs, cell wall teichoic 
acid deposition, sporulation and membrane modification and maintenance. Although not fully 
understood, the interplay of these systems along with dedicated resistance mechanisms has 
been suggested as a method of maximising resistance to antibiotics.  
Transcriptomic studies have been useful in establishing the relationships between bacterial 
stress regulons and antibiotics by providing a method for identifying how drugs influence 
biological processes 149,153,154. In this study, we wanted to understand how the presence of vanJ 
influences the genome-wide expression of genes in S. coelicolor compared to a ΔvanJ null 
mutant. In the previous section, we discussed how even the minimal induction of vanJ by 
teicoplanin was enough to considerably impact the gene expression of M600 in comparison to 
ΔvanJ. In this chapter, we discuss which genes and regulatory systems are impacted by 
teicoplanin. We also explore how different regulatory systems are affected between the two 
strains to provide some further information about a possible role for VanJ. Using literature on 
the homeostasis of the S. coelicolor cell envelope, several subsets of genes were selected to 
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carry forward for further functional characterisation to validate whether they had a specific role 
in resistance. Data tables for this section can be found in Appendix 1. 
4.2 Results 
4.2.1 Teicoplanin induces the expression of many genes known to have roles 
as transcriptional regulators   
Transcriptional regulation involves any method that a cell uses to regulate the synthesis of RNA 
from DNA. Although bacterial regulatory networks are less complex than eukaryotic signalling 
cascades, bacteria dedicate a large proportion of their genomes to the regulation of 
transcription. Approximately 900 gene products (12%) of the S. coelicolor genome is predicted 
to be involved in transcriptional regulation 155, including over 60 sigma factors, 79 TCSs and 
40 serine/threonine kinases (STKs) 156,157. Such regulatory capabilities have likely evolved to 
allow S. coelicolor to strictly regulate the complex mechanisms involved in morphological 
development and adapt to the fluctuating soil environment.  
Clusters 3 (GO:0016987, P-value = 1.00 x 10-3) and 5 (GO:0016987, P-value = 1.70 x 10-2)  
from the GO analysis had genes that were significantly enriched for ‘sigma factor activity’ 
(Figure 4.1). σ-factors are fundamental in directing RNA-polymerases to specific promoter 
sites to regulate the expression of related groups of genes that carry out a particular function 
within the cell 156. Well characterised sigma-factors involved in responding to cellular stress 
include a series of genes encoding σE (SCO3356), σQ (SCO4908), σR (SCO5216), σB 
(SCO0600), σL (SCO7278), and σM (SCO7314) that were all significantly upregulated in both 
strains. The σQ gene was the most strongly induced gene, increasing by 54 - 180 fold in both 
strains. This sigma factor has been previously implicated in morphological development and 
negatively regulating antibiotic production 158. σR is implicated in disulphide stress caused by 
oxidative damage 146 while σB, σL, and σM form a regulatory cascade with σB as the master 
regulator. The cascade regulates genes involved in differentiation, osmotic and oxidative stress 
responses in S. coelicolor 147,156. All these sigma factors showed a decline in activity in M600 
during later time points, suggesting that the inducers for these cascades had declined in activity.  
As expected, the cell envelope signal-transduction system was also strongly induced in both 










Figure 4.1 Teicoplanin induces genes involved in cell signal transduction in both strains. 
Expression profiles show genes encoding sigma factors, SigE signal transduction system and 
STK activity in S. coelicolor are presented. Time in minutes is along the x-axis, and average 
log2 abundance is along the y-axis. Each point is the average of two replicates.  
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Glycopeptide antibiotics are known to be potent inducers of the CseBC TCS, but the expression 
of this system typically declines after exposure to glycopeptide antibiotics that can also induce 
VanRS such as vancomycin. It is believed that this occurs because the expression of VanHAX 
alleviates the strain put on cells by the offending glycopeptide. The same response is not 
observed here presumably because there is minimal activation of the VanRS TCS by 
teicoplanin in M600. The response seen in ΔvanJ was strikingly different with a slower 
increase in activity over the 90 minutes, indicating that the weak induction of VanJ in M600 
could possibly promote the activation of the σE signal transduction system during earlier time 
points (Figure 4.1). But, as there is still induction of the σE signal transduction system in ΔvanJ, 
there are likely to be additional mechanisms that lead to the activation of this regulatory system 
in the presence of teicoplanin.  
Cluster 5 was enriched for genes predicted to encode ‘STK activity’ (GO:0004674, P-value = 
4.95 x 10-2) which are also involved in signal transduction within bacteria. They resemble the 
eukaryotic STKs (or Hanks-type kinases) that phosphorylate serine or threonine residues when 
activated 157,159,160. All genes within this ontology were significantly upregulated in both strains 
(Figure 4.1). These genes included pkaF (SCO2110) which has previously been characterised 
in S. coelicolor and encodes a sensory penicillin-binding associate serine/threonine kinase-
associated (PASTA) domain. pkaF has been implicated in negatively regulating the 
development of aerial hyphae, and actinorhodin production 161 and likely senses an 
environmental cue relating to PG due to predicted PASTA domain. These genes also exhibited 
delayed activation in ΔvanJ which also suggests that VanJ could be partially involved in 
triggering their activation and demonstrates the importance of VanJ during the response to 
teicoplanin.  
4.2.2 Exposure to teicoplanin affects the expression of genes involved in 
growth, metabolism and morphological development in S. coelicolor 
Genome-wide studies on cell wall targeting antibiotics have begun to unearth the systematic 
effects of antibiotics on cells, with resulting metabolic downshifts and decreased expression of 
genes involved in cellular growth and the upregulation of genes involved in the cell-envelope, 
osmotic-shock, heat-shock, redox-stress and the stringent stress-responses. There is also a 
commonality of the responses between antibiotics with different targets demonstrating the 
importance of these regulons during times of cellular stress 149,162. In this section, we explore 
how the characteristic signs of some of these biological processes are less evident after 
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exposure to teicoplanin in M600, emphasising the protective role VanJ provides against 
teicoplanin.  
4.2.1.1 The expression of genes relating to the ribosome and protein synthesis is 
significantly different between the M600 and ΔvanJ mutant 
Most genes encoding the 30S and 50S ribosome subunits except rpmF2 (SCO0436), rpmG3 
(SCO0570) and rpmE2-2 (SCO3427) were significantly downregulated in the ΔvanJ mutant by 
approximately 2 - 10 fold at 30 minutes. In contrast, only 14 out of 56 genes were significantly 
downregulated in M600 (Figure 4.2). Interestingly, the expression level of all these genes was 
quickly recovered in ΔvanJ after 30 minutes (Figure 4.2) suggesting that protein synthesis may 
have been rapidly arrested, and then restarted after the initial exposure to teicoplanin.  
Other groups of genes with predicted roles in ribosome biogenesis were also affected by 
teicoplanin. Clusters 1 (GO:0043022, P-value = 9.3 x 10-3) and 3 (GO:0043022, P-value = 9.31 
x 10-3) had genes enriched for ‘ribosome binding’ (Figure 4.2). Genes found in Cluster 1 
include infC, prfB, infA and prfA which encode factors involved in peptide chain elongation at 
the ribosome and their expression levels were also significantly downregulated during earlier 
time points followed by rapid recovery at 90 minutes only in ΔvanJ. Three genes were 
significantly upregulated by between 6.6 - 28.2 fold in both strains. These encoded the 
ribosome hibernation factor, hpf (SCO3009), SCO4278 which is predicted to encode the 
peptide chain release factor, and a GTPase with a predicted role in protein synthesis hflX 
(SCO5796).  
Teicoplanin also caused an increase in the expression of genes relating to stable RNAs. Cluster 
5 was over enriched for genes within the ontology ‘non-coding RNA (ncRNA) processing’ 
(GO:0034470, P-value = 3.7 x 10-2) with genes predicted to be involved in modifying the 
structural properties of rRNA. The expression of these genes increased by 1.8 - 6.7 fold in both 
strains. SCO2533 and SCO2599 were predicted to encode endoribonuclease activity involved 
in 16S ribosomal RNA (rRNA) maturation. SCO5708 is predicted to encode a ribosome 
binding factor involved in pre-processing of rRNA 163 and SCO5709 encodes a pseudouridine 
synthase which is involved in the modification of rRNA to convert uridine to pseudouridine. 
Psuedouridines are the most common modification seen in structural RNAs and are vital for 




Figure 4.2 The effects of teicoplanin on the expression of genes involved in proteins synthesis. 
Expression profiles show genes encoding the 30S and 50S subunits of the ribosome, ribosome 
binding proteins, ncRNA processing proteins and tRNA-synthetases in S. coelicolor are 
presented. Time in minutes is along the x-axis, and average log2 abundance is along the y-axis. 
Each point is the average of two replicates.  
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Some other genes encoding proteins which are involved in the synthesis of other stable RNAs 
were also affected by teicoplanin (Figure 4.2). SCO3397, encoding the lysyl-tRNA synthase 
(mprF), was upregulated by 2.9 - 11.8 fold in both strains. While the expression of the gene 
encoding threonyl-tRNA synthetase, SCO3778, was also upregulated by 8.7 - 13 fold in both 
strains.  
Here we present evidence that processes involved in protein synthesis and stable RNAs are 
affected in both strains. The changes in ribosome biogenesis are transient but are more strongly 
affected in VanJ in the first 30 minutes. This also includes three Cluster 3 genes encoding 
ribosome-binding proteins, all five genes encoding ncRNA processing proteins and SCO3397 
encoding the lysyl-tRNA synthase (Figure 4.2). SCO5708, SCO5709 and SCO5796 have all 
been implicated in the oxidative stress regulon and found to be under the control of σR 165. Two 
tRNA-synthetases discussed here, mprF and SCO3778, are also implicated in antimicrobial 
resistance. SCO3778 is essential for resistance to the macrolide antibiotic borrelidin in E. coli 
149,166. It may also have a similar role in protecting S. coelicolor from the damaging effects of 
one of its own polyketide natural products, actinorhodin (ACT). mprF has been well 
characterised in several bacteria including B. subtilis, Listeria monocytogenes and S. aureus 
and is known to add lysine groups to phospholipids. These modifications decrease the overall 
net negative charge of the membrane, repelling antimicrobial peptides and membrane targeting 
antibiotics such as daptomycin 53,66,167,168. This gene also belongs to the σE regulon and is 
essential for maximal resistance to both vancomycin and bacitracin in S. coelicolor, so this 
gene likely has a vital role in protecting the cell envelope from teicoplanin 149,150.  
4.2.1.2 Teicoplanin leads to a reduction in the expression of genes relating to carbon 
utilisation and DNA replication  
There were significant decreases in the expression of genes relating to carbon utilisation and 
DNA replication in both wild type M600 and ΔvanJ mutant. Although expression levels were 
quickly recovered after 30 minutes, more of these genes were only significantly downregulated 
in ΔvanJ when compared to M600 (Figure 4.3 and 4.4). All the genes enriched for ‘glycolytic 
process’ (GO:0006096, P-value = 1.72 x 10-5), were found to be DE in ΔvanJ and were 
downregulated by approximately 5 fold in the first 30 minutes. There were proportionally more 
genes also significantly downregulated which related to the ‘tricarboxylic acid cycle’ 
(GO:0006099, P-value = 3.48 x 10-5), ‘ATP synthetase complex’ (GO:0045259, P-value = 7.17 
x 10-10) and ‘pigment biosynthetic process’ (GO:0046148, P-value = 1.98 x 10-6) in ΔvanJ than 
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M600. Genes significantly enriched for the functional process ‘pigment biosynthetic process’ 
encode functions related to heme-production for the cytochromes which are involved in 
oxidative phosphorylation along with genes in making up the ATP synthase 169. These genes 
were downregulated by between 1.25 - 5 fold during the first 30 minutes after exposure to 
teicoplanin in both strains (Figure 4.3).  This suggests that both anaerobic and aerobic stages 
of respiration are affected in ΔvanJ, but anaerobic respiration may continue in M600. This may 
relate to the increased levels of cellular stress in relation to oxidative damage in ΔvanJ 
immediately after exposure to teicoplanin.  
Cluster 1 was also enriched for genes with functions that relate to DNA biosynthesis, including 
‘DNA replication’ (GO:0006260, P-value = 2.1 x 10-3), ‘DNA topoisomerase activity’ 
(GO:0003916, P-value = 1.21 x 10-5) and ‘quinolate synthetase A’ activity (GO:0008987, P-
value = 0.01). They were all significantly downregulated in ΔvanJ by between 2.5 - 10 fold, 
but only genes encoding the ribonuclease HII rnhB, (SCO5812), and a DNA gyrase-like protein 
(SCO5836) were significantly downregulated in both strains (Figure 4.4). This information, 
along with the data on genes functionally involved in carbon utilisation further support the 
hypothesis that processes relating to growth are more strongly affected in ΔvanJ when 
compared with M600. We suggest that a likely explanation for this is that the ΔvanJ strain is 
unable to cope with the increased cellular stress and resources are likely diverted away from 
active growth.  
4.2.1.3 Teicoplanin induced genes involved in the biosynthesis of arginine 
Genes involved in the biosynthetic pathway that converts L-histidine to arginine were strongly 
induced in response to teicoplanin. This process first begins with the conversion of L-histidine 
to L-glutamate. Cluster 7 was over- enriched for genes relating to ‘Histidine catabolic process’ 
(GO:0006548, P-value = 1.09 x 10-5) (Figure 4.5A) which included hutH, hutU and hutI. hutI 
was significantly upregulated by 3.8 fold in ΔvanJ, while hutU was upregulated by 3.2 fold in 
M600 (Figure 4.5B). A significant increase of hutH was observed in both strains by 
approximately 2 fold at 30 minutes. (Figure 4.5A). The remaining genes in this pathway were 
found in Cluster 3, which was enriched for genes in the ‘arginine biosynthetic process’ 
(GO:0006526, P-value = 1.51 x 10-7) (Figure 4.5B). All the arg genes were upregulated at 30 
minutes by approximately 5 - 30 fold in both strains and suggests that teicoplanin induces the 
shift in metabolism. In bacteria, arginine is a hub-metabolite, and it has been found to increase 











Figure 4.3 The outcome of exposure to teicoplanin on the expression of genes involved in 
carbon utilisation. Gene expression profiles for the ontologies: glycolytic process, tricarboxylic 
acid cycle, protein-transporting ATP synthase complex and pigment biosynthetic process. 
Time in minutes is along the x-axis, and average log2 abundance is along the y-axis. Each point 















Figure 4.4 The effects of teicoplanin on the expression of genes involved in DNA replication 
and biosynthesis. Gene expression profiles for the ontologies: DNA replication, DNA 
topoisomerase activity, and quinolinate synthetase A activity. Time in minutes is along the x-






Figure 4.5 Teicoplanin leads to the induction of genes involved in the pathways involved in 
the synthesis of arginine. (A) Metabolic pathway of the conversion of histidine to L-glutamate 
for S. coelicolor. Solid arrows indicate characterised steps with known genes, and dashed 
arrows indicate unknown mechanisms. Coloured arrows indicate the direction of expression 
after exposure to teicoplanin. Purple arrows indicate DE in both strains. Green arrows indicate 
DE in just the ΔvanJ mutant. (B) Expression profiles for the genes encoding the enzymes 
involved in the conversion of histidine to glutamate (left). The gene expression profile for the 
ontology arginine biosynthetic process is also shown (right). Time in minutes is along the x-
axis, and average log2 abundance is along the y-axis. Each point is the average of two 
replicates.   
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This metabolite is also a precursor for ectoine and the polyamines which are osmoprotectants 
in S. coelicolor. The polyamines have also been documented to protect cells against reactive 
oxygen species 171, which could suggest that arginine may be vital for protecting cells against 
the increased cell envelope stress caused by teicoplanin.    
 
4.2.1.4 Induction of genes involved in the synthesis of the hydrophobic coat of the aerial 
mycelium 
Streptomyces sp. exhibit complex life cycles with several distinct differential stages, preferring 
growth on solid substrates, which most likely emulates their environmental niche at the 
water/air and soil interface 60,172. Aerial hyphae must undergo several crucial checkpoints 
before differentiating into chains of unigenomic pigmented spores 173 which can be 
disseminated into the environment and germinate into new mycelium when the conditions are 
right. Vegetative mycelia are hydrophilic structures that ‘explore’ the damp environment of the 
soil in search of nutrients. However, as they differentiate into their reproductive life cycle, they 
develop a hydrophobic coat around their aerial mycelia to support their escape from the damp 
soil environment into the air. The hydrophobic coat, referred to as the rodlet layer, is essential 
for the formation of aerial mycelia and mature spores. It consists of a mosaic-like structure 
made up of chaplins, rodlins and SapB that are encoded for by the chpA-H, rdlAB and 
ramCSABR genes respectively with the bld genes playing a role in regulating differentiation 
108,173–177. Most of the genes involved in aerial hyphae development in S. coelicolor were not 
classified as DE in M600; however, the expression of chaplin genes, chpB, chpD, chpG, as 
well as the ramCSAB cluster were significantly, but transiently increased in ΔvanJ mutant at 
30 minutes (Figure 4.6). As many Streptomyces sp. do not sporulate in submerged cultures, 
bar several notable exceptions such as S. griseus, S. albus and S. acrimycini, 178, this was an 
unusual observation to make.  
4.2.1.5 The effects of teicoplanin on the expression of genes involved in sporulation 
As the wild type S. coelicolor sporulates, colonies change from white to grey as spores mature. 
Mutants unable to sporulate, remain white as they mature because they lack the grey pigment 
formed during the later stages of sporulation. These mutants have been termed whi (whi-te) 
mutants because of their lack of colouration as they develop 179. Aerial hyphae undergo several 
checkpoints before committing to sporulation which ensures that genomic DNA is correctly 





Figure 4.6 The effects of teicoplanin on the expression of genes involved in developmental 
processes with S. coelicolor. Time in minutes is along the x-axis, and average log2 abundance 
is along the y-axis. Each point is the average of two replicates.  
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At least five genes are involved in ‘early’ spore development, acting as checkpoints during the 
switch from vegetative to aerial growth. These genes encode the transcriptional regulators, 
WhiG (SCO5621), WhiA (SCO1950), WhiB (SCO3034), WhiH (SCO5819) and WhiJ 
(SCO4543), which are responsible for the correct positioning of septa in each pre-spore 
compartment and correctly partitioning genomic DNA 180,181.  
Few changes were noted in the expression of ‘early’ genes with a few exceptions. Teicoplanin 
induced the expression of whiB in M600 by 7.1 fold during the first 30 minutes, but no 
significant changes in expression were observed for the other four genes in this strain. 
Significant decreases in the expression of whiJ and whiG were observed in both strains within 
the 90 minutes time frame. Expression of whiA and ftsZ, which encodes the septal ring 180, were 
significantly downregulated only in ΔvanJ but the expression of both genes recovered almost 
back to normal level after 30 minutes. Increases in ssgB (SCO1541) expression by between 4.5 
and 6.1 fold was observed in both strains during the 90 minute time course (Figure 4.6). This 
gene is essential for septation and believed to encode an anchoring protein that targets septal 
ring to the membrane 180,182. Interestingly, the expression level of both whiB and ssgB declined 
after 30 minutes in M600, but continued to increase in ΔvanJ until 90 minutes, suggesting that 
there could be structural changes in both strains as a result of exposure to teicoplanin.  
‘Late’ developmental genes are induced once the hyphae commit to developing into spores and 
involves the rounding of pre-spore compartments simultaneously as the spore cell wall is 
thickened to produce thermoresistant and hydrophobic spores. This process starts with the 
transcriptional regulator, WhiI which sequentially activates the expression of sigma factor, σF, 
which in turn activates the whiE gene cluster (SCO5315, SCO5317-21). whiE ORFs I-VIII are 
responsible for producing the grey compound that gives mature spores their pigmentation 
183,184. Significant increases in the expression of both whiI and σF were shown in both strains at 
30 minutes, but their expression levels returned to pre-exposure levels at 90 minutes in only 
ΔvanJ. There were also significant but transient increases in the expression of whiE ORFs I-
IV and VIII (4.6 - 7.6 fold) during earlier time points in ΔvanJ, with expression levels 
decreasing at 90 minutes, providing further support to teicoplanin instigating developmental 
processes in these strains.   
Finally, the whiD gene is also an essential gene that is responsible for regulating the processes 
that thicken the cell wall surrounding spores 185. The expression of this gene significantly 
increased in by 14.1 fold in M600 and 6.5 fold in ΔvanJ over the 90 minutes time course 
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(Figure 4.6). Together these data suggest that teicoplanin could be influencing some of the 
processes that are involved in spore development, particularly in ΔvanJ. As spores are 
environmentally resilient, it is possible that some of the structures that make spores so resilient 
could protect against the damage caused by teicoplanin. It seems likely that the increased 
cellular stress observed in ΔvanJ may explain why more of these processes are induced in this 
strain, but further study needs to be carried out to identify whether these observations translate 
into morphological changes.  
4.2.1.6 Evidence of nitric oxide generation as a response to teicoplanin in ΔvanJ  
The metabolic processes that are involved in nitric oxide (NO) biosynthesis are still poorly 
understood in S. coelicolor, but it is believed to be generated from the conversion of nitrite 
(NO2-) to NO through an unidentified process. This small compound is present in times of 
stress and is linked with development processes, acting as an intra- and intercellular signalling 
molecule 186,187. Nitrite can be synthesised by nitrate reductases (Nar) which convert nitrate 
(NO3-) to nitrite. These data suggest that there could be changes in the levels of intracellular 
NO as there are changes in the expression of genes relating to the three nar clusters in S. 
coelicolor. There were significant increases in all nar genes in ΔvanJ, while only the third nar 
cluster along with narH were significantly induced in M600. This suggests that the absence of 
VanJ may lead to increases in the production of NO in the presence of teicoplanin. Increased 
intracellular NO levels could also provide an explanation as to why particular developmental 
processes are significantly affected in ΔvanJ at the 30-minute time point (Figure 4.6) as NO 
can act as a signalling molecule for some regulatory proteins such as the WhiB-like (wbl) 
proteins, (WhiB and WhiD) 188. 
4.2.1.7 Teicoplanin induces genes for antibiotic production in both strains 
Many biological processes are developmentally linked, including the production of many 
secondary metabolites. Two of the most well studied secondary metabolites in S. coelicolor are 
the antibiotics uncecylprodigiosin (RED), and ACT which are produced as cells switch from 
vegetative to reproductive growth 155,189. 20 out of 23 genes from the RED cluster were 
significantly upregulated in response to teicoplanin in both strains. Three genes were not DE 
across any of the time points, including redG (SCO5897), redF (SCO5897) and SCO5899. In 
contrast, only 6 out of 22 genes from the ACT cluster were DE in M600 compared to 16 out of 
22 genes in ΔvanJ. actVA2 (SCO5077) was the only gene that was downregulated, which 
occured in both strains (Figure 4.6). These data suggest that antibiotic production may increase 
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after exposure to teicoplanin, which is likely linked to the increased cellular stress caused by 
this drug.  
4.2.3 Effects of teicoplanin on the expression of genes relating to the cell 
envelope 
4.2.3.1 Teicoplanin causes changes in the expression of genes related to biosynthesis and 
maintenance of PG  
Significant decreases were observed in the expression of most genes involved in PG 
biosynthesis in both strains within the first 30 minutes. This aligns with previous data on other 
cell wall targeting antibiotics. Genes involved in the earliest steps of PG biosynthesis ddlA 
(SCO5560), murA (SCO2949) and murC (SCO6060) were only significantly downregulated in 
ΔvanJ, while murB (SCO4643) was not significantly DE in either strain. It should also be noted 
that uppS (SCO2509) and the proposed lipid II flippase, murJ (SCO3894), were also only 
significantly downregulated in the ΔvanJ strain (Figure 4.7).   
We also explored how teicoplanin affected the 21 different PBPs of S. coelicolor which in most 
instances are still poorly characterised 17. Eighteen of these showed some form of DE in either 
strain. There were similarities between both strains including the upregulation of two class A 
PBPs (SCO2897 and SCO5039), five class B PBPs (SCO1875, SCO3156, SCO3157, SCO3771, 
and SCO3847) and two class C PBPs (SCO0830 and SCO4847) (Figure 4.7). These genes 
increased in activity by between 3.1 - 38.7 fold with SCO1875 and SCO3771, showing the 
most significant changes in expression. Nine PBPs were only DE in ΔvanJ including the class 
A PBPs SCO3580 and SCO3901; the class B PBPs, ftsI (SCO2090), pbp2 (SCO2608) and 
SCO4013; and the class C PBP dacA (SCO3811). These genes were downregulated by between 
2.5 - 10 fold within the first 30 minutes. SCO5301 and SCO7050 were also significantly 
induced in ΔvanJ by 7.4 and 4.8 fold respectively (Figure 4.7). The subtle differences in the 
expression patterns of the PBPs between the strains could suggest that there are different 
requirements for PBPs between the strains in how they respond to teicoplanin. The transient 
changes in some of the PBPs in ΔvanJ could also be developmentally linked to the changes 
observed in sporulation genes. Interestingly, the majority of the PBPs that are influenced by 
teicoplanin in both strains are class B and C PBPs which operate away from the membrane in 
the PG layer. This is likely a response to the inhibition of transpeptidation by teicoplanin in the 










Figure 4.7 The effects of teicoplanin on the expression of genes involved in processes that 
synthesise and maintain the PG layer in S. coelicolor.  Time in minutes is along the x-axis and 
average log2 abundance is along the y-axis. Each point is the average of two replicates.  
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4.2.3.2 Both Strains showed a significant increase in the expression of genes involved in 
transport across the membrane 
Cluster 3 was significantly enriched for genes with functions relating to ‘response to drug’ 
(GO:0042493, P-value = 2.93 x 10-3), which contained four genes with predicted transporter 
activity. Membrane transporters have previously been implicated in the cell-envelope stress 
responses of B. subtilis 190, S. aureus 191 and S. coelicolor 149, but none of these particular genes 
have been implicated in resistance to glycopeptides in S. coelicolor. All genes enriched for this 
functional group were significantly upregulated in both M600 and ΔvanJ in response to 
teicoplanin (Figure 4.8). SCO3824 and SCO4359 belonged to the ATP-binding cassette (ABC) 
transporter superfamily and were upregulated by 24.6 and 15.2 fold in M600 and 7.3 and 4.2 
fold in ΔvanJ respectively. SCO2472 is a member of the ydcF-like superfamily of genes that 
also contain the sanA gene which has previously been found to complement a vancomycin-
sensitivity mutation in E. coli by an unknown mechanism 192. SCO2472 was upregulated by an 
astonishing 98.4 fold in M600 and 16.2 fold in ΔvanJ during earlier time points. The final gene, 
SCO3910, belongs the MOP superfamily, which is found throughout all domains of life and 
includes MurJ. These genes are also strongly related to multidrug resistance in cells and the 
transport of bulky membrane carriers such as lipid II 193. SCO3910 increased in activity by 8.9 
and 3.5 fold in M600 and ΔvanJ, respectively within the first 30 minutes of the time course 
(Figure 4.8). The products of these membrane transporters are likely involved in the removal 
or transport of toxic metabolites in response to teicoplanin, however the similarity of SCO2472 
to sanA and the predicted MOP domain of SCO3910 make them attractive genes to study in S. 
coelicolor in relation to glycopeptide resistance.  
4.2.3.3 There are observable differences in the expression of genes involved in membrane 
lipid biosynthesis between the two strains.  
How the glycopeptides affect the bacterial membrane is poorly understood. We therefore 
decided to explore the expression of the known genes involved homeostasis of the S. coelicolor 
cell membrane and its associated lipids. Firstly we observed that SCO6759-63 and SCO6766 
from the hopanoid cluster were significantly downregulated in ΔvanJ (Figure 4.9). These 
molecules are synthesised from isoprenoids and have a similar role as cholesterol in eukaryotic 
membranes, increasing membrane packing, to form discrete microdomains referred to as lipid 
rafts. These are usually associated with flotillin proteins, which are known to recruit other 




















Figure 4.8 Teicoplanin strongly induces the expression of genes with predicted transporter 
function that were associated with the ontology ‘Response to drug’. Time in minutes is along 

















Figure 4.9 Expression profiles for genes involved in hopanoid and flotillin biosynthesis in S. 
coelicolor are displayed. Time in minutes is along the x-axis and average log2 abundance is 
along the y-axis. Each point is the average of two replicates.  
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We also found the expression of two flotillin genes, SCO3286 and SCO3607, increased by up 
to 60 fold between the two strains at 30 minutes (Figure 4.9) which could highlight that 
teicoplanin leads to discreet changes in the architecture of the membrane, and the formation of 
flotillin microdomains in both strains. 
The major constituent of the bacterial membrane are phospholipids. These lipids consist of an 
acylated glycerophosphodiester that can be modified with many variable fatty acids and alcohol 
head groups. Initially, the acyl chains that make up the hydrophobic tails of phospholipids are 
synthesised through the fatty acid biosynthesis (FAB) pathway, which is well conserved within 
bacteria (Figure 4.10A). Teicoplanin was found to cause significant decreases in the 
expression of genes relating to FAB. fabI (SCO1814) and fabG (SCO1815) were 
downregulated in both strains by between 2.5 - 10 fold while fabD (SCO2387), fabH 
(SCO2388), fabF (SCO2390), SCO4636 and SCO4637 were only downregulated in ΔvanJ by 
between 2.5 - 10 fold within 30 minutes (Figure 4.10B).  
The latter stages of phospholipid biosynthesis involve loading the core structure with various 
head groups to generate the diverse array of membrane lipids. The expression of genes that are 
involved in the biosynthesis of CDP-DAG (SCO5626), PS (SCO6467), PE (SCO6468), PpG 
(SCO5753) and CL (SCO1389) were all significantly downregulated in ΔvanJ (Figure 4.11B). 
acylT (SCO1526) and pisA (SCO1527), which encode the enzymes that synthesise Ac-PIM1-2 
and PIP (Figure 4.11A), were significantly downregulated in both strains. In contrast, the genes 
that are involved in ornithine biosynthesis, olsA and olsB (Figure 4.11A), were significantly 
upregulated by 7.3 - 8.9 fold in the ΔvanJ mutant within the first 30 minutes (Figure 4.11B). 
Together these data suggest that teicoplanin likely leads to changes in the overall composition 
of the membrane in ΔvanJ with particular decreases in genes relating to positively charged 
phospholipids, while there are increases in the zwitterionic, ornithine lipid.  
4.2.3.4 There is evidence for phospholipid remodelling occurring in the cell membrane in 
response to teicoplanin 
The membrane surface is a dynamic structure that is continuously remodelled to adapt to novel 
environmental conditions. As previously mentioned, the gene encoding the tRNA synthetase, 
mprF, is strongly upregulated in both strains in response to teicoplanin. The product of this 
gene can add lysyl-groups to PpG to decrease the net negative charge of the bacterial membrane 
(Figure 4.12).   
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Figure 4.10 (A) Metabolic pathway involved in fatty acid biosynthesis. Solid arrows indicate 
steps with known genes and dashed arrows indicate unknown mechanisms with no candidate 
gene identified. Coloured arrows next to each gene indicate the direction of expression after 
exposure to teicoplanin, with purple arrows indicating DE in both strains and green arrows 
indicating DE in just the ΔvanJ mutant. (B) Expression profiles for genes encoding the 
enzymes involved in FAB process in S. coelicolor is presented below. Time in minutes is along 
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Figure 4.11 (A) Metabolic pathways involved in membrane lipid biosynthesis. Solid arrows 
indicate characterised steps with known genes and dashed arrows indicate unknown 
mechanisms. Coloured arrows next to each gene indicate the direction of expression after 
exposure to teicoplanin. Purple arrows indicate DE in both strains. Green arrows indicative DE 
in just the ΔvanJ mutant. (B) Expression profile for genes encoding the enzymes involved in 
membrane phospholipid biosynthesis and ornithine metabolism in S. coelicolor. Time in 
minutes is along the x-axis and average log2 abundance is along the y-axis. Each point is the 




Figure 4.12 Teicoplanin effects the expression of genes that are involved in degrading and 
modifying the bacterial membrane. The expression profile for genes in the glycerol operon is 
also shown. Time in minutes is along the x-axis, and average log2 abundance is along the y-




There are many other enzymes which also can modify the structure of phospholipids, including 
a large family of PAP all with a characteristic PAP2 domain that cleave phosphodiester bonds 
(Figure 4.13). The diversity of these enzymes in the metabolic processes surrounding 
phospholipids makes them an appealing target for study because of their possible interaction 
with lipid II and other molecules with a phosphodiester bond. A BLAST search predicted that 
18 genes had the PAP2 domain within the S. coelicolor genome. Only 12 of these were found 
to be DE (Figure 4.12). Seven were universal to both strains including SCO2335, SCO2807, 
SCO6355, SCO6356, SCO6378 and SCO6511, all of which showed an increase in expression 
by approximately 4 – 11 fold over the 90 minutes. Interestingly, the expression of SCO7587 
decreased in both strains by 2.5 - 3.3 fold in the first 30 minutes. SCO1047, SCO3725, 
SCO4843 and SCO6428 were all specifically DE in ΔvanJ. SCO1047, SCO4843 and SCO6428 
were all upregulated by 6.5 - 14 fold, and, SCO3725 was downregulated by 2.5 fold during the 
first 30-minutes. The transient induction of some of these genes in ΔvanJ reminiscent of the 
induction seen in some developmental genes discussed in in Section 4.2.2 could suggest that 
these genes are linked. The converse expression of SCO7587 in comparison to the other PAP 
may also suggest that the products of these genes have distinct roles in the membrane in 
response to teicoplanin and the resulting products of these enzymes may be involved in the 
adaptive response to the external environment.  
In addition to the PAPs, phospholipases also play a vital role in the metabolism of 
phospholipids, as well as host defence and signal transduction in many bacteria 194–196. 
Although poorly understood in S. coelicolor, they can be subdivided into four classes (A1, A2, 
C or D) based on the cleavage site on the phospholipid structure (Figure 4.13). Cluster 3 was 
enriched for genes with the functional group ‘lipase activity’ (GO:0016298, P-value = 5.0 x 
10-2), encompassing three genes with predicted hydrolysing activity (Figure 4.12). SCO3222 
showed strong induction (17-19 fold) during the time course in both strains and belongs to the 
phospholipase A (PLA) class of phospholipases, sharing 100% identity with PLA2 from 
Streptomyces violaceoruber. PLA2 enzymes cleave the 2-acyl bond of glycerophospholipids to 
produce a fatty acid and an LPA 194,197. Additionally, the expression of SCO2892 gene also 
increased by 4.7 - 7.8 fold in both strains and is predicted to belong to the thioesterase I/protease 
I/lysophospholipase (TAP) protein family 198. This promiscuous family is known to have broad 
specificity for mono-acyl phospholipids such as LPA which could suggest the products of these 
genes work synergistically to cleave the 1 and 2-acyl chains from phospholipids in response to 











Figure 4.13 Diagram showing the cleavage sites of phospholipase classes and PAP2 enzymes 
on phospholipids. Adapted from Titball (1998).  
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Most of the studies carried out to date on the processes involved in the recycling of 
phospholipids have used E. coli as a model. The complex processes that occur during the 
complex lifecycle of S. coelicolor are only just beginning to be understood. We know from E. 
coli that phospholipids are degraded to produce glycerophosphodiesters which differ based on 
their alcohol moiety. These can then undergo further degradation through the action 
glycerophosphodiester phosphodiesterases (GDPD), yielding sn-glycerol-3-phosphate (G3P) 
and the corresponding alcohol. GlpQ carries out this reaction in the E. coli periplasm and UgpQ 
in the cytosol, but both show broad specificity for glycerophosphodiesters 199,200. S. coelicolor 
has three homologues of glpQ (glpQ1-3) and four of ugpQ (ugpQ1-4), but other than some 
evidence for substrate-specific regulation in glpQ1 and glpQ2, little is known about the specific 
role of these GDPDs 201. Interestingly, only two of the GDPDs were differentially expressed in 
our dataset. ugpQ1 was significantly upregulated by 3.6 fold in M600, and glpQ2 was 
significantly upregulated by 3 fold in ΔvanJ (Figure 4.12). Together these data suggest that 
there could be increased GDPD activity occurring in response to teicoplanin, but why there are 
differences between the two strains is still unclear.  
In E.coli, the final stages of phospholipid metabolism involve transporting G3P back into the 
cell via the transporter GlpT, where G3P can be converted to dihydroxyacetone phosphate 
(DHAP) and shuttled into glycolysis or used for further rounds of membrane biosynthesis 62. 
S. coelicolor lacks a G3P transporter so G3P must instead be dephosphorylated to generate 
glycerol, before being transported across the membrane (personal communication with Colin 
P. Smith). We found that Cluster 7 was enriched for genes with functional groups involved in 
the ‘glycerol metabolic process’ (GO:0006071, P-value = 2.38 x 10-4). This included the three 
genes in the glycerol operon, glpFKD. These genes encode a membrane facilitator that 
increases the rate of glycerol diffusion across the membrane, a kinase that converts glycerol to 
G3P and a dehydrogenase that converts G3P to DHAP 202. The operon was significantly 
induced in both strains after exposure to teicoplanin and showed increases in activity between 
2.7 - 18 fold (Figure 4.12). The operon is known to be induced by G3P, suggesting that 
exposure to teicoplanin leads to increased concentrations of G3P or glycerol in the surrounding 
media 203. We speculate that if a response to teicoplanin leads to increased phospholipid 
degradation through the action of some of the gene products discussed in this section, it is 
plausible that the increased activity of the glycerol operon is due to increased concentration of 
breakdown products due to the action of the enzymes discussed here. And, as far as we’re 
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aware, this is currently an unexplored mechanism of teicoplanin and the glycopeptide 
antibiotics.  
4.3 Summary 
In this section, we presented the genome-wide comparisons of genes in S. coelicolor after 
exposure to teicoplanin. There were expected key similarities between both strains including 
increased activity in the regulators of the cell envelope, osmotic and oxidative stress responses 
in S. coelicolor. This reaffirms the data previously presented on the overlap between global 
stress response systems induced by antibiotics that target the cell wall in S. coelicolor 149. 
Unexpectedly, the σE signal transduction system, the cell envelope stress regulon and the 
induction of several STKs were induced more slowly in ΔvanJ. This suggests that the weak 
induction of VanJ in M600 is enough to affect the transcription of other genes and may 
highlight that VanJ is involved in induction of the σE signal transduction system.  
Currently the ligand for the CseC SK is unknown, but the system is triggered by a wide range 
of antibiotics and enzymes that affect the integrity of the cell wall 151. It has been suggested 
that either a common intermediate produced by cell wall targeting antibiotics may be the 
cognate ligand or instead, a biophysical change in the cell envelope is detected. The former 
explanation makes more logical sense with our data and would provide an explanation as to 
why induction of σE signal transduction system is delayed rather than inhibited in the ΔvanJ 
strain. VanJ may therefore be involved in generating this ligand in the presence of teicoplanin. 
However, if other pathways also generate this ligand, there would still be observable increases 
in these pathways, albeit at a slower rate. This delayed response appears to also be tied with 
the onset of the production of cellular stress markers that were observed during earlier time 
points in ΔvanJ. This indicates that even the limited induction of vanJ in M600 cells after 
exposure to teicoplanin, is profoundly effective at reducing the overall effects of cellular stress 
caused by teicoplanin.  
There were clear indications that processes relating to growth and development were more 
affected by teicoplanin in ΔvanJ. Notably, genes involved in ribosome biogenesis, protein 
translation, carbon utilisation, DNA replication, and cell envelope biosynthesis were all 
significantly downregulated during earlier time points but almost returned to pre-treatment 
levels by 90 minutes. Simultaneously, in ΔvanJ, there were transient increases in genes relating 
to the generation of the signalling molecule, NO and genes such as the whiE genes that relate 
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to spore maturation. It is not entirely clear whether these transcriptomic changes relate to 
physiological outcomes, but active growth is likely reduced to prevent cellular death by 
teicoplanin. What we do know is that WhiB and WhiD are involved in controlling hyphal 
growth and thickening the spore wall respectively, and the former makes up part of the cell 
envelope stress regulon 150. Although speculative, in the presence of teicoplanin and 
particularly in the absence of VanJ, these processes may reduce the damaging effects of 
teicoplanin through modifying cell ultrastructure 185, however further study needs to be carried 
out to confirm this. 
Most genes involved in the biosynthetic processes that convert histidine to arginine were 
strongly induced in both strains. Arginine has been implicated in the oxidative and salt stress 
responses in S. coelicolor and other bacteria in previous studies and is likely a metabolic 
precursor for ectoine and the polyamines, which can act as osmoprotectants under severe salt 
stress 170,171,204. Therefore, it is likely that arginine could provide a protective role against 
teicoplanin and the stress it exerts on the cell. 
Finally, teicoplanin appears to affect genes involved in the homeostasis of membrane lipids. 
Many genes involved in lipid modification and degradation were upregulated, while genes 
involved in the synthesis of negatively charged lipids were downregulated. There was also 
strong activity seen in the glycerol operon which is under strict catabolite repression in the 
absence of its positive inducer, G3P which is a breakdown product of phospholipids 203. From 
this information, it seems plausible that teicoplanin increases the rate of phospholipid turnover 
and G3P may accumulate in the growth media. It is also likely that S. coelicolor salvages this 
metabolite for further rounds of phospholipid biosynthesis or glycolysis through the activity of 
the glycerol operon. To our knowledge, this is currently an unreported mechanism of 
glycopeptide antibiotics, and so would be an exciting avenue to explore further in relation to 
antibiotic resistance.  
In the following sections, we characterise some of the genes in this section to identify which 
might be essential for resisting the effects of teicoplanin, and build a better model of how 
teicoplanin might interact with the cell surface, and potentially provide future drug targets for 
development.    
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Chapter 5. Functional Analysis of 
Candidate Genes to Identify Their Impact 
on The Phenotype of S. coelicolor to 





There were a substantial number of genes identified in Chapter 4 that were differentially 
expressed. Many of these genes appeared to relate to broader stress responses, but several 
groups of genes with previously uncharacterised roles in glycopeptide resistance were 
identified that had localised functions relating to the cell envelope. This section will tackle the 
question of whether any of these genes functionally contribute to antibiotic resistance towards 
a library of antibiotics, or if the genes likely represented a collective stress response caused by 
teicoplanin. To understand any relationship between AMR and these target genes, an antibiotic 
library was selected encompassing antibiotics that target different stages of PG biosynthesis, 
the cell membrane, protein synthesis and DNA replication (Summarised in Table 5.1). A small 
selection of glycopeptide antibiotics were also used for further characterisation of genes that 
demonstrated interesting phenotypes against the general antibiotic library. These glycopeptide 
antibiotics had a variety of secondary and tertiary modifications, including various 
glycosylation patterns and lipophilic side chains (Figure 5.1).  
To test for changes in phenotype, the agar dilution method is the ‘golden standard’ for 
measuring the sensitivity of microorganisms to antibiotics and has been particularly important 
when assessing the efficacy of novel or modified agents in comparison to reference drugs. The 
method can also be used to compare the sensitivity of different species or strains of 
microorganisms that may have different genetic backgrounds in order to identify phenotypic 
changes caused by mutations or the expression of particular genes. The European Committee 
for Antimicrobial Susceptibility Testing (EUCAST) first established the procedures to record 
the MIC of bacteria accurately in the early 2000s, with minor amendments made in following 
years 132,205. The method involves agar plates with serial dilutions of the selected antibiotic that 
are then seeded with known concentrations of the target bacteria usually in 5 - 10 µL aliquots. 
Either positive or negative changes in sensitivity indicate that the independent variable being 
tested has influenced the phenotype. These studies can inform which modifications are the most 
successful and can aid in future drug development.  
The purpose of this study was to identify which genes are involved in response to teicoplanin 
by genetically manipulating S. coelicolor M600 and ΔvanJ background strains to identify any 
changes in the phenotype.   
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Table 5.1 List of antibiotics used in this study and their bacterial targets.  
  





 Balhimycin  
Bind lipid II and inhibit 
transglycosylation 
Weakens the cell wall 
and makes cells 







Bind lipid II and inhibit 
transglycosylation and 
transpeptidation 
Weakens the cell wall 
and makes cells 
susceptible to lysis 
206 
Ramoplanin Binds both MurG and 
transglycosylases 
Weakens the cell wall 
and makes cells 
susceptible to lysis 
207 
Carbenicillin Bind to PBPs, blocking 
transpeptidation 
Weakens the cell wall 
and makes cells 
susceptible to lysis 
208 
D-cycloserine Inhibits D-Ala-D-Ala 
ligase 
Weakens the cell wall 
and makes cells 
susceptible to lysis 
209 
Flavomycin Inhibits transglycosylases Weakens the cell wall 
and makes cells 
susceptible to lysis 
210 
Nisin Binds to the lipid 
pyrophosphate  








Novobiocin Binds to DNA gyrase Inhibiting DNA 
replication 
213 





Figure 5.1 Chemical structures of the glycopeptide antibiotics used in this study. The four 
lipoglycopeptide antibiotics are displayed at the bottom showing their lipophilic side chains.    
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The two most common methods for understanding the function of individual genes are through 
the generation of gene overexpression strains and gene knockout mutants. Having both 
phenotypes is essential for assigning function to a particular gene and can indicate the 
importance of specific genes in different environmental conditions. Two major vector systems 
were employed in this work. The first was the integrative pIJ10257 plasmid (Figure 5.2) which 
strongly expresses genes that are put under the control of its ermE-promoter (ermE-p) adjacent 
to a multiple cloning site 37. This promoter originates from Saccharopolyspora erythrea 214 and 
allows for high-level expression of genes in S. coelicolor and has previously been used to 
demonstrate that vanJ is required for teicoplanin resistance 115.  
The second system employed in this project is the pCRISPomyces-2 plasmid that has been 
engineered with a codon optimised cas9 gene for Streptomyces 130. The plasmid also has a 
scaffold sequence that facilitates binding to the Cas9 protein and a BbsI cut site where a short 
nucleotide sequence can be inserted next to the scaffold to produce a gRNA. This gRNA is 
what functions to guide the Cas9 protein to a specific DNA sequence where it cuts the DNA, 
causing a double-stranded break (DSB). The plasmid can also be engineered with a 
homologous region flanking the DSB so that when the cell tries to repair the DNA damage, the 
homologous region is used as a template for repair and the DNA sequence is modified 215. A 
second CRISPR plasmid was also used in this work to try and generate knockout mutants, and 
both are shown in Figure 5.3.  
5.2 Results 
5.2.1 Selection of genes to construct overexpression plasmid DNAs in S. 
coelicolor  
A total of ten genes were selected to test for their ability to confer antimicrobial resistance to 
S. coelicolor wild type M600 and ΔvanJ mutant strains. As there was no way of predicting 
which genes would influence the sensitivity of S. coelicolor to the library of antibiotics, genes 
were chosen from several groups of genes involved in different aspects of the cell envelope. 
This included, seven PAP2 genes, the three glycerol operon genes, and two genes enriched 
with the ‘response to drug’ functional group, and all successfully cloned in pIJ10257 and 
















Figure 5.3 Plasmids maps for the two CRISPR plasmids pCRISPomyces-2 (A) and 





Two of the PAP genes, SCO6355 and SCO6356 were adjacent in an operon that also contained 
SCO6357 which belongs to the widespread dedA/tvp38 family of putative proton transporters 
that are important for sustaining the membrane potential in E. coli 216–218. The operon also 
contained a predicted TCS SCO6354-53, indicating the potential for autoregulation. Both 
SCO6357 and SCO6354-53 were also introduced into S. coelicolor and are discussed later in 
the chapter.  
Several trials attempted to clone SCO2335 into pIJ10257, but all resulting plasmids were found 
to contain the same substitutions at 743bp (T  C) and 2077bp (T  C) which would result 
in a conversion from a valine to an alanine and a conversion of a tryptophan to an arginine, 
respectively. Polymerases with proof-reading capabilities were used in the amplification of 
DNA, so it was unlikely that this was caused by errors in the replication. It was possible that 
this mutation is a sequence variant in M600 that is not found in the published M145 strain of 
S. coelicolor. All other sequences aligned perfectly with the annotated S. coelicolor genomic 
DNA sequences. All resulting plasmids used for this study are summarised and demonstrated 
in Figure 5.4. Integration of each resulting plasmid into the genomic DNA of the background 
strain was confirmed through colony PCR. The CFU/µL was then used to estimate the volume 
of spores needed to make the selected concentrations used for MIC testing. The CFU/µL of 
each strain is listed in Table 5.2.  
Several failed attempts to clone both CRISPR plasmids were carried out, and it was eventually 
decided that both plasmids must be toxic to S. coelicolor as the empty vectors produced no 
successful exconjugants. These experiments were abandoned and since this work, several new 
S. coelicolor optimised plasmids have been developed which are mentioned in the discussion.  
5.2.2 MIC test of engineered S. coelicolor strains against the library of 
antibiotics  
S. coelicolor, like many other actinomycetes, exhibits high-level intrinsic resistance to many 
antibiotics. This has likely resulted from an evolutionary arms race between neighbouring 
organisms within the complex soil microbiome where organisms are competing for the same 
nutrients. Both control strains of sc10257m and sc10257v showed the same phenotype against 
most antibiotics tested with the exception of kanamycin and vancomycin (Table 5.3). The 
sc10257v strain was vastly more resisatant to kanamycin which is likely due to the apramycin 




Figure 5.4 Plasmid maps for pIJ10257 derivative plasmids.   
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Table 5.3 List of MIC values for all overexpressing constructs used in this study. Values are 
the average of three biological replicates and values indicate µg/mL of antibiotic needed to 
prevent any growth on the media. The two control strains were modified to contain the empty 
pIJ10257 vector. T (teicoplanin), V (Vancomycin), R (ramoplanin), C (carbenicillin), D-c (D-
cycloserine), F (flavomycin), Ni (nisin), Du (duramycin), N (novobiocin), and K (Kanamycin).  
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Both apramycin and kanamycin are aminoglycoside antibiotics, and the resistance gene likely 
provides resistance towards both. The increased sensitivity toward vancomycin observed in 
sc10257v  has also been seen in other ΔvanJ strains conjugated with pIJ10257, although it is 
unclear why this occurs 115. Both strains exhibited high-level resistance to both carbenicillin 
and flavomycin, and the true MIC exceeded the antibiotic concentrations that were possible to 
test (Table 5.3).  
5.2.2.1 Overexpression of the glycerol catabolic cluster affected the MIC towards 
vancomycin and teicoplanin 
The glycerol cluster includes the glycerol operon, consisting of glpFKD, which are regulated 
by the negative regulator, gylR (Figure 5.5A). These genes are involved in the uptake and 
metabolism of glycerol from the surrounding media (Figure 5.5B). Overexpressing some 
genes from this cluster affected the MIC of vancomycin and teicoplanin in S. coelicolor. 
Overexpression of SCO1659 and SCO1660 genes in the ΔvanJ background (scSCO1659v and 
scSCO1660v) increased the sensitivity of S. coelicolor 2 fold against teicoplanin but no 
changes were observed in M600 background strains overexpressing any of the genes. 
Interestingly, overexpression of all three genes from this cluster increased resistance of ΔvanJ 
background to vancomycin as the MIC increased by 2 fold (Table 5.3). This may suggest that 
these genes complement the more sensitive vancomycin phenotype observed in ΔvanJ 
background strains. This could also indicate that this sensitive phenotype has something to do 
with glycerol metabolism.  
5.2.2.2 Overexpression of genes enriched for the functional group ‘response to drug’ 
increased sensitivity of S. coelicolor toward vancomycin and teicoplanin 
We have already discussed how membrane transporters are likely to be involved in the removal 
of toxic metabolites in the presence of glycopeptide antibiotics. But we became interested in 
SCO2472 and SCO3910 because the former is a homologue of the sanA gene from E. coli and 
sfiX from S. typhimurium which are believed to be involved in the barrier function towards cell 
envelope damaging reagents, including vancomycin 192,219. Previous studies have shown how 
these genes can restore intrinsic vancomycin resistance in vancomycin-susceptible strains of 
both bacteria. SCO3910, on the other hand, was predicted to encode a MOP domain similar to 
































Figure 5.5 (A) Diagram showing the genetic organisation of the glycerol operon and (B) shows 
the functional processes that each gene of the glycerol operon encodes.  
SCO1658 SCO1659 SCO1660 SCO1661 
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We did not observe any indications that over-expression of either of these genes positively 
affected the phenotype of either M600 or ΔvanJ background strains towards teicoplanin or 
vancomycin, but instead increased sensitivity to teicoplanin and vancomycin (ΔvanJ 
background only) by 2-fold (Table 5.3). It is therefore likely that these genes have a role not 
related specifically to glycopeptide antibiotics, and may be involved in rectifying general 
cellular stress or become increase cellular stress when expressed above a certain threshold.  
5.2.2.3 Overexpression of PAP genes diversely affects the susceptibility profile of S. 
coelicolor  
Overexpression of PAP genes in S. coelicolor produced no changes in the MIC towards 
kanamycin, novobiocin, flavomycin or carbenicillin but noticeable differences were seen in the 
MIC of some other antibiotics that target cell wall biosynthesis. Overexpression of SCO2335, 
SCO2807 and SCO6511 increased sensitivity of S. coelicolor toward teicoplanin in ΔvanJ 
background by 2 fold, with no change in phenotype observed for in M600 background strains 
(Table 5.3). Overexpression of SCO6356 increased resistance toward vancomycin in ΔvanJ by 
2 fold. Strains overexpressing SCO6355 showed a 2 – 4 fold increase in sensitivity towards 
both vancomycin and nisin. Expression of all PAP2 candidate genes, except SCO6355, 
increased the sensitivity of S. coelicolor toward ramoplanin or D-cycloserine. However, 
interestingly this was the only gene to significantly increase the sensitivity of S. coelicolor 
toward a lantibiotic, duramycin, by more than 4 fold (Table 5.3). 
5.2.3 Phylogenetic analysis of the PAP2 domains from Streptomyces PAP 
suggests possible functional subclasses 
A phylogenetic relationship was determined based on the protein sequences available for all 
genes with PAP2 domains in S. coelicolor and the two closely related Streptomyces strains, 
Streptomyces lividans and Streptomyces venezualae (Figure 5.6). Each strain had at least one 
protein sequence in each major phylum, suggesting that there are distinct classes of PAP2 
containing proteins in Streptomyces. PAP2 domains from genes that produced more similar 
MIC profiles when overexpressed in S. coelicolor, including SCO2335 and SCO2807 as well 
as SCO6511 and SCO6356, were found in similar clades. The clade containing the PAP2 
domain of SCO6355 also contained the three other S. coelicolor genes, SCO1102 (Ippα), 
SCO1753 (Ippβ) and SCO5674 which were not differentially expressed in the RNA-seq dataset 
in either strain.  
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Figure 5.6 The evolutionary history inferred using the maximum likelihood method for the 
protein-coding sequences of PAP2 domains in S. coelicolor (SCO), S. lividans (SLI) and S. 
venezualae (vnz). Forty-five amino acid sequences were used, and bootstrap values (>70%) are 




These data corroborate with data in the previous section, demonstrating that the PAP2 genes 
within S. coelicolor could possibly fall into distinct classes that may have specific roles during 
particular cellular events. We have also demonstrated that these classes could be widely 
distributed throughout the Actinomycetes, which could indicate their diverse roles within the 
membranes of these organisms.  
5.2.4 Further characterisation of the SCO6357-53 operon  
Two PAP2 genes, SCO6355 and SCO6356, were found within a suspected polycistronic unit 
including three other genes SCO6357, SCO6354 and SCO6353 (Figure 5.7). SCO6357 has 
been confirmed to be the transcriptional start site 221, and the downstream products follow the 
same transcriptional pattern characteristic of an operon (Figure 5.7). SCO6357 has also been 
confirmed to be downstream from a predicted σE regulon promoter sequence 150, meaning that 
this operon could have a functional role cell envelope stress response. SCO6357 is predicted to 
encode a DedA/Tvp38-like protein which are commonly found throughout prokaryotic 
genomes, but their specific function remains elusive. There is some evidence that it functions 
as proton-motive force-driven antiporter in E. coli, and disruption can lead to sensitivity against 
cationic compounds 216,217. SCO6354-53 are predicted to encode for a histidine kinase and a 
response regulator in a TCS. The presence of this TCS suggests the possibility for 
autoregulation or that its involvement in a regulatory cascade.  
Overexpressing SCO6357 or SCO6354-53 did not affect the susceptibility of S. coelicolor 
toward teicoplanin, vancomycin and most of the other cell wall targeting antibiotics (Table 
5.4). Overexpression of SCO6357 did increase the resistance of S. coelicolor to the lantibiotics 
nisin and duramycin by 2 fold in the M600 background. However, the overexpression of both 
SCO6357 and SCO6354-53 in ΔvanJ background increased the sensitivity of S. coelicolor 
toward duramycin by between 2-4 fold. SCO6357 also increased the resistance against 
kanamycin by 2 fold in the ΔvanJ background. Although kanamycin does not have a mode of 
action that targets the cell envelope or its biosynthesis, it is plausible based on their predicted 
function, that this gene plays a role in the barrier function of the cell membrane, possibly 














Figure 5.7 Plot showing the expression of the SCO6357-53 operon over 90 minutes after 
exposure to teicoplanin, for both M600 and ΔvanJ. Each point is the average of two biological 
replicates. The genomic sequence with the transcriptional start site (TSS) and location of the 
σE regulon promoter shown 88bp upstream of the operon are shown. The genomic organisation 
of the operon is also displayed at the bottom of the image.   
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Table 5.4 MIC values determined for the antibiotic library for strains overexpressing genes 
from the SCO6357-53 operon. T (teicoplanin), V (Vancomycin), R (ramoplanin), C 
(carbenicillin), D-c (D-cycloserine), F (flavomycin), Ni (nisin), Du (duramycin), N 

















5.2.5 Understanding the role of SCO6355 in antibiotic resistance  
A series of vancomycin and teicoplanin disc diffusion assays were carried out using SCO6355 
overexpression constructs. There were significant differences (P<0.0005) between the average 
diameters of the inhibitory zones (DIZ) of the two control strains against vancomycin but no 
significant differences against teicoplanin. As predicted, the DIZ around both antibiotic discs 
of all tested strains overexpressing SCO6355 were larger in ΔvanJ background than M600 
background. The average DIZ of SCO6355 overexpressing S. coelicolor constructs, regardless 
of its background, was significantly bigger around vancomycin disc compared to those of the 
corresponding controls (Figure 5.8). These results are consistent with the MIC results shown 
in Table 5.3 as the overexpression of SCO6355 significantly increased the sensitivity of S. 
coelicolor toward vancomycin in both M600 and ΔvanJ background, indicating that this gene 
likely antagonises the endogenous vancomycin-resistance system in S. coelicolor.  
S. coelicolor is highly resistant to vancomycin but displays varying susceptibility to a 
structurally diverse range of glycopeptide antibiotics. We now understand that this is reliant on 
the level of detection by the VanS protein 100. Further MIC test for a small library of 
glycopeptide antibiotics was also carried out using the control strains along with scSCO6355m 
and scSCO6355v, to identify relationships between SCO6355 and glycopeptide structure. Both 
control strains exhibited between intermediate or high-level resistance to vancomycin, 
balhimycin, ristocetin, oritavancin and telavancin but they exhibited relatively high sensitivity 
toward chloroeremomycin and teicoplanin as shown with very low MIC scores (Table. 5.5 and 
Figure 5.9). The overexpression strains exhibited 4 fold increased sensitivity toward 
vancomycin and balhimycin and 2 fold toward ristocetin (Table 5.5). No changes in sensitivity 
were observed against chloroeremomycin or any of other lipoglycopeptides tested. We also 
didn’t observe any MIC changes for vancomycin derivatives with putrescine substituted onto 
the seventh amino acid nor were they observed for this vancomycin-putrescine derivative with 
a chlorobiphenyl group substituent (data not shown). Together these data suggest that 
overexpressing SCO6355 increases the sensitivity of S. coelicolor toward vancomycin and 
other glycopeptide structurally similar glycopeptides. However, the same phenotype is not seen 
with glycopeptides such as the lipoglycopeptide antibiotic or chloroeremomycin. We note that 
all these glycopeptide antibiotics poorly induce the van resistance system, so from this we can 
suggest that the enzymatic function of SCO6355 may interfere with the sensory capabilities of 
VanS to detect certain glycopeptide antibiotics like vancomycin. As a result, there is weaker 















Figure 5.8 Disk diffusion assay of sc10257m (1), sc10257v (2), scSCO6355m (3) and 
scSCO6355v (4) against V (vancomycin 100 µg) and T (teicoplanin 30 µg). The diameter of 
the inhibitory zones (DIZ) was an average of four random measurements shown in the table in 
the top right with SD and plotted on the bar graph at the bottom of the table. An unpaired T-
test was carried out to show significance was <0.0005.  
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Table 5.5 List of MIC values of glycopeptide antibiotics for the control strains and strains 
overexpressing SCO6355. Values are the average of three biological replicates and indicate 
µg/mL of antibiotic needed to prevent any growth on the media. Red values indicate decreased 
resistance when compared to controls. V (Vancomycin), T (teicoplanin), Bal (balhimycin), Ri 
















Figure 5.9 Image of colonies on plates showing the MIC of each strain against the glycopeptide 
antibiotics vancomycin (Top), balhimycin (Middle) and ristocetin (Bottom). Antibiotic 
concentration in µg/mL is shown along the top, and the strains are listed on the left.  
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5.3 Summary  
This section focused on the functional characterisation of the teicoplanin-responsive DE genes 
that were discussed in Chapter 4. The selected genes came from three different categories: the 
three genes in the glycerol operon that relate to glycerol metabolism; two strongly induced 
membrane transporters; and five genes with predicted PAP2 activity. The additional genes 
within the SCO6357-53 operon, SCO6357 and SCO6354-53 were also cloned into pIJ10257 
and conjugated into S. coelicolor to characterise their possible involvement in resistance to the 
glycopeptide antibiotics. Unfortunately, we failed to successfully conjugate either CRISPR 
plasmid into S. coelicolor regardless of any genetic manipulation, and therefore we were not 
able to generate knock-out mutants for any of the selected genes. But, a total of 14 plasmids 
were used in this study (including two pIJ10257 controls) to generate 28 strains of S. coelicolor 
in two different background strains, M600 and ΔvanJ.  
The two background controls (sc10257m and sc10257v) both showed the same pattern of 
sensitivity towards the antibiotic library, but sc10257v was 2 fold more sensitive to 
vancomycin. Overexpressing SCO2472 or SCO3910 increased sensitivity of S. coelicolor to 
teicoplanin regardless of its background but increased sensitivity toward vancomycin was only 
observed in the M600 background strains. Overexpressing any of the three genes from the 
glycerol operon complemented the vancomycin sensitive phenotype seen only in ΔvanJ 
background. Both scSCO1659v and scSCO1660v were 2 fold more sensitive to teicoplanin but 
only in M600 background.  
There were significant changes in the phenotype of S. coelicolor in strains overexpressing 
genes with predicted PAP2 domains. Overexpression constructs within this category 
demonstrated diverse phenotypes towards different cell envelope targeting antibiotics 
suggesting that the products of these genes correlate with the physiology of the cell envelope. 
The amino acid sequences of these genes were compared with the sequences of the predicted 
PAP2-containing protein sequences in closely related Streptomyces. Unsurprisingly, genes that 
produced similar MIC profiles against the antibiotic library were grouped more closely 
together. The distribution of these classes seems to be prevalent in the Streptomyces species 
compared in this study, but further work needs to be done to identify how prevalent these 
classes of PAP are in the actinomycetes and their specific roles in the bacterial membrane.  
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SCO6355 became a focus of this section because overexpression of this single gene 
significantly increased sensitivity to vancomycin and to other cell wall-specific antibiotics such 
as the lantibiotic duramycin. Further MIC and disc diffusion assay tests indicated that 
overexpression of SCO6355 significantly contributed to the sensitive phenotype of S. 
coelicolor toward glycopeptide antibiotics structurally similar to vancomycin. This suggests 
that SCO6355 antagonises the intrinsic vanHAX resistance system in S. coelicolor possibly 
through affecting the composition of the bacterial cell membrane. Understanding the 
mechanistic relationship between SCO6355 and vancomycin will be vital for developing 
strategies that are able to circumvent glycopeptide resistance in glycopeptide resistance 
pathogenic bacteria.   
143 
 
Chapter 6. Investigation of the Production 
of Glycerol as a result of Exposing S. 





Although the MIC data presented in Chapter 5 did not indicate that expressing genes within 
the glycerol operon strongly increases the fitness of S. coelicolor in the presence of the 
antibiotic library tested, we still wanted to explore the possible involvement of glycerol in the 
response to teicoplanin as this is still an unexplored and unreported outcome of glycopeptide 
antibiotics 149 
The glycerol operon is positively induced in the presence of glycerol in the media 203 and it has 
been speculated that it is the G3P generated from the phosphorylation of glycerol by GlpK that 
acts as a positive regulator of the promoter sites in the glycerol operon and the gylR gene 
(Figure 6.1) 222. The glycerol operon is regulated by the product of the gylR gene, which is 
induced by glycerol and weakly repressed by glucose generating a negative feedback loop in 
the presence of glycerol. In S .coelicolor, glycerol is likely the final product in the breakdown 
of phospholipids, being released from G3P before it can be transported back into cells, where 
it can be shuttled into glycolysis or used for further rounds of phospholipid biosynthesis 
(Personal communication with Colin P. Smith, 2020).  
We previously speculated that the large increase in the activity of the glycerol operon could be 
due to the increased degradation of phospholipids, leading to increased concentrations of G3P 
and glycerol in the culture media used to grow S. coelicolor. In this section, we investigate the 
likelihood of phospholipid degradation through the application of a colorimetric assay that is 
able to detect changes in glycerol concentration. To test this hypothesis, a 2-step colourimetric 
assay was designed based on the work of Bompelly and Skaf (2014) who laid out the 
foundations for determining the concentration of glycerol in biodiesel 223. This method relies 
on the oxidation of one molecule of glycerol by periodate (IO4-) to produce two molecules of 
formaldehyde (Figure 6.2A) which can then be quantified using the colourimetric, Nash test 
(Figure 6.2B) 224. The Nash test involves reacting formaldehyde with the ester, acetylacetone 
using ammonium acetate as a catalyst to produce the soluble yellow compound 
diacetyldihydrolutidine (DDL). The amount of light absorbed by DDL can then be used to 
determine the concentration of glycerol in the original sample. 
Further understanding of the molecular processes that bacterial cells carry out in response to 
stressful environments such as those that are created by antibiotics is crucial for indicating how 



















Figure 6.1 The metabolic pathways for glycerol and how these are possibly linked with 
glycolysis and phospholipid biosynthesis in S. coelicolor. Genes involved in biosynthetic 


















Figure 6.2 The two-step reaction to produce two molecules of formaldehyde from glycerol 
under oxidative conditions (A). The reaction found in (B) shows the reaction to produce DDL 




6.2.1 Standard curves to determine the limitations of the colourimetric assay 
Standard curves were produced using both formaldehyde and NMMP spiked with glycerol to 
observe the stoichiometric relationship between the two reactions (Figure 6.3A and B). 
Although both reactions showed strong linear relationships (R2 > 0.95) with clear linear 
boundaries, the curve for NMMP spiked with glycerol was less steep than that observed for 
formaldehyde. There also appeared to be increased background noise in NMMP, indicating 
that one component in NMMP could be reacting with one of the components in either the first 
or second steps of the assay. As a result, the second standard curve with NMMP + glycerol was 
used for the indirect measurement of the concentration of glycerol in subsequent reactions 
(Figure 6.3B). 
6.2.2 Understanding the growth kinetics of S. coelicolor  
A growth curve was carried out for both strains of S. coelicolor to determine the OD540nm of 
cultures grown for 24h in NMMP culture media. Both M600 and ΔvanJ strains were observed 
to have similar growth kinetics with ΔvanJ initially growing more slowly. Both strains reached 
mid-log phase at approximately 18h and reached a maximum observable growth at around 24h, 
after which cultures started to produce antibiotics and it became impossible to get an accurate 
OD reading (Figure 6.4A).  
We also carried out the colourimetric test on the growth media of cultures grown for 12, 15, 18 
and 21h to indicate whether cellular growth influenced the outcome of the assay. Although 
there was a slight decline in the absorbance (OD410nm) in the colorimetric assay at 18h when 
using media from ΔvanJ cultures compared to cultures taken from M600. This demonstrated 
that providing the background noise is taken into consideration, this assay should be suitable 
for indirectly measuring any increases in glycerol produced as a result of antibiotic exposure 
(Figure 6.4B). And, any changes seen in the assay are likely to be a result of exposing cells to 
antibiotic rather than because of cellular growth.  




























Figure 6.3 (A) shows the standard curve for formaldehyde concentration (mM) against 
absorbance (OD410nm). (B) The standard curve for NMMP spiked with corresponding glycerol 
concentrations (mM) against absorbance (OD410nm). The formulae for the curves are displayed 
along with the R2 value in the top right hand corner of each plot. Each point is the average of 













Figure 6.4 Absorbance (OD540nm) for the growth curve of S. coelicolor (A) for M600 (M) and 
ΔvanJ (V) over 24h. The second plot (B), shows the absorbance observed (OD410nm) for the 
colourimetric assay carried out on the supernatants of cultures grown in time (hours) along the 
x-axis. Absorbance readings are the average of three biological replicates, and the horizontal 
dashed line indicates an OD540nm = 0.4 (mid-log growth).    
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6.2.3 Indirect measurement of glycerol production as a result of exposure to 
teicoplanin 
Four antibiotics were assayed against S. coelicolor to identify whether glycerol production was 
specific to teicoplanin. Bacitracin and ramoplanin were selected because they both have 
different targets to teicoplanin, but also target the later stages of PG biosynthesis. Kanamycin 
was selected as a non-cell envelope targeting antibiotic negative control. Lethal concentrations 
of each antibiotic were used to ensure all cells were appropriately ‘challenged’ by each 
antibiotic. Figure 6.5 demonstrates that glycerol concentration increased at 2h and 4h by up to 
8 µM after exposing M600 to teicoplanin, bacitracin and ramoplanin. The effects were minimal 
for the kanamycin control, suggesting that this could be a result of cell envelope targeting 
antibiotics that typically cause cell lysis.  
The same assay was carried out on the ΔvanJ mutant, and although less glycerol was observed 
in the media during earlier time points, glycerol concentrations increased to 8 - 10µM for 
teicoplanin, bacitracin and teicoplanin by 4h. Glycerol concentration also increased by 2 - 4µM 
over the 4h time course after exposing cells to kanamycin, indicating that the observed increase 
in glycerol is likely to be the result of stress and evidently cell death caused by antibiotics. The 
lower perceived glycerol concentration in ΔvanJ at earlier time points could also be a result of 
a decrease in the expression of genes relating to growth when cells are exposed to teicoplanin 
that we presented in Chapter 4. If increases in glycerol are the result of cell death, then less 
cell death may occur in ΔvanJ while processes involved in growth are slowed, if similar 
changes in gene expression are also caused by the other three antibiotics.  
To assess whether the results observed in Figure 6.5 were the result of cell death caused by 
antibiotic dosage, assays were carried out using different concentrations of teicoplanin and 
kanamycin (Figure 6.6). Sub-lethal concentrations of both kanamycin and teicoplanin cause 
decreases in the concentration of glycerol in the media in comparison to the negative control. 
Presumably, this is due to continued cellular growth as a result of sub-lethal concentrations 
used to challenge cells. In contrast, lethal concentrations (10 µg/mL) of both antibiotics caused 
increases in glycerol concentration even after 1h of treatment. These data explain why we saw 
increased expression of genes of the glycerol operon in response to teicoplanin, but have not 



















Figure 6.5 Plots showing the estimated glycerol concentration in M600 and ΔvanJ (VANJ) 
cultures at 2 and 4h after exposing cells to one of four different antibiotics bacitracin, 
kanamycin, ramoplanin and teicoplanin. Experiments are the average of three biological 
















Figure 6.6 Plot showing how the dosage-response of kanamycin and teicoplanin affect the 
estimated glycerol concentration after exposing M600 to each antibiotic for 1, 2 and 4h. 
Antibiotic concentration are shown in the legend and experiments are the average of three 




This chapter has demonstrated that the two-step colourimetric assay first involving the 
oxidation of glycerol, to produce two molecules of formaldehyde, followed by the esterification 
of formaldehyde with acetylacetone to produce DDL, can be used to indirectly measure 
glycerol concentration in cultures of S. coelicolor. Although the assay did produce some 
background noise, this was minimally affected in actively growing cultures. The results from 
these experiments also demonstrated that glycerol was produced as a result of exposure to 
teicoplanin, but similar effects were also observed for both ramoplanin and bacitracin, and with 
higher doses of kanamycin. This dose dependence on glycerol production suggests that glycerol 
production is likely the result of cell death caused by lethal concentrations of antibiotics, rather 
than a specific mechanism as a result of teicoplanin. This would also explain why the glycerol 
operon became more active in the ΔvanJ strain, which is now known to exhibit greater signs 
of cellular stress as a result of teicoplanin, so was likely to experience higher rates of cellular 
death. We also conclude that this effect has not been observed previously because earlier 








7.1 Pre-analysis of the teicoplanin induced RNA-seq dataset  
NGS technologies have progressed the field of RNA biology, giving researchers access to the 
transcriptome in unprecedented detail to identify novel RNAs, and accurately quantify 
transcripts with an almost infinite dynamic range, all without prior knowledge of functional 
genes 136,225. Moreover, providing care is taken during sample preparation and experimental 
design, experimental replicates are typically more congruent 226. In recent years, a consensus 
of a few pipelines for carrying out transcriptomic studies has arisen. That being said, there are 
still steps that must be taken to ensure that minimal bias is introduced into the pipeline.  
The primary source of bias in NGS data comes from the loss of material and quantitative bias, 
but every step in the analysis pipeline can introduce bias into the dataset 138. To prevent the 
loss of material, ideally, RNA molecules would be sequenced in their entirety. Third-generation 
sequencing technologies, such as the Oxford Nanopore Technologies or the Pacific Biosciences 
SMRT systems overcome assembly problems, allowing the recovery of full-length transcripts 
121,145. However, the Illumina technology employed in this work still uses fragmented RNA 
(~50 bp) from purified samples that are then amplified and sequenced as individual fragments. 
These short fragments are aligned to a reference and assembled back into transcripts in silico, 
followed by quantification using statistical software. Additionally, short-read sequencing 
technologies are still more cost-effective and provide much higher accuracy per base. Previous 
groups have attempted to lay out a comprehensive survey for the best practices to date involved 
in RNA-seq 145, and this section will discuss the QC steps taken to ensure confidence in the 
findings. These steps are summarised in Table 7.1.   
7.1.1 Addressing the bias introduced through library construction and NGS 
In this study, two experimental questions were addressed. What were the significant differences 
in the transcriptomes of M600 and ΔvanJ? As well as, what genes are involved in the direct 
transcriptional response to teicoplanin? The experimental set up used to answer these questions 
involved sequencing RNA sampled at 0, 30 and 90 minute time points for M600 and ΔvanJ 
mutant strains after being exposed to teicoplanin (10 µg/mL). Before any core analysis, the 
quality of the sequence data was assessed to ensure that there were minimal sequencing errors.  
Illumina sequencing has come a long way in recent years, but errors commonly occur after 
guanine, and adenines are sometimes substituted for cytosines 227–230.    
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Table 7.1 QC steps that were undertaken during this project to ensure the reliability of the 








Newer HiSeq sequencers released in 2010 improved upon their previous machine, decreasing 
error rates, while increasing data acquisition 228. Even with these advances, the technology can 
still be prone to errors, particularly with sequences that have a high G+C content which would 
be expected in S. coelicolor. The FastQC tool did not indicate any concerns with the quality of 
the data presented in this work, demonstrating that the RNA-extraction produced high-quality 
material for sequencing. 
Each library was sequenced in duplicate, and to a depth of more than 10 million reads, 
theoretically covering the entire S. coelicolor genome (Section 3.2.1). These two factors are 
essential to consider together because even though RNA-seq is usually replicable at the level 
of sequencing, increasing the number of biological replicates improves the statistical inference. 
Sequencing samples to a greater depth captures information from rare or lowly expressed 
transcripts 145, but models have demonstrated that there is a theoretical saturation point for any 
RNA-seq library where increasing depth is limited in the amount of additional statistical power 
it provides. Instead, resources should be put into increasing the number of biological replicates, 
as this will improve the chances of identifying biologically relevant DE 231. This study lacked 
a third replicate, however we discuss how this was dealt with in later sections.  
7.1.2 QC checks for the pre-analysis of the RNA-seq dataset 
Raw RNA-seq data is never used directly for differential expression analysis because library 
differences inherently bias the data. Normalising libraries based on their size is the most 
common method to remove differences in sequence depth. After the transcripts were 
assembled, any counted at less than 1-CPM were removed from the library (Figure 3.3). This 
meant that any reads counted less than 10 - 20 times in any given sample were removed from 
the data, which is justified both statistically and biologically because these RNAs are unlikely 
to be biologically relevant to gene expression. And, failure to remove them would interfere 
with the statistical power of any tools used to identify DE 122. The sequencing process can also 
introduce systemic technical effects leading to differences in the size of each library. Each 
library was normalised using the TMM method to scale each dataset based on their size (Figure 
3.4). Samples VANJ_T30_A and _B both had higher densities of reads than the other samples, 
but after applying the TMM method, the differences in these samples were noticeably reduced. 
The TMM method was used in this work for its efficacy and ease with the limma pipeline 
123,232, but several other suitable normalising methods also exist.  
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The limma + voom pipeline was implemented for this study as limma performs on par with 
other DE statistical software such as edgeR, NOISeq and DESeq2, while effectively controlling 
FDR even with smaller sample sizes making it appropriate for our smaller dataset 123,233,234. 
Limma was initially used for linear modelling in microarray analysis but has recently been 
updated to make it accessible for count-based RNA-seq data. One thing to take into 
consideration from this pipeline was that statistical analysis for microarray data worked on the 
basis of fluorescence data which was assumed to be normally distributed. RNA-seq data 
consists of direct counts, and it has been argued that count-based statistics should be used. A 
property of count-based data is that it has unequal variability even after log transformation, and 
larger counts have more significant standard deviations 234. The voom tool provides a way of 
removing the mean-variance relationship (Figure 3.5), giving a visual representation of the 
mean and variance are not independent of each other before applying the algorithm. This 
heteroscedasticity of the data is decreased by the incorporation of voom’s precision weights 
within limma’s empirical Bayes statistics. A secondary feature of the voom plots also indicates 
whether lowly expressed genes were filtered adequately, as lowly expressed genes would 
accumulate nearer the origin 234. As this did not occur, it was assumed that the filtering step 
had been carried out effectively.  
7.1.3 Most of the variation observed between the two strains occurs at the 30 
minute time point 
Previous work has demonstrated that VanJ is an anchored protein with an N-terminal 
membrane-spanning region and an external-facing catalytic domain. There are no phenotypic 
differences in the sensitivity of both M600 and vanJ towards teicoplanin because teicoplanin 
is a poor-inducer for VanS in S. coelicolor 115. The PCA in Chapter 3 (Figure 3.6) indicated 
that there are substantial differences in the gene expression of both strains at the 30 minute 
time point. The PCA highlighted that the 0 and 90 minute time points are more similar than the 
30 minute time points suggesting the initial genetic response to teicoplanin differs in both 
strains. This was an unexpected outcome because van gene transcription is tightly controlled 
by the VanR/VanS TCS in S. coelicolor. Because of this, the concentration of VanJ is believed 
to be negligible when no or very poor inducers are present.  
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7.1.4 Using the TREAT method to identify DEGs 
Identifying DEGs is a challenge in every RNA-seq pipeline. Mathematically, any gene that 
differs in its expression level from one condition to another is statistically significant if enough 
replicates are carried out. However, the biological significance of such changes may be trivial 
if the change in abundance is low relative to other genes 124. On top of this, it is also becoming 
more apparent that changes in transcription do not always equate to physiological outcome 
235,236. It is essential to implement thresholds that define the limits of what can be classified as 
a DEG to control the FDR or biologically insignificant DE.  
Historically, log-fold changes and P-values have been used, but independently they both suffer 
type I error or do not take gene-wise variability into account 124,237. The TREAT method 
combines elements from previous methods, to test for a more representative measure of 
differential expression 124. Although considered relatively conservative, the TREAT method 
has been shown to outperform other t-test based methods for differential expression analysis, 
while effectively controlling the FDR. The number of DEGs were drastically reduced in each 
pairwise comparison demonstrating the profound effect this method has on the data. A more 
stringent 2-fold cut-off was used as a means of compensating for having fewer biological 
repeats, and making it more likely that biologically significant genes would be identified.  
The differences seen in both strains at 30 minutes was an unexpected outcome as we knew that 
teicoplanin is a weak inducer for the expression of van genes, so it was assumed that deleting 
vanJ would not have a significant impact on the teicoplanin susceptibility of S. coelicolor 110. 
However, we noted that there were significant differences in the number DEGs between the 30 
minute time points of M600 and ΔvanJ strains, as shown by comparison E and H (Table 3.3). 
There were substantially more DEGs in ΔvanJ, demonstrating the pleiotropic effects caused by 
the loss of vanJ when cells are exposed to teicoplanin. This supports the hypothesis proposed 
from the PCA in Figure 3.6, that most of the variation between the datasets occurs at the 30 
minute time points and that VanJ may play a role in transcriptional regulation within S. 
coelicolor.  
Here we present for the first time, evidence that there is activity of VanJ in the presence of 
teicoplanin in S. coelicolor even though teicoplanin is a poor inducer of the van system. 
Secondly, we also show that it is likely that VanJ has a role to play in the immediate response 
to teicoplanin as the expression profiles of both strains differs most at 30 minutes after exposure 
160 
 
to the antibiotic. However, as there is less variation between the strains at later time points, the 
loss of VanJ must be compensated for during later time points in ΔvanJ.  
7.1.5 A cluster analysis demonstrated the profound differences in the initial 
response to teicoplanin between the two strains 
To elaborate on a possible role for VanJ in S. coelicolor, DEGs were clustered into seven 
distinct clusters in order to make them more manageable than a larger dataset. A second benefit 
of clustering is that genes that are regulated similarly are more likely to be grouped together as 
genes that are regulated in a similar way are more likely to share similar regulatory pathways 
and be involved in corresponding functional processes 142. 
Again, this data offers further supported that there were significant differences in how the two 
strains responded to teicoplanin. From the data, seven distinct clusters were produced that could 
be classified into four different groups depending on their regulation within the two strains. 
Clusters 2, 4 and 6 all contained genes that were mostly DE in ΔvanJ, confirming that there is 
a different response to teicoplanin in the absence of vanJ (Figure 3.7). Clusters 3, 5 and 7 
contained genes that were induced in both strains, but it was clear from Cluster 3 and 5 that 
genes within these clusters are induced more slowly within ΔvanJ (Figure 3.7).  
Though the specific role of VanJ remains elusive, the evidence presented here demonstrates 
that the weak induction of VanJ caused by teicoplanin is enough to profoundly affect the gene 
expression of M600 in comparison to ΔvanJ. VanJ belongs to a broad class of EEP enzymes 
which all cleave phosphate groups, but can be involved in many different cellular functions. 
Other bacterial members of this family include YafD from Samonella enterica, which provides 
resistance to egg yolk albumin 238,  and Spy0747 from Streptococcus spp. which is believed to 
be a nuclease involved in virulence 239. The enzymatic processes encoded for by EEP domains, 
could suggest that VanJ may have some role in cell signalling, but how this occurs is still 
unclear. We discuss this further in the following section and how this relates to the regulatory 
systems of S. coelicolor, but further work will need to be carried out to elucidate the 





7.2 Genome-wide transcriptional analysis of the response of 
M600 and ΔvanJ towards teicoplanin 
To interpret the DE analysis and identify higher biological functions that were affected by 
teicoplanin exposure, two approaches were used to assign meaning to the RNA-seq dataset. 
The goal of using these two methods was not for comparison, but instead to gain a better idea 
of how teicoplanin affected the gene expression in both strains. The first method used 
information currently available on the genome of S. coelicolor. The second attempted to assign 
a higher biological function to each of the genes found within each cluster through an 
enrichment analysis using a gene ontology (GO) database. The former method is more 
laborious, requiring extensive knowledge of the genetics of S. coelicolor, however it allows 
more freedom when you want to obtain information about biological processes with limited 
information. The second method was a more efficient method for assigning function to genes 
but relies on curated databases which can quickly become outdated for organisms are not well 
studied. This section will look at the genes that were identified using either of the two methods 
and what can be inferred from the DEGs 122,125,126.  
7.2.1 Differences observed in signal transduction systems and how this gives 
insight into a possible role for VanJ 
In the previous section, it became clear that there were critical differences between the 
responses of the two strains to teicoplanin, and analysis of the DEGs highlighted that this likely 
occurs because of the deregulation of certain transcriptional regulators. Both strains showed 
increased activity in regulators for cell envelope, oxidative and osmotic stress responses, with 
declines in the latter during later time points. This is supported by data on other cell wall 
targeting antibiotics and shows the overlap of stress responses for seemingly different types of 
cell stress149.  
What was apparent between the two strains was that genes involved in the σE signal 
transduction system remained active across the 90 minutes. This confirmed previous work and 
demonstrated the immense cell wall stress caused by teicoplanin in S. coelicolor 100. In the 
presence of glycopeptides such as vancomycin, expression of the σE signal transduction system 
declines as the van genes are induced. This gradually decreases cell wall stress over time until 
the damage can be rectified in cells. The lack of decline observed in M600 and more so in 
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ΔvanJ, demonstrates how potent teicoplanin is to these cells. We were surprised to see that the 
loss of vanJ, strongly affected the rate of induction for the σE signal transduction system which 
may suggest that VanJ is involved in activating CseC SK. Currently, the nature of ligand 
perceived by the CseC sensor protein is unknown, but due to its ability to respond to a broad 
range of cell envelope stress factors, it is improbable that each of these factors can act as the 
direct ligand. Instead, it has been suggested that CseC may detect an intermediate that 
accumulates as a result of cell envelope damage. Alternatively, a biophysical property of the 
cell envelope, such as turgor pressure could activate CseC 151. Our data is more logically 
explained by the first theory, as an intermediate generate through the action of VanJ could 
interact with CseC increasing the rate of induction. However, as there is still induction of the 
signal transduction system, the intermediate could still be accumulated through other unknown 
mechanisms, leading to the delayed response observed in ΔvanJ.  
7.2.2 The σE regulon and its likely importance in response to teicoplanin  
The σE regulon within S. coelicolor was recently published, and it emphasised the pleiotropic 
nature of this sigma factor 150. It has been found to regulate over 50 targets with direct 
implications in PG biosynthesis, cell wall teichoic acid deposition, sporulation, and membrane 
surface modifications. Unsurprisingly, a number of the genes mentioned in Chapter 4 also 
belonged to the σE regulon (Figure 7.1), with all genes showing increased activity in both 
strains after exposure to teicoplanin. As previously discussed, genes in ΔvanJ were induced at 
a slower rate than in M600, but the activity for most of these genes was similar to that of M600 
by 90 minutes.  
The regulon included four PBPs (SCO1875, SCO2897, SCO4847, and SCO5039) were 
included in this list with SCO1875, SCO2897 and SCO5039 previously implicated in resistance 
to vancomycin 149. The mprF gene also belongs to this regulon and has been found to protect 
cells against the osmotic stress caused by bacitracin, vancomycin, and CAMPs by modifying 
the net charge of the membrane by adding lysyl-groups to PG, reducing the interactions at the 
membrane surface 53,54,149. Finally, several genes with predicted roles in phospholipid 
metabolism were also found in the σE regulon. Of these, this included a gene encoding predicted 
phospholipase (SCO2892) as well as genes encoding PAPs (SCO2807, SCO4133 and the 












Figure 7.1 Heatmap showing the relative changes in log2 fold expression for genes in the 
published σE regulon mentioned in this work between M600 and ΔvanJ strains. Key in the 




Together it is likely that there is a broad response to teicoplanin with many genes working 
synergistically to enact a defence against this drug. Further functional characterisation of some 
of these individual genes will be required to pinpoint which genes if any are more important in 
response to teicoplanin, however the ones tested in this study did not affect the sensitivity of S. 
coelicolor towards teicoplanin (Section 7.3). 
7.2.3 ΔvanJ mutant exhibits more significant cellular stress than the wild 
type M600 in response to teicoplanin 
Streptomyces are non-motile bacteria that cannot move to new sources of nutrition during times 
of starvation. Instead, Streptomyces switch from vegetative growth to reproductive growth, 
producing secondary metabolites and spores which are more capable of surviving in adverse 
conditions than vegetative cells. There are many factors involved that control these intricate 
processes 240,241. However, one of the more important factors is the highly phosphorylated 
guanine nucleotide (p)ppGpp master regulator, known as the stringent factor. The stringent 
factor is generated predominantly by the ribosome-bound RelA, which synthesises the stringent 
factor from ATP and GTP when an uncharged tRNA binds the acceptor site of a translating 
ribosome during times of nutritional stress 148,242–244. The increased intracellular pool of 
stringent factor directly binds the RNA-polymerase, directing gene transcription away from 
genes involved in growth, including stable RNAs (Figure 4.2), ribosomal proteins (Figure 
4.2), DNA replication (Figure 4.4), FAB (Figure 4.10), PG biosynthesis (Figure 4.7) and 
membrane lipids (Figure 4.11). Conversely, genes involved in other stress responses (Figure 
4.1), proteolysis, amino acid metabolism (Figure 4.5), cellular communication, antibiotic 
resistance and morphological development (Figure 4.6) are all known to be positively 
regulated by the stringent factor in Streptomyces 148,149,245.  
Although no significant changes in the expression the ppGpp synthetase, relA were observed 
(data not shown), the data presented here indicate that teicoplanin affects similar processes as 
ppGpp. Hesketh et al., (2011) have previously commented on this effect, where vancomycin, 
bacitracin and moenomycin all modulated the gene expression of S. coelicolor as if ppGpp was 
being synthesised. However, ppGpp could not be detected after exposure to vancomycin, so it 
was suggested that cell wall targeting antibiotics could modulate some of the same genes as 
ppGpp or trigger the same signalling cascades. It is not clear why these processes are more 
significantly affected in ΔvanJ, but the absence of VanJ and the subsequent delay in activating 
the cell envelope stress response could mean ΔvanJ relies on other stress responses to cope 
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with the stress caused by the drug immediately after exposure until alternative pathways can 
be switched on. This further demonstrates the important role of VanJ in the presence of 
teicoplanin. 
7.2.4 Developmental genes that were influenced by teicoplanin exposure 
As we have discussed, teicoplanin affects S. coelicolor similarly to ppGpp, which is activated 
under nutritional stress. We also found evidence that some genes involved spore development 
were also induced in response to teicoplanin including the chaplin genes, the ramCSAB operon, 
ssgB and the late spore developmental genes whiI, sigF and whiE orfs I-IV and VIII. Sporulation 
occurs in S. coelicolor, usually during a nutritional downshift, leading to a colony-wide shift 
from vegetative growth to reproductive growth 172,178. Streptomyces rarely sporulate in 
submerged cultures, and it is believed that S. coelicolor fails to progress from the pre-
sporulation stage of development to form mature spores in submerged culture. Transcriptomic 
analysis of cultures grown on solid and liquid substrates have shown a surprisingly small 
number of differences in the activity of genes in the two different conditions. Failure to progress 
developmentally appears to relate to the inactivity of genes involved in the hydrophobic coat 
or spore pigment and includes the chpF, rdlA and the whiE genes 246. 
Studies have demonstrated that modifying the media with calcium and proline 178, mechanically 
breaking large mycelial clumps into smaller fragments 172, over-expressing ssgA 247, or 
knocking out argR 248 can all lead to the production of spore-like structures in S. coelicolor. 
However, even though these structures are morphologically related to spores, they are often 
less stable than true spores 178. Although the complexities of sporulation in submerged cultures 
are still poorly understood in S. coelicolor, there was evidence to suggest that teicoplanin 
induced several systems involved in the production of spores in the absence of VanJ. 
Interestingly, there were indications that some of the late sporulation genes mainly involved in 
spore pigment production and hydrophobic coat formation were transiently activated in 
response to teicoplanin in vanJ (Figure 4.6). This information, along with the induction of 
several genes involved in hydrophobic coat formation and late spore development, could 
implicate that a developmental shift from mycelial growth to sporulation is a survival strategy 
for ΔvanJ, however further work will need to be carried out to identify whether these 
transcriptomic changes relate to phenotypic changes in spores. . 
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Remarkably, both strains also prominently overexpressed the wbl genes, whiB and whiD. whiB 
encodes a developmental regulator that regulates the length of aerial hyphae and location of 
sporulation septa and the regulator encoded by whiD, which is involved in the maturation of 
cell wall in developing pre-spores 185. Curiously, whiB is also part of the σE regulon, and some 
whiB homologues in M. tuberculosis can be induced in response to particular cell wall stress 
249 indicating that whiB could be broadly involved in the cell wall stress response. Both whiB 
and whiD also belong to an actinomycete specific gene family which encode Wbl-proteins with 
[4Fe-4S] clusters, that have redox properties 188. The Wbl proteins are known to interact with 
the gaseous molecules of nitric oxide (NO) which has an essential role in many bacterial 
processes including host defence, AMR and cellular communication during development in the 
Streptomyces 188,250,251. We did note that after exposure to teicoplanin, genes involved in the 
NO metabolic processes were induced in both strains. If NO is generated as a result of the 
stressful conditions caused by teicoplanin, it could act as one of the regulatory ligands for the 
Wbl-proteins and promote the development of spores 241. Both proteins may broadly slow the 
growth of hyphae and thicken the cell walls of spores, which we hypothesise could counteract 
the effects of teicoplanin by preventing lysis in a subset of the population, and possibly ensure 
the survival of some spores from the colony until teicoplanin is no longer at lethal 
concentrations.  
7.2.5 Changes in arginine metabolism could be linked to osmoprotection  
Genes relating to the regulation and biosynthesis of arginine were strongly induced in both 
strains (Figure 4.5). This also included the pleiotropic negative regulator of the arg genes, 
ArgR, which has also been demonstrated to positively regulate the expression of ACT and RED 
through comparisons of an argR knockout strain with wild type cells in S. coelicolor 248. 
Arginine itself is an essential precursor for several secondary metabolites in the Streptomyces, 
including clavulanic acid from Streptomyces clavuligerus NRRL 3585 and streptomycin from 
Streptomyces griseus 252,253. There is little information available on the role of arginine in 
secondary metabolite production in S. coelicolor and to our knowledge it is not involved in the 
synthesis of ACT or RED. Nevertheless, in S. coelicolor, arginine has been found to increase 
in concentration in response to increased salt stress, suggesting that it could act as an 
osmoprotectant alongside ectoine and proline 170. Previously published studies have 
demonstrated that vancomycin increases the concentration of arginine residues in the cytosolic 
fraction supporting the evidence that arginine could be acting as an osmolyte in the presence 
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of glycopeptide antibiotics 204. It would be interesting to develop this further and identify 
whether arginine is necessary for tolerating glycopeptides and why this is the case. It would 
also be interesting to identify whether similar outcomes are also observed in clinical pathogens 
which could identify whether the arginine pathway could be a future drug target providing the 
enzymes involved in this pathway were sufficiently different from eukaryotic counterparts. 
7.2.6 Elevated transcription of olsAB in ΔvanJ further suggests that 
teicoplanin induces developmental processes 
Ornithine is one of the intermediates in arginine biosynthesis, and it can also be used in the 
production of clavulanic acid in S. clavuligerus 252. In S. coelicolor, it is involved in the 
production of the phosphate-free membrane lipid, OL. The data here not only presented 
increases in the expression of genes involved in arginine biosynthesis but also olsAB in the 
ΔvanJ background (Figure 4.11). olsAB are required for the production of OL in bacterial 
membranes, and this membrane lipid has been identified in S. coelicolor cultures that are in the 
later stages of development or under phosphate limiting conditions 60. There were no 
indications of phosphate starvation in either strain of S. coelicolor (data not shown) therefore 
it seems likely that the increased activity of these genes could be linked to the increased activity 
seen in genes relating to spore maturation and development. Further work would need to be 
done to understand whether these genes are related to antibiotic resistance as the literature 
currently does not indicate any relationship between OL production and the glycopeptide 
antibiotics, but with OL being a zwitterionic phospholipid, this does not rule out that there 
could be additional changes in membrane charge brought about in ΔvanJ after exposure to 
teicolanin.  
7.2.7 Changes in membrane transport  
Membrane transporters are essential for cellular function, allowing the selective transport of 
metabolites, either actively or passively across the membrane. They are implicated in protein 
secretion 254, provide either self- or acquired-resistance to antibiotics 29,255, regulate the 
membrane potential 256 and are also involved in the flippase activity required to transport 
charged lipid carriers involved in the biosynthesis of cell wall polymers 46. Both SCO3824 and 
SCO4359 encode proteins belonging to the ABC-transporter superfamily, which use ATP to 
actively transport a broad range of substrates (Figure 4.8). Many drugs such as macrolides and 
bacitracin are transported across the membrane in this manner 29,255. Neither gene has been 
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reported to be involved in the general cell envelope stress response of S. coelicolor, but ABC-
transporters are frequently identified in cell envelope stress regulons for different antibiotics 
191,257–259. Although it is not clear what role these transporters play in response to glycopeptide 
antibiotics, they are possibly involved in the removal of toxic metabolites such as free radicals, 
from the cell, if they cannot be metabolised.  
A gene encoding the third membrane transporter, SCO3910, was also upregulated in response 
to teicoplanin. Predicted to encode a MOP transporter (Figure 4.8), which are widespread 
amongst eukaryotes and prokaryotes and couple substrate export with the flow of K+/Na+ ions 
down an electrochemical gradient 193,260. Not only are they prolific transporters for toxic 
metabolites, they are also implicated in the transport of intermediates that are used in the 
generation of cell wall glycans such as PG, LPS and the capsular polysaccharide in bacteria 261. 
Although there were no increases seen in the activity of genes involved in PG biosynthesis in 
response to teicoplanin, vancomycin-intermediate S. aureus (VISA) has been known to have 
unusually thick cell walls that prevent the drug from reaching the membrane surface. As there 
were no increases observed for genes involved in PG biosynthesis, it is unlikely that SCO3910 
is exporting PG precursors, but there is still the possibility that it may play a role in the transport 
of other lipid carriers that could prevent the access of teicoplanin to the membrane 257. 
SCO2472 has not previously been implicated in the cell envelope stress response to other 
antibiotics in S. coelicolor 149 (Figure 4.8). However, its homologues sanA from E. coli and 
sfiX from Salmonella typhimurium are both implicated in restoring intrinsic vancomycin 
resistance in vancomycin-sensitive mutant strains. The expression of sanA is also essential for 
determining the sensitivity of E. coli to detergents and bile salts, suggesting that these genes 
could be broadly specific for in environments that affect the outer membrane of Gram-negative 
bacteria 192,219. SCO2472 showed an extraordinary increase in activity in response to 
teicoplanin in both M600 and vanJ mutant strains, suggesting that SCO2472 may also play a 
role in the barrier function of S. coelicolor towards teicoplanin, however it is unclear whether 
this gene will have the same function in S. coelicolor as it lacks an outer membrane. 
7.2.8 Evidence of phospholipid remodelling in S. coelicolor cell membrane in 
response to teicoplanin  
Bacterial membranes are highly dynamic structures and are remodelled continuously in 
response to environmental changes 60. Clear evidence for phospholipid remodelling was 
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identified in this study, showing that this is one response to teicoplanin exposure (Figure 4.12). 
Other genes have previously been identified, which remodel the membrane surface affecting 
its properties towards cell wall stress. mprF was strongly upregulated in this dataset and is 
known to form part of the σE regulon and provides resistance to both vancomycin and bacitracin 
in S. coelicolor 149,150. The product of mprF was first identified as an enzyme that could reduce 
the overall negative charge at the surface of bacterial membranes by adding lysine groups to 
PpG 53. In doing so, bacteria can broadly prevent molecules such as cyclic antimicrobial 
peptides, daptomycin and vancomycin from reaching their target sites at the membrane surface 
53,262,263.    
Several other genes that are likely to play roles in the modification and turn-over of membrane 
phospholipids were also upregulated. Two major groups of enzymes have been identified to be 
involved in phospholipid turn-over in bacteria, and they prevent the accumulation of 
phospholipid degradation products that could affect the membrane architecture 58. These 
include the phospholipases and PAP2 enzymes. A group of genes encoding lipases were 
identified in the cluster analysis including SCO3222 which was predicted to encode a PLA2 
enzyme responsible for cleaving the 2-acyl bond of glycerophospholipids, producing a fatty 
acid and an LPA 194,197. The gene encoding PLA1 responsible for cleaving the 1-acyl bond of 
glycerophospholipids in S. coelicolor is currently unknown, but one other gene from this 
ontology, SCO2892, could fulfil this role. The SCO2892 protein is uncharacterised but has the 
SGNH-fold that is found in a promiscuous group of enzymes that have broad hydrolytic 
activities including the E. coli thioesterase I/protease I/lysophospholipase (TAP) protein, with 
broad specificity for mono-acyl phospholipids, such as LPA 198. The products of SCO3222 and 
SCO2892 may work in unison to liberate fatty acids from phospholipids in response to 
teicoplanin.  
The role of enzymes containing PAP2 domains is becoming more prominent in membrane 
homeostasis because of their prolific phosphatase activity. Other members of this family 
include BcrC from Bacillus sp. and PgpB from E. coli. BcrC is a UPP-phosphatase that 
competes with bacitracin for its target, UPP, increasing bacitracin resistance when expressed 
45. PgpB is more diverse in its phosphatase activity and has not only demonstrated UPP-
phosphatase activity but the ability to cleave a wide range of phosphodiesters 68. Three genes 
with PAP2 domains have previously been described in S. coelicolor including ippα (SCO1102) 
and ippβ (SCO1753) which are involved in the production of DAG from PA in the 
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triacylglycerol (TAG) biosynthesis pathway 264. The product of SCO6355 is also predicted to 
belong to this family; however, no functional role has previously been assigned 67. A BLAST 
search revealed that 15 other genes encoded PAP2 domains in the S. coelicolor genome. 12 out 
of 15 genes were differentially expressed in response to teicoplanin with six positively 
regulated in both strains. The genes, ippα and ippβ were not differentially expressed, but 
SCO6355 was along with the SCO6537-53 operon. There appeared to be converse regulation 
of SCO7587 in comparison to those positively induced PAP2 genes highlighting that these 
genes could have distinct functions within the membrane. The strain specificity observed in the 
increased expression of SCO1047, SCO4843 and SCO6428 also supported that these genes 
may have specific roles in each strain and that the transient inducted of these genes in particular 
may also be linked to the increase in developmental genes associated with spore development 
previously discussed in the ΔvanJ background. 
Further support for the remodelling of the cell membrane came from an increase seen in the 
two GDPD encoding genes and the glycerol operon. GDPDs carry out the final step of 
phospholipid recycling by degrading glycerophosphodiesters that are released during the 
catabolism of phospholipids through lipases and PAP2s 199,200. This allows cells to recycle the 
liberated G3P which can then be used for further phospholipid biosynthesis or as a carbon 
source if converted to DHAP 62. The process that transports G3P back into cells is not known 
in S. coelicolor, but the GlpT transporter carries out this role in E. coli. It is also not entirely 
clear if S. coelicolor possess a G3P-phosphatase to degrade G3P into glycerol and Pi, but we 
know that glycerol is passively transported back into cells aided by the facilitator, GlpF. The 
kinase, GlpK and the G3P-dehydrogenase, GlpD are encoded for by adjacent genes in the 
glycerol operon and are responsible for the phosphorylation of glycerol to G3P and the 
dehydration of G3P to DHAP. The operon these genes belong to is strongly induced in the 
presence of glycerol 202,203, which we observed in our dataset suggesting that there are 
significant increases in glycerol which likely originated from the membranes of bacteria 
through either phospholipid degradation or lysis of neighbouring cells. Further understanding 
of the mechanisms behind this observation will be important in developing our understanding 




7.3 Functional analysis of selected genes 
7.3.1 Challenges with generating knock out mutants using CRISPR 
Both overexpression and knock out strains are essential tools in functional genomics for 
studying the roles of specific genes. The methods for overexpressing genes in S. coelicolor 
have been well established, but the historical methods of gene editing were time-consuming 
and somewhat limited 265. They also did not allow for adequate multiplexing of knockouts 
which can be necessary for Streptomyces due to the high level of redundancy within their 
genomes. At the time of these experiments, four CRISPR toolkits were available for the 
Streptomyces spp. which have previously been reviewed 266.  
We pursued two novel CRISPR systems that were supposedly optimised for the Streptomyces 
spp. The pCRISPomyce-2 plasmid has been used with high success to engineer several species 
of Streptomyces including S. lividans 130.  The novel Streptomyces pCRISPomyces-2 plasmid 
system was engineered to target the vanRS cluster in M600. Theoretically, knocking out vanRS 
should strongly sensitise strains of S. coelicolor to vancomycin so identification of desired 
mutants would be easy to identify with replica plating on selective and non-selective media. 
Unfortunately, we were unable to obtain any successful exconjugants as confirmed by PCR, 
for the pCRISPomyces-2 CRISPR vector nor its derivative plasmids pCRvanRS-1 and -2. 
Since the time of this study, Wang et al., (2016) have published a more comprehensive protocol 
for gene editing with this system in the Streptomyces 265.  
We also tested a second CRISPR plasmid, pKCcas9dO because it has previously been 
successfully conjugated into S. coelicolor M145 131. However, we also failed to conjugate this 
plasmid into M600. It has been suggested that some CRISPR plasmids are toxic to strains of S. 
coelicolor such as M600 (M. Hutchings, personal communication) due to the generation of 
DSB at off-targets 266. To curtail this problem, a novel CRISPR system has been developed, 
which involves DSB-free editing. The CRISPR-cBEST system instead can convert a single 
cytidine to thymine, allowing the insertion of stop codons into DNA sequences with high-
fidelity 267. Theoretically, this system simplifies the amount of genetic manipulation needed to 
edit the genome and can be multiplexed to improve the outcome of CRISPR in Streptomyces. 
There is currently the intention for this work to be carried on through a future MRes project to 
confirm whether it is possible to use either of the two DSB or DSB-free CRISPR editing 
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methods in S. coelicolor M600. This will become an invaluable tool for understanding the 
relationship of the genome and the phenotype of cells in the presence of different antibiotics.  
7.3.2 The influence of the glycerol operon on the susceptibility of S. coelicolor 
towards glycopeptide antibiotics  
The glycerol operon consists of glpFKD and is known to contribute to escalating the rate of 
diffusion of glycerol across the membrane via a membrane transporter encoded by glpF 
(Figure 5.6). Once glycerol diffuses across the membrane, it is phosphorylated by GlpK to 
produce G3P. G3P can be used for phospholipid biosynthesis or shuttled into the glycolytic 
pathway after being converted to DHAP by the product of glpD 62. These genes in the glycerol 
operon were selected for functional study in S. coelicolor M600 and vanJ background strains 
for MIC testing against a library of antibiotics. The library consisted of six antibiotics that 
targeted PG biosynthesis, two antibiotics that targeted the cell membrane, one antibiotic that 
inhibited DNA replication and one antibiotic that inhibited protein synthesis (Table 5.1).  
The glycerol operon of S. coelicolor is subject to catabolite repression, being inhibited in the 
presence of glucose, but induced in the presence glycerol 203. It has been proposed that the 
system is in place to help maintain intracellular concentrations of G3P, which acts as a building 
block for cell wall teichoic acids and phospholipids, or can be converted to DHAP and shuttled 
into glycolysis 202,203. The glycerol operon is not known to be involved in the response to 
vancomycin in S. coelicolor nor is it involved in the response to other cell wall targeting 
antibiotics. GlpD has been shown to be essential for the tolerance for the beta-lactam, 
ampicillin and ofloxacillin, and deletion of this gene decreases the amount of persister cells in 
chronic E. coli infections which is important in the development of multidrug tolerance 268. 
Overexpression of glpF or glpK results in S. coelicolor becoming more sensitive to teicoplanin, 
but this result was observed only in the ΔvanJ background. Intriguingly, integration of plasmids 
containing any gene from the glycerol operon led to the suppression of the vancomycin-
sensitive phenotype in the ΔvanJ strain (Table 5.3). It is not clear why this occurs, but possibly 
the same mechanism that promotes persister cell formation in E. coli, may also benefit ΔvanJ 
in the presence of vancomycin, possibly through increasing the amount of DHAP available for 
glycolysis 202. Alternatively, glycerol can also act as an osmoprotectant in some species such 
as yeast 269, and may therefore provide protection from the increased osmotic stress caused by 
teicoplanin. Both of these hypotheses could be involved in counteracting the negative impact 
of the loss of VanJ, restoring high-level vancomycin resistance to ΔvanJ background strains 
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7.3.3 The results of the colourimetric test suggest that lethal concentrations 
of antibiotics lead to increased concentration of glycerol in the media 
MIC testing suggested that some of these glycerol operon genes could be decreasing the 
sensitivity to vancomycin in the ΔvanJ background mutant, so we were still interested in 
exploring the mechanisms behind the strong induction of the glycerol operon in response to 
teicoplanin. Using a colourimetric assay developed by Bompelli and Skaf (2014), we were able 
to quantify the concentration of glycerol in cultures of S. coelicolor after exposure to antibiotics 
in Chapter 6. The assay has previously shown to be reasonably robust in complex mixtures of 
biodiesel containing complex macromolecules 223. The NMMP media used to grow submerged 
S. coelicolor cultures was also found to generate background noise, which could be offset with  
absorbance values that were adjusted to take into consideration a ‘media control’. We also 
found that the assay was replicable, providing the incubation periods were strictly followed, 
and samples were stored on ice while setting up each reaction.  
The data generated in Figure 6.5 supported the hypothesis that glycerol concentration did 
increase in the media after exposure to teicoplanin, but this was also observed for the other cell 
wall targeting antibiotics bacitracin and ramoplanin. Furthermore, a dosage response indicated 
that the concentration of antibiotic applied to the sample affected the concentration of glycerol 
in the media, with higher concentrations of both teicoplanin and kanamycin causing the same 
response (Figure 6.6). Together these data suggest that the increase in glycerol concentration 
might be the result of lethal concentrations of antibiotic which in turn lead to increased activity 
on the glycerol operon rather than a specific mechanism involved in the response to teicoplanin. 
The greater increase in these genes in ΔvanJ is likely due to the loss of VanJ in its membrane, 
which we now know leads to increased cellular stress, and therefore are likely to exhibit greater 
cellular death in response to teicoplanin.  
7.3.4 The negative impact of SCO2472 and SCO3910 on glycopeptide 
sensitivity 
Two genes from the ‘response to drug’ ontology were also selected and overexpressed to see 
their effect on the MIC of glycopeptide antibiotics. SCO2472 was chosen for its strong 
resemblance to the E. coli, sanA and S. typhimurium, sfi genes. Although these Gram-negative 
bacteria usually show intrinsic resistance to vancomycin, both of these genes have been 
implicated in complementing a vancomycin-sensitive phenotype in their respective strains 
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192,219. Overexpression of the sanA gene also abolishes sensitivity to detergents, and Rida et al. 
(1996) suggest that sanA could, therefore, be broadly implicated in the barrier function of E. 
coli. Unexpectedly, overexpressing SCO2472 increased sensitivity to teicoplanin in both 
background strains and increased sensitivity to vancomycin in the M600 background strain. It 
can be hypothesised that SCO2472 may have a different function in the cell envelope in Gram-
positive bacteria, or both genes form part of the general cell stress response. The other gene 
selected for overexpression study was SCO3910. With a predicted MOP domain, this gene 
belongs to a family of genes encoding membrane transporters that have broad functionality. 
This includes the predicted lipid II flippase, MurJ, the E. coli multidrug resistance protein, 
MtdK, and the glycolipid transporters for cell wall glycans 38,220,261. The same phenotypes were 
observed in strains overexpressing SCO3910 as SCO2472 (Table 5.3). Further work still needs 
to be done to identify whether overexpression of these genes increases the susceptibility of S. 
coelicolor to other cell wall specific antibiotics. However, it is clear that they both negatively 
impact the function of the cell envelope and likely increase cellular stress in the presence of 
glycopeptide antibiotics.  
7.3.5 The involvement of PAPs in the maintenance of the cell membrane in 
the presence of cell envelope targeting antibiotics 
PAPs are a large family of enzymes found in prokaryotes and eukaryotes, with roles in cleaving 
phosphodiester bonds found in many membrane lipids. They all can be characterised by a 
KXXXXXXRP-(X12-54)-PSGH-(X31-54)-SHXXXD (PAP2) motif 270. Prominent members of 
this family include BcrC and PgpB which are both involved in resistance to bacitracin 45,68,69,271. 
Ippα and Ippβ have been characterised in S. coelicolor for their role in TAG biosynthesis, 
cleaving PA to produce DAG in the TAG biosynthetic pathway 264. The diverse functionality 
of these enzymes made them an exciting group of genes to pursue for their potential 
involvement in their response to teicoplanin.  
The data presented here demonstrated that overexpressing some of the PAP encoding genes in 
S. coelicolor widely affects sensitivity towards a range of cell wall targeting antibiotics. 
SCO2335/SCO2807 and SCO6356/SCO6511 showed close phylogenetic relationships along 
with highly similar MIC profiles against the antibiotic library when overexpressed, indicating 
that the pairs are functional homologues. The subtle differences in the MIC patterns between 
these gene pairings also support the hypothesis that there are subclasses of PAP in the S. 
coelicolor genome.  
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The overexpression of any of these PAP genes increased the sensitivity of S. coelicolor to the 
majority of cell envelope targeting antibiotics. We note that this is in stark contrast to other 
membrane modifying enymes such as MprF which is known to add lysyl groups to PG 
decreasing the negative charge of the membrane and broadly increasing resistance to osmotic 
stress caused by CAMPs, vancomycin, bacitracin, moenomycin and daptomycin 53,54,66,272. It is 
plausible that the PAPs presented here could be carrying out an opposing role that increases 
the negative charge of the membrane by generating negatively charged membrane lipids. 
Decreased concentrations of PpG in the membrane are associated with high resistance to 
antibiotics such as vancomycin and daptomycin 273, so it is rational to assume that 
overexpressing these genes could be generating a higher concentration of PpG in the 
membrane. Alternatively, as these PAP genes were all upregulated in response to teicoplanin; 
one cannot also rule out the possibility that these genes may also work cooperatively, which 
could explain why any strain expressing genes encoding PAPs, including the three genes 
(SCO2807, SCO6355 and SCO6356) that belonged to the σE regulon 150, did not show any 
increase in resistance to teicoplanin. Understanding these mechanisms is important because 
these enzymes are widely distributed amongst bacteria, including clinical pathogens, and 
therefore may serve as future drug targets to exploit.  
7.3.6 The proposed role of SCO6355  
Although the function of the SCO6357-53 operon remains to be understood, overexpression of 
SOC6355 appears to sensitise S. coelicolor to a narrow range of glycopeptide antibiotics 
(vancomycin, balhimycin and ristocetin) which it normally displays high-level resistance to 
and the lantibiotic duramycin. Interestingly, however, overexpression of this gene did not 
change the susceptibility of S. coelicolor toward the lipoglycopeptides (e.g. teicoplanin, 
telavancin, dalbavancin and oritavancin), chloroeremomycin (Table 5.5) or vancomycin 
derivatives with putrescine substituted onto the seventh amino acid and a vancomycin-
putrescine derivative with a chlorobiphenyl group (data not shown). The protein-coding 
sequence of SCO6355 also showed a close phylogenetic relationship with Ippα and Ippβ 
(Figure 5.10). From this information, several hypotheses can be proposed about the possible 
function of SCO6355 in S. coelicolor.  
Firstly, overexpressing SCO6355 made S. coelicolor hypersensitive to the class I type B 
lantibiotic duramycin. This 19 amino acid tetracyclic peptide that is effective against both 
Gram-positive bacteria and some fungi, and it is known to specifically target zwitterionic 
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ethanolamine phospholipids which includes one of the most abundant bacterial phospholipids, 
PE 274,275. Annotated sequence data has shown that SCO6355 lacks the phosphatidylserine 
decarboxylase domain present in Psd that is used to convert PS to PE. Instead, its product may 
generate a more unstable phospholipid such as PA from either PG or CL, that is shuttled along 
the PE biosynthetic pathway indirectly increasing the abundance of PE 67. It is also possible 
that the product of SCO6355 could carry out a multiplicity of reactions similar to PgpB from 
E. coli, generating several membrane lipids, including PE, that make S. coelicolor more 
sensitive to these specific antibiotics.  
Secondly, the specificity of the glycopeptide sensitive phenotype observed in SCO6355 
overexpressing construct is not affected by the core heptapeptide backbone structure. The core 
structure of ristocetin is more similar to teicoplanin with the heptapeptide backbone containing 
an asparagine and leucine that is replaced by two arylglycine residues (1, 3). In contrast, 
vancomycin shares only a macrocyclic tetrapeptide (4-7) with ristocetin which is invariant 
except for the extent of chlorination of ring 6. Additionally, vancomycin, balhimycin and 
chloroeremomycin all share the same aglycone, yet the sensitivity to chloroeremomycin does 
not change in strains overexpressing SCO6355 (Figure 5.1) 72,276,277. The presence of either an 
aryl- or alkyl- hydrophobic side chain is an important factor in determining whether or not 
there is a change observed in the MIC as all lipoglycopeptide antibiotics, including a 
vancomycin putricine-derivative, showed no changes in MIC when comparing controls with 
strains overexpressing SCO6355.  
Other than lipophilic side chains, glycopeptides are commonly modified with the halogens (Br 
or Cl) and can be glycosylated with an assortment of sugars that can range from the modest 
aglycone structure to the elaborately decorated ristocetin which adorns six sugar residues 78. 
These modifications can improve solubilisation, provide structural rigidity and alter the 
propensity of some glycopeptides to form cooperative dimers 277–279. The sugars that are present 
on position 6 are more important than those in position 4 for increasing the likelihood of 
forming dimers, but the sugar residues help to form a sophisticated network of hydrogen bonds 
on the ‘back-face’ of the molecule (Figure 1.15). There is speculation that this improves the in 
vitro activity of some glycopeptides such as chloroeremomycin which strongly dimerises, over 
other glycopeptides like vancomycin, which weakly associates with itself 279–281. Dimerisation 
also helps to bury hydrophobic surfaces, but if the expression of SCO6355 affects 
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electrochemical properties near the surface of the membrane the propensity of some 
glycopeptides to dimerise at the membrane surface may increase, improving their activity.  
Together these two bits of information suggest overexpressing SCO6355 may increase the 
amount of zwitterionic phospholipid PE in the membrane by decreasing the overall negative 
charge of the cell surface. As a result, S. coelicolor becomes more sensitive to duramycin, 
which targets PE, sequestering it in the membrane. Many modifications to the cell envelope 
also affect the sensitivity of cells to other drugs, and in this case vancomycin, balhimycin and 
ristocetin, which all show increased activity against strains of S. coelicolor expressing 
SCO6355. What sets these antibiotics apart from other glycopeptides like teicoplanin is that 
they lack a hydrophobic side chain. In general, glycopeptide antibiotics containing hydrophobic 
side chains poorly dimerise in comparison with other counterparts such as chloroeremomycin. 
It seems possible that the surface modification that is induced by the product of SCO6355 
increases the ability of these three glycopeptide antibiotics to dimerise at the cell surface, 
improving their biological activity (Figure 7.2). Alternatively, this modification could also 
interfere with the ability of S. coelicolor to identify the cell wall damage through existing 
sensory systems or even the VanS sensor kinase to recognise these drugs as ligands. Further 
experiments will need to be carried out to identify whether either of these hypotheses is correct. 
Together, this information could also be used to develop strategies for improving the efficacy 
of vancomycin-like glycopeptides in glycopeptide-intermediate and resistant pathogens; 
however, more work still needs to be done to understand the mechanisms behind the 












Figure 7.2 Diagram to show the possible mechanisms of both MprF and the SCO6355 proteins 
in the S. coelicolor cell membrane. MprF is known to decrease the overall negative charge of 
the membrane by converting PpG to lysl-PpG, which increases resistance to high osmotic stress 
and drugs that target the cell envelope. We propose that in this work that the SCO6355 PAP 
could be carrying out an opposing role, as cells overexpressing SCO6355 became 
hypersensitive specifically to duramycin and exhibited intermediate level resistance towards a 
narrow group of vancomycin like glycopeptide antibiotics. By affecting the electrochemical 
properties of the bacterial membrane, the activity of these antibiotics is modulated 
demonstrating the importance of the bacterial membrane in the mechanism of action of many 
drugs that target the cell envelope. PG, peptidoglycan, CM, cell membrane, +, positively 
charged membrane lipids, -, negatively charged membrane lipids.   
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7.4 Conclusions and future perspectives  
The first aim of this study was to identify the transcriptomic differences between S. coelicolor 
M600 and a ΔvanJ mutant strain in response to the lipoglycopeptide antibiotic, teicoplanin. In 
doing so, it was hoped that a possible role for the teicoplanin specific resistance marker, VanJ, 
could be elucidated. The evidence presented here demonstrated that there were profound 
differences in the transcriptomic responses of the two strains to teicoplanin. This was regardless 
of teicoplanin acting as a poor inducer of the endogenous glycopeptide resistance cluster TCS, 
VanR/VanS. From this, we can conclude that even significantly marginal levels of the VanJ 
protein in the wild type S. coelicolor membrane can still influence drastic transcriptomic 
changes different from a background lacking vanJ. 
There were approximately double the number of DEGs in ΔvanJ compared to M600 after 30 
minutes when cells were exposed to teicoplanin. Transcriptomic profiling also demonstrated 
that ΔvanJ cells presented more signs of cellular stress, with systems involved in active growth 
downregulated during earlier time points. Activation of transcriptional regulators involved in 
the cell envelope induction system was delayed in ΔvanJ when compared with M600, which 
indicated that VanJ could be involved in the activation of CseC. As transcription of the system 
did still occur in ΔvanJ, VanJ is likely not the only mechanism involved in activating the 
induction system in the presence of teicoplanin. We also found that some of the genes involved 
in late spore development were unexpectedly induced in ΔvanJ, and two developmental 
regulators whiB and whiD were induced in both strains. We propose that the processes 
regulated by these genes may have a role in counteracting the effects of teicoplanin 
To further understand these dynamics, we want to carry out several quantitative Real-Time 
quantitative Reverse Transcription PCR (qRT-PCR) studies on how the expression of some of 
these genes are affected between wild type M600, ΔvanJ mutant and a vanJ overexpressing 
strain of S. coelicolor. Further studies also need to be carried out to distinguish whether the 
developmental genes involved in sporulation and development that were transiently 
upregulated in ΔvanJ truly relate to morphological changes. Developmental changes such as 
antibiotic production can be seen with the naked eye in broth, but morphological changes 
should be visible with light or fluorescent microscopy to visualise spore development. There 
is also an intention to extend the transcriptomic data presented here to include data on the three 
other clinically approved lipoglycopeptide antibiotics oritavancin, dalbavancin and telavancin, 
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to compare with the data in response to teicoplanin in this study. Together, these data would 
indicate how similarly lipoglycopeptides affect the transcriptome of S. coelicolor and how 
VanJ may protect S. coelicolor from teicoplanin.  
The second aim of this project was to investigate novel genes for their potential involvement 
in the adaptive response to teicoplanin. A list of genes were selected for their potential 
involvement in cell envelope homeostasis. Although overexpression strains were generated 
from this list of genes, it proved impossible to generate any CRISPR knock out mutants using 
both the pCRISPomyces-2 and pKCcas9dO vector systems as both appeared lethal in M600. 
However, a newer DSB-free CRISPR system that involves less genetic manipulation in cells 
has been developed that we hope will work in M600 267. If this system works in S. coelicolor, 
it will also allow the multiplexing of knockouts to identify the architecture of antimicrobial 
resistance networks. This will prove invaluable for studying whether any of the genes in this 
study could have been working synergistically with other genes. As no single gene was 
demonstrated to increase resistance to teicoplanin, it could be that this particular gene list 
required the interplay of other factors to affect the sensitivity profile to teicoplanin.  
We found a family of PAP that specifically increase the susceptibility of S. coelicolor to 
different groups of cell envelope targeting antibiotics. Genes with the PAP2 functional domain 
have been implicated in several functional roles within bacterial membranes, including 
bacitracin resistance and phospholipid turnover. Phenotypic data based off of the PAP genes 
studied indicate that there are at least three different subclasses of PAP within S. coelicolor. 
Combined with the phylogenetic analysis, this value could be much higher. There are 
indications that the functional subclasses are essential for membrane functionality due to the 
sensitisation of S. coelicolor to a broad range of antibiotics when overexpressing different 
members of this gene family.  
One member of this family, SCO6355, was particularly interesting as it generated a 
hypersensitive phenotype toward the lantibiotic duramycin while creating intermediate levels 
of sensitivity to several glycopeptide antibiotics, including vancomycin. Because the 
overexpression of SCO6355 made cells hypersensitive to duramycin, it is likely its product 
increases the concentration of PE in the membrane as this is the direct target for duramycin. 
The close phylogenetic relationship SCO6355 has with Ippα and Ippβ indicates that SCO6355 
could also be involved in the synthesis of DAG. It is not uncommon for PAP to produce 
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multiple products, but further work will need to be carried out to understand the mechanism of 
this enzyme.  
Understanding how SCO6355 increases sensitivity towards vancomycin will be vital in 
understanding how to counteract endogenous resistance systems such as the van cluster. 
Further experiments will include the purification of the SCO6355 protein for the 
characterisation of its enzyme kinetics, allowing us to identify its target specificity. We also 
want to use mass spectrometry or thin-layer chromatography to further characterise the lipid 
profile of S. coelicolor in response to teicoplanin and other glycopeptide antibiotics so that we 
can highlight whether changes in the phospholipid makeup of the membrane is involved in 
responding to teicoplanin. We also would extend this work to cover strains overexpressing PAP 
to identify their involvement in membrane lipid homeostasis.  
Final thoughts 
Although more work needs to be carried out to understand the mechanism of VanJ, this study 
has stressed the importance of VanJ in the presence of teicoplanin within S. coelicolor. 
Furthermore, the action of VanJ is likely to involve multiple systems within S. coelicolor which 
work synergistically to maximise resistance towards teicoplanin-like glycopeptide antibiotics. 
We also demonstrate that the second group of membrane enzymes, the PAP, are implicated in 
the barrier function of the cell. Increasing their expression levels harms the fitness of S. 
coelicolor in the presence of different groups of cell wall targeting antibiotics. We became 
particularly interested in one of these genes, SCO6355 because its overexpression produced 
intermediate levels of resistance towards vancomycin, ristocetin and balhimycin, as well as a 
hypersensitive phenotype against duramycin. S. coelicolor usually exhibits high-level 
resistance to vancomycin due to its native van resistance system indicating that overexpressing 
SCO6355 interferes with this mechanism, resulting in increased potency of vancomycin and 
similar glycopeptides. Although we cannot conclude the exact mechanism by which this 
occurs, it is clear the expression of SCO6355 improves the in vivo activity of these drugs. 
Understanding how this occurs could be instrumental in developing novel vancomycin 
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Appendix: Genes identified as differentially expressed in either strain of this RNA-seq dataset comparing T30/T0 or T90/T30 time points. Fold-
change (FC) is also shown next to the adjusted P-value which is highlighted in red if value <0.05. 
SCO_ID Annotation Gene Function 
M600 T30 - T0 M600 T90 - T30 VANJ T30 - T0 
VANJ T90 - 
T30 
FC adj.P.val FC adj.P.val FC adj.P.val FC adj.P.val 
                        
Carbon utilisation 
      
  
   
SCO1214 ATP-dependent 6-phosphofructokinase 3 pfkA3 Glycolysis 0.6 n/s 0.8 n/s 0.2 3.0E-21 2.4 4.3E-06 
SCO1930 Cytochrome c oxidase assembly protein subunit 15 
 
cytochrome biosynthesis 0.3 1.9E-10 1.1 n/s 0.2 2.2E-21 2.4 6.0E-04 
SCO1934 Protoheme IX farnesyltransferase   cytochrome biosynthesis 0.3 3.3E-10 0.8 n/s 0.1 2.2E-25 2.4 1.5E-04 
SCO1942 Glucose-6-phosphate isomerase 2 pgi2 Glycolysis 0.7 n/s 0.9 n/s 0.2 3.1E-16 3.2 9.0E-11 
SCO1945 Triosephosphate isomerase tpiA Glycolysis 0.7 n/s 0.8 n/s 0.2 4.4E-24 3.3 6.0E-17 
SCO1946 Phosphoglycerate kinase pgk Glycolysis 0.8 n/s 0.8 n/s 0.2 1.8E-22 3.6 6.1E-18 
SCO1947 Glyceraldehyde-3-phosphate dehydrogenase gap1 Glycolysis 0.7 n/s 0.6 n/s 0.2 3.6E-26 2.7 1.1E-14 
SCO2014 Pyruvate kinase pyk1 Glycolysis 0.7 n/s 0.8 n/s 0.2 6.1E-21 3.2 2.4E-15 
SCO2126 Glucokinase glk Glycolysis 0.6 n/s 1 n/s 0.2 1.9E-21 3.3 7.0E-15 
SCO2736 citrate synthase citA TCA cycle 2.8 4.7E-05 0.8 n/s 1.1 n/s 1.9 n/s 
SCO3096 Enolase 1 eno1 Glycolysis 0.9 n/s 0.9 n/s 0.3 1.2E-18 3.4 1.3E-18 
SCO3311 Delta-aminolevulinic acid dehydratase hemB cytochrome biosynthesis 0.2 1.2E-15 1.3 n/s 0.2 1.8E-20 1.7 n/s 
SCO3317 Putative uroporphyrin-III C-
methyltransferase/uroporphyrinogen-III synthase 
  cytochrome biosynthesis 0.4 2.2E-03 1.4 n/s 0.2 1.0E-13 3 5.5E-07 
SCO3318 Porphobilinogen deaminase 1 hemC1 cytochrome biosynthesis 0.3 2.4E-12 1.1 n/s 0.2 6.9E-23 1.8 n/s 
SCO3319 putative glutamyl-tRNA reductase hemA cytochrome biosynthesis 0.4 5.2E-05 1.3 n/s 0.2 1.3E-19 1.9 n/s 
SCO3649 Fructose-bisphosphate aldolase fba Glycolysis 0.8 n/s 0.8 n/s 0.2 1.3E-22 3.1 1.8E-15 
SCO4808 succinyl-CoA synthetase beta chain sucC TCA cycle 0.6 n/s 0.9 n/s 0.2 5.3E-28 3.5 2.4E-20 
SCO4809 succinyl CoA synthetase alpha chain sucD TCA cycle 0.6 n/s 1 n/s 0.2 1.3E-26 3.6 9.3E-20 
SCO4827 malate dehydrogenase mdh TCA cycle 0.8 n/s 0.7 n/s 0.3 4.2E-18 3.8 9.5E-18 
SCO4855 Succinate dehydrogenase iron-sulfur subunit dhsB TCA cycle 0.4 3.5E-12 0.9 n/s 0.1 1.8E-27 2.8 2.8E-11 
SCO4856 putative succinate dehydrogenase flavoprotein subunit dhsA TCA cycle 0.3 7.8E-15 0.8 n/s 0.1 5.6E-29 2.6 1.8E-09 
SCO4858 putative succinate dehydrogenase membrane subunit 
 
TCA cycle 0.3 1.1E-13 0.7 n/s 0.1 9.5E-26 3 1.6E-09 
SCO5226 ribonucleotide-diphosphate reductase large chain nrdL Nucleotide biosynthesis  0.6 n/s 0.7 n/s 0.3 7.8E-16 1.7 n/s 
SCO5281 putative 2-oxoglutarate dehydrogenase 
 
TCA cycle 0.4 9.9E-15 1.4 n/s 0.1 2.1E-30 4.1 8.4E-22 
SCO5370 ATP synthase delta chain atpH ATP production 0.6 n/s 1.5 n/s 0.2 4.1E-27 4 1.5E-21 
SCO5371 ATP synthase alpha chain atpA ATP production 0.5 6.9E-04 1 n/s 0.1 1.4E-29 3.3 5.1E-19 
SCO5372 ATP synthase gamma chain atpG ATP production 0.6 n/s 1.1 n/s 0.2 1.1E-26 3.7 1.2E-19 
SCO5373 ATP synthase beta chain atpD ATP production 0.5 n/s 1 n/s 0.2 1.3E-28 3.3 1.2E-18 
SCO5374 ATP synthase epsilon chain atpC ATP production 0.5 n/s 0.9 n/s 0.2 3.5E-25 2.8 7.6E-12 
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SCO5423 Pyruvate kinase pyk2 Glycolysis 0.6 n/s 1 n/s 0.2 8.7E-25 3.7 1.2E-17 
SCO5859 ferrochelatase hemH cytochrome biosynthesis 0.5 n/s 1.4 n/s 0.2 1.2E-16 2.8 4.7E-09 
SCO6031 uroporphyrinogen decarboxylase hemE cytochrome biosynthesis 0.3 9.2E-10 1.2 n/s 0.2 1.1E-21 2.5 8.8E-05 
SCO7000 isocitrate dehydrogenase idh TCA cycle 0.8 n/s 0.8 n/s 0.2 4.6E-23 3.6 2.0E-19         
  
   
DNA Replication           n/s         
SCO2162 Quinolinate synthetase A  nadA Nucleotide biosynthesis  1 n/s 0.7 n/s 0.4 9.8E-12 3.2 1.1E-14 
SCO3543 DNA topoisomerase I topA DNA replication 0.7 n/s 1.1 n/s 0.3 1.9E-18 2.8 1.3E-12 
SCO3873 DNA gyrase subunit A  gyrA DNA replication 0.8 n/s 0.9 n/s 0.2 6.2E-23 2.9 1.1E-14 
SCO3874 DNA gyrase subunit B gyrB DNA replication 1.2 n/s 1 n/s 0.2 6.6E-22 3.7 1.7E-18 
SCO5803 SOS regulatory protein lexA DNA repair 1.2 n/s 0.9 n/s 0.4 3.6E-08 3 5.5E-11 
SCO5805 ribonucleotide reductase nrdJ DNA replication 0.7 n/s 0.9 n/s 0.2 2.7E-24 2.9 2.9E-14 
SCO5812 Ribonuclease HII rnhB DNA replication 0.9 n/s 0.4 6.0E-03 0.3 2.9E-17 1.4 n/s 
SCO5822 putative DNA gyrase subunit B gyrB2 DNA replication 0.6 n/s 1.1 n/s 0.2 1.6E-23 3.7 3.2E-17 
SCO5836 DNA gyrase  
 
DNA replication 0.4 4.6E-08 1.1 n/s 0.1 8.5E-25 2.7 3.6E-09 
                        
Translation 
       
  
   
SCO0436 50S ribosomal protein L32-2 rpmF2 Translation 0.9 n/s 1.8 n/s 0.8 n/s 1.1 n/s 
SCO0569 50S ribosomal protein L36 2 rpmJ2 Translation 1.7 n/s 0.9 n/s 0.6 n/s 2.8 6.4E-04 
SCO0570 50S ribosomal protein L33 3 rpmG3 Translation 1.4 n/s 1.1 n/s 0.6 n/s 2.1 n/s 
SCO1150 50S ribosomal protein L31 type B 1 rpmE2-1 Translation 6.6 6.6E-11 0.5 n/s 2.2 n/s 1.3 n/s 
SCO1505 30S ribosomal protein S4 rpsD Translation 0.6 n/s 1 n/s 0.2 7.3E-27 3.2 3.4E-17 
SCO1598 50S ribosomal protein L20 rplT Translation 0.8 n/s 0.7 n/s 0.3 1.1E-20 2.2 5.1E-04 
SCO1599 50S ribosomal protein L35 rpmI Translation 0.9 n/s 0.7 n/s 0.3 2.1E-18 2.4 2.2E-08 
SCO1600 Translation initiation factor  infC Initiating translation 1 n/s 0.9 n/s 0.7 n/s 1.4 n/s 
SCO2533 Endoribonuclease  ybeY Maturation of rRNA 5.8 8.5E-24 0.9 n/s 1.5 n/s 2.7 2.3E-11 
SCO2563 30S ribosomal protein S20 rpsT Translation 0.6 n/s 0.8 n/s 0.2 2.1E-26 2.9 2.0E-14 
SCO2596 50S ribosomal protein L27 rpmA Translation 0.4 5.2E-05 0.7 n/s 0.1 5.9E-28 2.1 n/s 
SCO2597 50S ribosomal protein L21 rplU Translation 0.5 n/s 1 n/s 0.1 6.7E-29 3.5 3.3E-19 
SCO2599 Ribonuclease E   Maturation of rRNA 2.4 4.4E-10 1.4 n/s 4.2 4.6E-10 1.8 n/s 
SCO2972 Peptide chain release factor 2 prfB Terminates translation 0.5 n/s 1.1 n/s 0.2 2.2E-21 3 1.2E-10 
SCO3009 Ribosome hibernation promoting factor hpf Arresting translation 5.5 2.6E-22 1.1 n/s 1.8 n/s 5.7 1.1E-23 
SCO3397 putative integral membrane lysyl-tRNA synthetase mprF lysyl-tRNA synthesis 11.8 2.7E-30 0.6 n/s 2.9 2.2E-13 2.4 1.3E-09 
SCO3425 putative 30S ribosomal protein S18 rpsR2 Translation 1.6 n/s 1.1 n/s 2.7 n/s 0.3 n/s 
SCO3427 50S ribosomal protein L31 type B 2 rpmE2-2 Translation 1.4 n/s 1.4 n/s 1.7 n/s 0.7 n/s 
SCO3429 50S ribosomal protein L28-2 rpmB2 Translation 0.8 n/s 1.2 n/s 3.5 3.8E-02 0.2 9.8E-03 
SCO3430 putative 30S ribosomal protein S14 rpsN Translation 1.1 n/s 1.2 n/s 3 1.3E-02 0.1 4.1E-06 
SCO3778 putative threonyl tRNA synthetase   threonyl-tRNA synthesis 13 2.3E-17 0.6 n/s 8.9 9.4E-14 0.7 n/s 
SCO3880 50S ribosomal protein L34 rpmH Translation 0.4 5.6E-04 0.6 n/s 0.1 2.9E-26 2.7 1.1E-09 
SCO3906 putative 30S ribosomal protein S6 rpsF Translation 0.3 8.5E-16 0.8 n/s 0.1 9.8E-29 2.4 3.7E-07 
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SCO3908 putative 30S ribosomal protein S18 rpsR Translation 0.3 8.6E-12 1 n/s 0.1 2.0E-26 3.3 6.3E-14 
SCO3909 50S ribosomal protein L9 rplI Translation 0.4 7.5E-12 1.1 n/s 0.1 1.2E-27 2.8 1.8E-11 
SCO4278 Ribosome associated protein 
 
Peptide release 15.6 3.0E-23 0.7 n/s 8.1 8.9E-15 2.5 1.6E-05 
SCO4635 50S ribosomal protein L33 2 rpmG2 Translation 0.4 3.2E-04 0.6 n/s 0.1 1.2E-27 1.9 n/s 
SCO4648 50S ribosomal protein L11 rplK Translation 0.5 n/s 1.1 n/s 0.2 1.5E-27 3.7 9.3E-20 
SCO4649 50S ribosomal protein L1 rplA Translation 0.5 n/s 0.9 n/s 0.2 1.2E-27 3.5 2.1E-19 
SCO4653 50S ribosomal protein L7/L12 rplL Translation 0.6 n/s 1.1 n/s 0.2 4.5E-28 3.1 7.6E-18 
SCO4659 30S ribosomal protein S12 rpsL Translation 0.7 n/s 0.8 n/s 0.2 7.7E-25 2.5 6.8E-10 
SCO4660 30S ribosomal protein S7 rpsG Translation 0.7 n/s 0.7 n/s 0.2 3.3E-24 2.2 4.2E-05 
SCO4701 30S ribosomal protein S10 rpsJ Translation 0.4 1.7E-10 1 n/s 0.1 3.2E-28 2.2 3.1E-03 
SCO4702 50S ribosomal protein L3 rplC Translation 0.5 3.4E-03 0.9 n/s 0.1 7.8E-29 2.7 7.1E-13 
SCO4703 50S ribosomal protein L4 rplD Translation 0.5 7.7E-05 0.9 n/s 0.1 5.2E-29 2.9 4.5E-15 
SCO4704 50S ribosomal protein L23 rplW Translation 0.6 n/s 0.9 n/s 0.2 6.5E-27 2.8 1.8E-14 
SCO4706 30S ribosomal protein S19 rpsS Translation 0.5 n/s 0.7 n/s 0.2 3.5E-25 2.2 5.4E-03 
SCO4707 50S ribosomal protein L22 rplV Translation 0.6 n/s 0.8 n/s 0.2 1.1E-24 2.9 5.0E-14 
SCO4708 30S ribosomal protein S3 rpsC Translation 0.9 n/s 1.3 n/s 0.2 8.2E-18 4.2 6.4E-18 
SCO4709 50S ribosomal protein L16 rplP Translation 0.9 n/s 1 n/s 0.3 3.7E-17 3.7 1.1E-15 
SCO4710 50S ribosomal protein L29 rpmC Translation 0.9 n/s 0.9 n/s 0.2 9.8E-19 3.2 1.1E-13 
SCO4711 30S ribosomal protein S17 rpsQ Translation 0.8 n/s 1.2 n/s 0.2 1.9E-19 3.6 2.5E-16 
SCO4712 50S ribosomal protein L14 rplN Translation 0.9 n/s 0.9 n/s 0.3 3.6E-16 2.7 3.0E-08 
SCO4713 50S ribosomal protein L24 rplX Translation 0.7 n/s 0.7 n/s 0.2 3.4E-13 2.3 n/s 
SCO4715 30S ribosomal protein S14 rpsN Translation 0.8 n/s 0.8 n/s 0.3 6.0E-16 2.6 2.3E-07 
SCO4716 30S ribosomal protein S8 rpsH Translation 0.6 n/s 1.1 n/s 0.2 2.0E-22 3.2 1.9E-13 
SCO4717 50S ribosomal protein L6 rplF Translation 0.7 n/s 1 n/s 0.2 8.7E-26 3.6 4.5E-20 
SCO4718 50S ribosomal protein L18 rplR Translation 0.7 n/s 1 n/s 0.2 3.4E-24 3.2 1.1E-15 
SCO4719 30S ribosomal protein S5 rpsE Translation 0.7 n/s 1 n/s 0.2 4.0E-26 3.3 2.6E-19 
SCO4720 50S ribosomal protein L30 rpmD Translation 0.7 n/s 1.1 n/s 0.2 1.8E-20 3.6 1.3E-16 
SCO4721 50S ribosomal protein L15 rplO Translation 0.7 n/s 0.9 n/s 0.2 3.2E-25 3 2.5E-16 
SCO4725 Translation initiation factor IF-1 infA Starts translation 0.7 n/s 0.9 n/s 0.2 1.7E-24 3.2 3.2E-16 
SCO4726 50S ribosomal protein L36 1 rpmJ1 Translation 0.7 n/s 1.1 n/s 0.2 4.3E-22 3 1.8E-13 
SCO4727 30S ribosomal protein S13 rpsM Translation 0.5 n/s 0.7 n/s 0.2 1.9E-25 2.5 2.3E-09 
SCO4728 30S ribosomal protein S11 rpsK Translation 0.7 n/s 1.1 n/s 0.2 1.6E-23 3.9 5.6E-20 
SCO4730 50S ribosomal protein L17 rplQ Translation 0.9 n/s 1.2 n/s 0.2 3.9E-24 3.2 6.2E-19 
SCO4734 50S ribosomal protein L13 rplM Translation 0.5 2.3E-05 0.8 n/s 0.1 4.8E-29 2.7 5.6E-13 
SCO4735 30S ribosomal protein S9 rpsI Translation 0.4 1.6E-14 0.7 n/s 0.1 2.6E-29 4.2 2.3E-21 
SCO5252 Dihydrofolate reductase    Nucleic acid biosynthesis 3.6 2.5E-14 0.5 n/s 1.1 n/s 1.9 n/s 
SCO5359 50S ribosomal protein L31 rpmE Translation 0.5 n/s 0.8 n/s 0.2 8.2E-24 3 1.7E-13 
SCO5360 Peptide chain release factor 1 prfA Terminates translation 0.5 n/s 1.1 n/s 0.2 1.5E-23 3 1.7E-11 
SCO5564 50S ribosomal protein L28-1 rpmB1 Translation 0.3 3.5E-18 0.7 n/s 0.1 3.5E-30 1.9 n/s 
SCO5571 50S ribosomal protein L32-1 rpmF1 Translation 0.6 n/s 0.8 n/s 0.2 5.7E-24 3 1.3E-12 
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SCO5591 30S ribosomal protein S16 rpsP Translation 0.6 n/s 0.9 n/s 0.2 3.9E-28 2.6 5.9E-11 
SCO5595 50S ribosomal protein L19 rplS Translation 0.4 1.4E-13 0.7 n/s 0.1 1.3E-27 2.3 1.1E-05 
SCO5624 30S ribosomal protein S2 rpsB Translation 0.5 n/s 1 n/s 0.2 1.6E-27 3.4 7.6E-19 
SCO5708 Ribosome binding factor   Maturation of rRNA 4.5 1.2E-20 0.7 n/s 1.1 n/s 2.3 4.1E-05 
SCO5709 Pseudouridine synthase 
 
rRNA modification 3.7 3.1E-18 1 n/s 1 n/s 3.7 1.9E-18 
SCO5736 30S ribosomal protein S15 rpsO Translation 0.4 5.2E-06 1.2 n/s 0.1 3.0E-26 3.3 7.7E-15 
SCO5796 GTPase hflX Possible role in protein synthesis 28.2 8.7E-35 0.8 n/s 8.6 4.1E-27 2.8 1.1E-16 
                        
Transcription 
      
  
   
SCO0600 RNA polymerase sigma factor sig8 σB Sigma factor 5.3 1.4E-24 0.4 3.3E-08 1.3 n/s 3.1 5.2E-16 
SCO0803 putative RNA polymerase sigma factor 
 
Sigma factor 4.1 3.9E-17 1 n/s 1.3 n/s 2.5 2.9E-07 
SCO0870 putative two-component system response regulator   Histidine kinase response regulator 0.2 4.5E-12 0.7 n/s 0.1 1.0E-19 1.8 n/s 
SCO0871 putative two-component sensor protein 
 
Histidine kinase response regulator 0.3 4.6E-12 0.9 n/s 0.1 8.2E-23 1.7 n/s 
SCO1876 putative RNA polymerase sigma factor   Sigma factor 48.4 1.3E-24 1.5 n/s 7.6 1.4E-16 3.6 3.5E-16 
SCO2110 putative eukaryotic-type serine/threonine protein kinase pkaF Serine/threonine response regulator 4.6 4.6E-22 1 n/s 1.2 n/s 2.7 1.3E-11 
SCO2639 putative RNA polymerase sigma factor   Sigma factor 28.2 2.3E-18 1.3 n/s 6.8 7.4E-11 2.4 4.1E-04 
SCO2666 putative serine/threonine protein kinase 
 
Serine/threonine response regulator 5.3 5.0E-22 1 n/s 1.4 n/s 2.3 4.2E-05 
SCO2974 serine/threonine protein kinase pkaA Serine/threonine response regulator 3.2 1.3E-15 0.9 n/s 1 n/s 2.7 9.5E-11 
SCO3202 RNA polymerase principal sigma factor σhrdD Sigma factor 22.6 6.0E-29 0.9 n/s 4.9 2.6E-18 0.6 n/s 
SCO3356 ECF sigma factor σE Sigma factor 14.2 2.9E-32 0.9 n/s 4.6 1.9E-22 2.9 3.9E-17 
SCO3358 two-component system response regulator cseB Histidine kinase response regulator 14.8 1.5E-28 0.9 n/s 3.6 2.0E-14 3.2 3.1E-16 
SCO3613 putative RNA polymerase sigma factor   Sigma factor 6 9.3E-24 0.8 n/s 1.6 n/s 2.2 2.0E-04 
SCO3821 serine/threonine protein kinase pksC Serine/threonine response regulator 5.1 3.7E-24 0.8 n/s 1.5 n/s 2.6 3.4E-12 
SCO4005 putative RNA polymerase sigma factor   Sigma factor 74.6 1.0E-26 0.5 n/s 26.5 1.4E-20 1.7 n/s 
SCO4155 putative two-component system sensor 
 
Histidine kinase response regulator 13.7 7.0E-25 1.3 n/s 4.4 8.2E-15 2.9 6.2E-13 
SCO4156 putative two-component systen response regulator   Histidine kinase response regulator 21.8 1.3E-24 1.3 n/s 5 9.6E-14 4.4 1.8E-18 
SCO4895 putative ECF sigma factor 
 
Sigma factor 4.7 1.2E-17 0.7 n/s 2 n/s 1.8 n/s 
SCO4908 putative RNA polymerase sigma factor σQ Sigma factor 182.9 5.1E-25 0.6 n/s 54.8 7.2E-18 2.7 6.2E-08 
SCO5147 putative ECF-subfamily sigma factor 
 
Sigma factor 9.5 1.3E-27 0.9 n/s 2.6 6.2E-09 4.2 2.2E-21 
SCO5216 RNA polymerase sigma factor σR Sigma factor 2.9 1.4E-13 0.7 n/s 0.8 n/s 2.7 4.5E-11 
SCO5934 putative sigma factor 
 
Sigma factor 9.2 1.2E-14 1.8 n/s 3.2 1.2E-04 3.3 3.5E-10 
SCO6520 putative RNA polymerase sigma factor   Sigma factor 7.2 4.0E-20 0.5 n/s 1.9 n/s 2.1 n/s 
SCO7278 putative RNA polymerase sigma factor σL Sigma factor 3 5.2E-13 0.4 1.5E-05 0.6 n/s 2.6 1.2E-08 
SCO7314 probable RNA polymerase sigma factor σM Sigma factor 9.6 2.1E-23 0.7 n/s 1.8 n/s 5.2 2.3E-19 
SCO7327 putative two-component system sensory histidine kinase 
 
Histidine kinase response regulator 0.5 3.1E-02 0.7 n/s 0.2 5.0E-19 0.6 n/s 
                        
Amino acid metabolism 
      
  
   
SCO1570 argininosuccinate lyase argH Arginine biosynthesis  14.7 1.5E-29 0.8 n/s 4.8 1.2E-19 2.8 8.3E-14 
SCO1576 arginine repressor argR Arginine biosynthesis  24 5.4E-31 0.9 n/s 5.8 7.9E-21 2.9 1.4E-14 
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SCO1577 acetonitrile aminotransferase argD Arginine biosynthesis  29.6 1.4E-33 0.6 n/s 3.4 3.7E-02 2.6 2.1E-13 
SCO1578 acetylglutamate kinase argB Arginine biosynthesis  31.6 3.9E-32 0.7 n/s 8 1.2E-23 2.6 5.4E-12 
SCO1579 putative glutamate N-acetyltransferase argJ Arginine biosynthesis  30.7 4.2E-33 0.8 n/s 8.2 4.0E-25 3.1 1.0E-17 
SCO1580 N-acetyl-gamma-glutamyl-phosphate reductase argC Arginine biosynthesis  31.2 4.3E-31 0.9 n/s 8.4 3.0E-23 2.9 6.5E-14 
SCO3070 Imidazolonepropionase hutI Histidine metabolism 2 n/s 1.4 n/s 3.8 5.0E-07 0.9 n/s 
SCO3073 urocanate hydratase hutU Histidine metabolism 3.2 1.8E-09 1.1 n/s 1.1 n/s 0.8 n/s 
SCO3221 Prephenate dehydrogenase   Tyrosine metabolism 14.9 3.2E-12 6.2 1.9E-15 8.8 7.3E-12 4.8 2.8E-18 
SCO3229 Putative 4-hydroxyphenylpyruvic acid dioxygenase 
 
Tyrosine metabolism 13.1 1.5E-11 7.3 2.0E-16 7.4 5.4E-11 6.3 3.7E-21 
SCO4932 histidine ammonia-lyase hutH Histidine metabolism 1.5 n/s 3.8 1.7E-11 2.3 1.1E-02 5.4 3.7E-21 
SCO5976 ornithine carbamoyltransferase argF Arginine biosynthesis  10.3 1.4E-25 0.6 n/s 3.2 2.4E-11 2.5 2.9E-08 
SCO7036 argininosuccinate synthase argG Arginine biosynthesis  13.5 7.0E-32 0.8 n/s 3.8 1.5E-19 3.4 1.9E-20         
  
   
Sporulation                       
SCO1541 sporulation-specific cell devision protein ssgB Early Sporulation 3.7 5.9E-05 0.8 n/s 2 n/s 4.1 9.0E-09 
SCO1950 probable cell division protein whiA Early Sporulation 1 n/s 1.4 n/s 0.4 3.1E-07 3.2 8.8E-13 
SCO2082 cell division protein ftsZ Early Sporulation 1.2 n/s 1 n/s 0.3 1.3E-17 3.5 3.7E-18 
SCO3034 transcriptional regulator whiB Early Sporulation 7.1 8.5E-23 0.9 n/s 1.4 n/s 2 n/s 
SCO4035 RNA polymerase sigma factor sigF Late Sporulation 0.6 n/s 7.5 n/s 5.5 9.6E-06 0.2 2.4E-04 
SCO4543   whiJ Early Sporulation 1.1 n/s 0.6 n/s 0.4 3.0E-04 1.4 n/s 
SCO4767 transcriptional regulator whiD Late Sporulation 1.6 n/s 12.5 6.6E-10 4.2 4.2E-04 2.3 4.3E-02 
SCO5314   whiE 
ORFVII 
Late Sporulation 1 n/s 0.9 n/s 2.3 n/s 0.5 n/s 
SCO5315 polyketide cyclase whiE 
ORFVI 
Late Sporulation 4.4 7.9E-07 1 n/s 1.5 n/s 0.8 n/s 
SCO5316 acyl carrier protein whiE 
ORFV 
Late Sporulation 1 n/s 0.7 n/s 2.1 n/s 0.3 n/s 
SCO5317 polyketide beta-ketoacyl synthase beta whiE 
ORFIV 
Late Sporulation 1.7 n/s 1.2 n/s 6.3 2.9E-10 0.1 1.2E-09 
SCO5318 polyketide beta-ketoacyl synthase alpha whiE 
ORFIII 





Late Sporulation 0.5 n/s 2.4 n/s 4.6 2.5E-04 0.2 1.3E-04 
SCO5320   whiE 
ORFI 
Late Sporulation 0.9 n/s 0.8 n/s 6.1 1.1E-08 0.1 1.2E-08 
SCO5321 polyketide hydroxylase whiE 
ORFVIII 
Late Sporulation 1.2 n/s 1 n/s 7.6 2.0E-11 0.1 6.8E-11 
SCO5621 RNA polymerase sigma factor whiG Early Sporulation 0.6 n/s 0.6 n/s 0.4 3.3E-02 0.7 n/s 
SCO5819 sporulation transcription factor whiH Early Sporulation 0.8 n/s 0.6 n/s 0.9 n/s 0.7 n/s 
SCO6029 two-component regulator whiI Early Sporulation 1.4 n/s 1.8 n/s 3.1 2.6E-03 0.3 7.9E-03         
  
   
Aerial mycelium                     
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SCO1674 chaplin-C chpC Aerial mycelium  1.3 n/s 1 n/s 0.8 n/s 1.6 n/s 
SCO1675 chaplin-H chpH Aerial mycelium  1 n/s 0.7 n/s 0.3 2.3E-08 2.4 7.1E-03 
SCO1800 chaplin-E chpE Aerial mycelium  1.4 n/s 0.7 n/s 1.1 n/s 1.3 n/s 
SCO2699 chaplin-G chpG Aerial mycelium  0.7 n/s 0.8 n/s 3.6 8.9E-03 0.2 5.1E-04 
SCO2705 chaplin-F chpF Aerial mycelium  0.9 n/s 1.8 n/s 2.3 n/s 1 n/s 
SCO2717 chaplin-D chpD Aerial mycelium  1.1 n/s 0.7 n/s 3.5 2.5E-02 0.3 n/s 
SCO2719 rodlin protein rdlB Aerial mycelium  2.7 n/s 1.3 n/s 2.5 n/s 0.8 n/s 
SCO3323 putative RNA-polymerase sigma factor bldN Aerial mycelium  1 n/s 0.5 n/s 1 n/s 1 n/s 
SCO4091 putative DNA binding protein bldC Aerial mycelium  0.5 n/s 1.3 n/s 0.2 5.7E-24 4.2 9.5E-17 
SCO4768 putative two-component regulator bldM Aerial mycelium  1 n/s 0.9 n/s 0.5 n/s 1.4 n/s 
SCO5723 putative regulator  bldB Aerial mycelium  0.8 n/s 0.8 n/s 0.2 8.7E-14 3.4 3.0E-10 
SCO6681 probable SapB synthase ramC Aerial mycelium  0.7 n/s 2.5 n/s 3.7 6.8E-08 0.3 5.1E-07 
SCO6682 lanthionine-containing peptide SapB precursor ramS Aerial mycelium  1.3 n/s 2.2 n/s 0.6 n/s 2.6 2.9E-02 
SCO6683 ABC transporter ATP binding protein ramA Aerial mycelium  1 n/s 2.4 n/s 4.5 5.8E-09 0.2 2.0E-08 
SCO6684 ABC transporter ATP binding protein ramB Aerial mycelium  1.5 n/s 2.2 n/s 8.5 6.5E-11 0.1 2.6E-10 
SCO6685 response regulator ramR Aerial mycelium  5.9 4.9E-13 0.6 n/s 2.2 n/s 1.2 n/s 
SCO7257 chaplin-B chpB Aerial mycelium  0.8 n/s 1.3 n/s 7.8 1.1E-05 0.1 2.8E-06 
                        
Antibiotic production 
      
  
   
SCO5071 hydroxylacyl-CoA dehydrogenase   ACT production 2 n/s 8.5 n/s 6.4 2.6E-03 2.6 n/s 
SCO5072 hydroxylacyl-CoA dehydrogenase 
 
ACT production 1.4 n/s 13.2 1.0E-06 6.8 2.0E-07 2.9 4.6E-07 
SCO5073 putative oxidoreductase   ACT production 3.2 n/s 8.1 2.5E-05 7 3.9E-08 1.8 n/s 
SCO5074 putative dehydratase 
 
ACT production 1.3 n/s 6.3 1.2E-03 2.9 4.5E-02 4.6 3.2E-11 
SCO5075 putative oxidoreductase ORF4 ACT production 1.1 n/s 3.6 3.6E-03 3.4 1.1E-05 1.8 n/s 
SCO5076 integral membrane protein actVA1 ACT production 0.7 n/s 1.2 n/s 0.8 n/s 1.5 n/s 
SCO5077 uncharacterised protein actVA2 ACT production 0.4 9.8E-03 1.2 n/s 0.3 1.0E-05 2.8 1.4E-04 
SCO5078 uncharacterised protein actVA3 ACT production 1 n/s 1.5 n/s 1.3 n/s 1.5 n/s 
SCO5079   actVA4 ACT production 1.7 n/s 1.9 n/s 2 n/s 2.8 1.5E-05 
SCO5080 putative hydrolase actVA5 ACT production 1.9 n/s 2 n/s 3.6 1.4E-06 1.3 n/s 
SCO5081   actVA6 ACT production 2.2 n/s 2 n/s 3.2 1.0E-02 1.5 n/s 
SCO5082 putative transcriptional regulatory protein actII-1 ACT production 0.9 n/s 0.8 n/s 0.4 6.5E-06 2.3 9.3E-03 
SCO5083 putative actinorhodin transporter actII-2 ACT production 0.7 n/s 1 n/s 1.4 n/s 0.5 n/s 
SCO5084 putative membrane protein actII-3 ACT production 0.7 n/s 1.4 n/s 1.5 n/s 0.5 n/s 
SCO5085 actinorhodin cluster activator protein actII-4 ACT production 2.3 4.5E-02 1.7 n/s 1.1 n/s 5.6 1.5E-18 
SCO5086 ketoacylreductase actIII ACT production 1.4 n/s 2.8 n/s 4.6 1.4E-05 1.1 n/s 
SCO5087 actinorhodin polyketide beta-ketoacyl synthase alpha 
subunit 
actIORF1 ACT production 0.8 n/s 3.1 n/s 4.4 5.2E-07 0.7 n/s 
SCO5088 actinorhodin polyketide beta-ketoacyl synthase beta 
subunit 
actIORF2 ACT production 0.9 n/s 3.1 n/s 5 9.0E-07 0.5 n/s 
SCO5089 actinorhodin polyketide synthase acyl carrier protein actIORF3 ACT production 0.5 n/s 2.3 n/s 4.5 1.9E-02 1.3 n/s 
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SCO5090 actinorhodin polyketide synthase bifunctional 
cyclase/dehydratase 
actVII ACT production 1.1 n/s 2.1 n/s 4.3 2.2E-05 0.6 n/s 
SCO5091 cyclase actIV ACT production 1.4 n/s 1.8 n/s 5.8 1.4E-08 0.4 5.1E-03 
SCO5092 actinorhodin polyketide putative dimerase actVB ACT production 1.2 n/s 2 n/s 3.9 3.3E-03 0.7 n/s 
SCO5877 transcriptional regulator redD Undecylprodigiosin 6.8 1.0E-15 2 n/s 3.9 1.3E-07 10.1 2.9E-24 
SCO5878 polyketide synthase redX Undecylprodigiosin 6.7 1.5E-17 2.9 9.1E-09 5.2 1.4E-13 6.9 1.3E-23 
SCO5879 acyl-coa dehydrogenase  redW Undecylprodigiosin 3 1.5E-04 2.9 1.3E-04 2.7 4.7E-03 8.9 2.8E-22 
SCO5880 
 
redY Undecylprodigiosin 1.9 n/s 3.2 9.3E-03 1.2 n/s 12.2 3.1E-18 
SCO5881 response regulator redZ Undecylprodigiosin 10.4 9.8E-28 0.5 n/s 3.8 3.7E-15 2.3 1.4E-06 
SCO5882 
 
redV Undecylprodigiosin 1.3 n/s 8.7 1.4E-03 10.8 1.7E-10 0.6 n/s 
SCO5883 hypothetical protein redU Undecylprodigiosin 1.9 n/s 6.7 1.9E-02 10.7 1.9E-08 0.8 n/s 
SCO5884 hypothetical protein 
 
Undecylprodigiosin 0.9 n/s 10.5 1.7E-04 4.6 1.5E-04 3.5 2.4E-08 
SCO5885 putative membrane protein   Undecylprodigiosin 0.7 n/s 12.9 4.3E-03 3.4 n/s 6.4 4.5E-11 
SCO5886 3-oxoacyl-[acyl-carrier-protein] synthase II redR Undecylprodigiosin 1.7 n/s 11.3 7.7E-11 6.6 1.1E-09 4.5 1.8E-16 
SCO5887 acyl carrier protein redQ Undecylprodigiosin 1.2 n/s 9.3 7.3E-05 3.7 n/s 14.7 1.2E-16 
SCO5888 3-oxoacyl-[acyl-carrier-protein] synthase  redP Undecylprodigiosin 1.1 n/s 30.7 1.6E-09 5.4 1.1E-07 4 7.9E-14 
SCO5889 hypothetical protein redO Undecylprodigiosin 0.3 n/s 65.6 1.3E-06 6.5 5.4E-03 7.8 1.8E-11 
SCO5890 putative 8-amino-7-oxononanoate synthase redN Undecylprodigiosin 2.8 5.2E-03 0.9 n/s 3 8.7E-05 2.8 6.1E-08 
SCO5891 putative peptide synthase redM Undecylprodigiosin 0.8 n/s 28.5 9.3E-07 9.3 2.8E-09 1.9 n/s 
SCO5892 polyketide synthase redL Undecylprodigiosin 2 n/s 18.4 6.6E-09 9 2.2E-17 0.1 1.5E-17 
SCO5893 oxidoreductase redK Undecylprodigiosin 1.6 n/s 6.2 3.9E-02 6 5.2E-06 1.2 n/s 
SCO5894 thioesterase redJ Undecylprodigiosin 1.9 n/s 4.9 n/s 7.8 1.1E-07 0.5 n/s 
SCO5895 putative methyltransferase redI Undecylprodigiosin 1.6 n/s 5.9 4.1E-03 6.7 1.3E-06 1.2 n/s 
SCO5896 phosphoenolpyruvate-utilising enzyme redH Undecylprodigiosin 1.4 n/s 4.1 1.1E-03 6.3 4.7E-10 1.1 n/s 
SCO5897 putative oxidase redG Undecylprodigiosin 1.8 n/s 1.7 n/s 2.5 n/s 0.5 n/s 
SCO5898 probable membrane protein redF Undecylprodigiosin 1 n/s 0.9 n/s 0.7 n/s 1.9 n/s         
  
   
Nitrate Reductase                     
SCO0216 putative nitrate reductase alpha chain narG2 Nitrate reductase 0.5 n/s 1.4 n/s 2.6 1.5E-03 0.4 n/s 
SCO0217 putative nitrate reductase beta chain narH2 Nitrate reductase 0.6 n/s 1.3 n/s 3.1 3.2E-03 0.2 1.9E-05 
SCO0218 putative nitrate reductase delta chain narJ2 Nitrate reductase 0.7 n/s 0.9 n/s 8.1 1.2E-07 0.1 1.4E-07 
SCO0219 putative nitrate reductase gamma chain narI2 Nitrate reductase 0.6 n/s 1 n/s 4.5 3.9E-04 0.1 1.3E-05 
SCO4947 putative nitrate reductase alpha chain narG3 Nitrate reductase 1.5 n/s 2.1 n/s 3.7 7.3E-11 1.1 n/s 
SCO4948 putative nitrate reductase beta chain narH3 Nitrate reductase 1.7 n/s 2.1 n/s 5.1 3.5E-09 0.7 n/s 
SCO4949 putative nitrate reductase delta chain narJ3 Nitrate reductase 1.8 n/s 2.1 n/s 5.8 3.8E-07 0.4 2.8E-02 
SCO4950 putative nitrate reductase gamma chain narI3 Nitrate reductase 1.6 n/s 2.6 n/s 5.1 1.0E-05 0.5 n/s 
SCO6532 putative nitrate reductase gamma chain narI Nitrate reductase 0.4 n/s 0.9 n/s 2.4 n/s 0.2 3.5E-03 
SCO6534 putative nitrate reductase beta chain narH Nitrate reductase 3 n/s 0.4 n/s 3.9 4.3E-04 0.2 6.6E-04 
SCO6535 putative nitrate reductase alpha chain narG Nitrate reductase 1 n/s 1 n/s 2.6 4.8E-04 0.2 3.9E-09 




      
  
   
SCO2472 putative integral membrane protein   Membrane transport 98.4 3.9E-18 0.9 n/s 16.2 4.5E-13 2.7 2.9E-07 
SCO3824 putative ABC-transporter ATP-binding component 
 
Membrane transport 24.6 1.9E-20 0.7 n/s 7.3 6.1E-13 1.7 n/s 
SCO3910 putative membrane protein   Membrane transport 8.9 1.3E-20 0.5 n/s 3.5 6.5E-09 1.1 n/s 
SCO4359 putative ABC transport system ATP-binding protein 
 
Membrane transport 15.2 1.3E-21 1 n/s 4.2 1.1E-10 2.7 8.5E-08 
                        
Peptidoglycan 
      
  
   
SCO1326 undecaprenyl pyrophosphate phosphatase  uppP Peptidoglycan biosynthesis 0.1 1.5E-13 1 n/s 0.1 6.2E-18 0.7 n/s 
SCO1875 putative secreted penicillin binding protein 
 




murG Peptidoglycan biosynthesis 0.4 3.8E-04 0.9 n/s 0.2 6.2E-22 2.5 4.4E-06 
SCO2086 UDP-N-acetylmuramoylalanine-D-glutamate ligase murD Peptidoglycan biosynthesis 0.3 3.1E-13 1.2 n/s 0.1 1.3E-24 2.1 n/s 
SCO2087 phospho-N-acetylmuramoyl-pentapeptide-transferase murX Peptidoglycan biosynthesis 0.2 4.6E-19 1.1 n/s 0.1 3.9E-28 2.8 4.4E-09 
SCO2088 UDP-N-acetylmuramoylalanyl-D-glutamyl- 2,6-
diaminopimelate- D-alanyl-alanyl ligase 
murF Peptidoglycan biosynthesis 0.3 6.5E-17 1.2 n/s 0.1 7.2E-28 2.3 3.2E-04 
SCO2089 UDP-N-acetylmuramoylalanyl-D-glutamate- 2,6-
diaminopimelate ligase 
murE Peptidoglycan biosynthesis 0.3 1.0E-12 1.2 n/s 0.2 1.4E-23 2.4 1.8E-04 
SCO2090 cell division protein ftsI Class B PBP 0.5 n/s 1.2 n/s 0.4 4.3E-08 1.3 n/s 
SCO2504 glycyl-tRNA synthetase glyS Peptidoglycan biosynthesis 0.4 8.0E-11 0.8 n/s 0.1 8.2E-29 2.7 7.3E-12 
SCO2509 undecaprenyl phosphate synthetase uppS Peptidoglycan biosynthesis 0.5 n/s 0.9 n/s 0.2 3.0E-13 1.5 n/s 
SCO2608 penicillin binding protein pbp2 Class B PBP 1.6 n/s 0.8 n/s 0.9 n/s 0.1 2.9E-16 
SCO2897 probable secreted penicillin-binding protein 
 
Class A PBP 10.7 1.0E-26 0.8 n/s 2.8 1.2E-09 3.8 1.2E-18 
SCO2949 UDP-N-acetylglucosamine transferase murA Peptidoglycan biosynthesis 1.6 n/s 0.9 n/s 0.4 1.8E-03 3.6 6.6E-15 
SCO3156 putative penicillin-binding protein 
 
Class B PBP 4.1 2.7E-19 0.9 n/s 1.4 n/s 4 1.2E-19 
SCO3157 putative penicillin-binding protein   Class B PBP 5.5 1.2E-23 1.1 n/s 1.7 n/s 3.5 2.2E-18 
SCO3580 putative transpeptidase 
 
Class A PBP 0.7 n/s 1 n/s 0.2 1.6E-20 3.1 1.0E-12 
SCO3771 putative secreted penicillin binding protein   Class B PBP 22.5 2.2E-16 0.9 n/s 7.8 1.4E-14 0.9 n/s 
SCO3847 putative secreted penicillin-binding protein 
 
Class B PBP 2.5 1.1E-09 0.6 n/s 0.7 n/s 2.5 1.4E-10 
SCO3894 Putative peptidoglycan lipid II flippase murJ Peptidoglycan biosynthesis 0.8 n/s 0.9 n/s 0.4 2.1E-10 2 n/s 
SCO3901 putative secreted penicillin-binding protein 
 
Class A PBP 0.6 n/s 0.9 n/s 0.2 7.2E-23 2.4 2.4E-07 
SCO3904 Lipid II:glycine glycyltransferase femX Peptidoglycan biosynthesis 0.4 7.0E-06 1 n/s 0.2 1.1E-23 3 4.5E-12 
SCO4013 putative secreted penicillin-binding protein 
 
Class B PBP 0.8 n/s 1.2 n/s 0.2 1.0E-18 4.3 2.7E-18 
SCO4643 UDP-N-acetylenoylpyruvoylglucosamine reductase murB Peptidoglycan biosynthesis 0.8 n/s 1.4 n/s 0.5 n/s 2.1 n/s 
SCO5039 putative penicillin-binding protein 
 
Class A PBP 2.3 3.3E-05 1.2 n/s 0.5 n/s 3.9 2.9E-18 
SCO5301 putative secreted penicillin-binding protein   Class B PBP 1.5 n/s 1.3 n/s 7.4 9.6E-10 0.1 7.6E-09 
SCO5560 D-alanine-D-alanine ligase ddlA Peptidoglycan biosynthesis 0.7 n/s 1.1 n/s 0.3 7.5E-16 3.2 1.2E-12 
SCO6060 UDP-N-acetylmuramoyl-L-alanine ligase murC Peptidoglycan biosynthesis 0.7 n/s 0.9 n/s 0.3 2.1E-14 2.4 3.0E-05 
SCO0830 putative penicillin binding protein 
 
Class C PBP 12.7 4.47E-09 1.3 n/s 7.3 8.04E-08 0.8 n/s 
SCO4847 putative D-alanyl-D-alanine carboxypeptidase   Class C PBP 2.6 2.83E-10 0.8 n/s 0.8 n/s 2.5 1.05E-08 
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SCO7050 putative D-alanyl-D-alanine carboxypeptidase 
 
Class C PBP 1.2 n/s 1.2 n/s 4.8 1.79E-06 0.1 6.04E-07 
SCO3811 putative D-alanine-D-alanine carboxypeptidase dacA Class C PBP 0.7 n/s 0.5 n/s 0.3 2.21E-13 1.2 n/s         
  
   
Membrane Homeostasis                     
SCO0920 Lyso-ornithine lipid acyltransferase olsA Ornithine lipid biosynthesis  0.7 n/s 3.6 n/s 8.9 1.4E-08 0 8.8E-09 
SCO0921 Ornithine-acyl[acyl carrier protein] N-acyltransferase olsB Ornithine lipid biosynthesis  1.1 n/s 0.5 n/s 7.3 5.5E-07 0.1 4.8E-07 
SCO1047 putative integral membrane protein 
 
Phosphatidic acid phosphatase enzyme 0.7 n/s 1.7 n/s 6.5 1.9E-07 0.0 3.4E-08 
SCO1090 putative phosphodiesterase ugpQ1 Glycerophosphoryl diester 
phosphodiesterase 
4.3 5.9E-08 0.7 n/s 1.5 n/s 2.1 n/s 
SCO1389 Putative CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyl-transferase 
cls-II Cardiolipin biosynthesis 0.6 n/s 0.6 n/s 0.2 2.2E-14 1.9 n/s 
SCO1419 putative phosphodiesterase ugpQ2 Glycerophosphoryl diester 
phosphodiesterase 
1.4 n/s 1.2 n/s 0.8 n/s 1.4 n/s 
SCO1423 Dolichol-phosphate mannosyltransferase ppm1 Polyprenylphosphate mannose 
biosynthesis 
0.6 n/s 1.2 n/s 0.2 6.3E-20 2.7 3.0E-07 
SCO1525 Phosphatidylinositol alpha-mannosyltransferase pimA Phosphatidylinositol biosynthesis  0.8 n/s 1 n/s 0.4 1.1E-06 1.6 n/s 
SCO1526 putative acyltransferase acylT Phosphatidylinositol biosynthesis  0.4 6.3E-04 1 n/s 0.3 4.6E-13 1.3 n/s 
SCO1527 CDP-diacylglycerol inositol 3-phosphatidyltransferase pisA Phosphatidylinositol biosynthesis  0.4 1.1E-05 0.9 n/s 0.2 1.9E-16 1.9 n/s 
SCO1565 putative phosphodiesterase glpQ1 Glycerophosphoryl diester 
phosphodiesterase 
0.5 n/s 0.9 n/s 1.2 n/s 0.5 n/s 
SCO1658 Regulatory gene  gylR Transcriptional regulation of the 
glycerol operon 
0.5 n/s 1.9 n/s 0.6 n/s 3.4 1.7E-09 
SCO1659 putative glycerol uptake facilitator protein glpF Glycerol metabolic process 0.8 n/s 3.5 6.2E-06 1.6 n/s 17.7 8.3E-23 
SCO1660 putative glycerol kinase glpK Glycerol metabolic process 0.7 n/s 2.7 5.2E-04 0.6 n/s 15.3 2.3E-24 
SCO1661 putative glycerol-3-phosphate dehydrogenase glpD Glycerol metabolic process 0.9 n/s 2.7 2.6E-04 1 n/s 8.9 4.3E-23 
SCO1814 putative enoyl-(acyl-carrier-protein) reductase fabI Fatty acid biosynthesis 0.3 2.8E-16 0.6 n/s 0.1 5.6E-29 2.4 5.6E-07 
SCO1815 probable 3-oxacyl-(acyl-carrier-protein) reductase fabG Fatty acid biosynthesis 0.4 4.0E-12 0.6 n/s 0.1 3.5E-29 2.4 2.7E-07 
SCO1968 putative phosphodiesterase glpQ2 Glycerophosphoryl diester 
phosphodiesterase 
1.7 n/s 0.8 n/s 0.7 n/s 2.3 1.9E-02 
SCO2132 putative glycosyl transferase pimB Phosphatidylinositol biosynthesis  0.6 n/s 1.2 n/s 0.5 n/s 1.4 n/s 
SCO2255 Putative membrane protein 
 
Endonuclease/Exonuclease/Phosphatase 22.7 8.5E-30 0.7 n/s 7.1 5.5E-21 2.4 9.4E-08 
SCO2335 putative integral membrane protein   Phosphatidic acid phosphatase enzyme 3.4 8.2E-16 1.1 n/s 1.3 n/s 2.5 5.1E-08 
SCO2387 malonyl CoA:acyl carrier protein malonyltransferase fabD Fatty acid biosynthesis 0.8 n/s 0.7 n/s 0.2 1.0E-25 2.7 2.2E-12 
SCO2388 3-oxoacyl-[acyl-carrier-protein] synthase III fabH Fatty acid biosynthesis 0.5 n/s 0.4 n/s 0.1 2.9E-29 2 n/s 
SCO2390 3-oxoacyl-[acyl-carrier-protein] synthase II fabF Fatty acid biosynthesis 0.7 n/s 0.7 n/s 0.2 3.1E-26 2.2 2.8E-05 
SCO2807 putative integral membrane protein   Phosphatidic acid phosphatase enzyme 6.6 1.9E-24 0.7 n/s 1.7 n/s 2.2 3.1E-03 
SCO2892 putative secreted protein  
 
Hydrolase 6.9 3.2E-25 0.9 n/s 1.7 n/s 3.0 6.6E-15 
SCO3154 Dolichyl-phosphate-mannose-protein 
mannosyltransferase 
pmt Polyprenylphosphate mannose 
biosynthesis 
0.7 n/s 0.9 n/s 0.7 n/s 1.1 n/s 
SCO3222 putative secreted protein  
 
Hydrolase 14.3 1.1E-11 5.0 9.5E-13 6.8 6.1E-08 10.3 3.8E-23 
SCO3286 Putative membrane protein YqiK   Flottilin  60.7 4.8E-34 0.9 n/s 46.5 2.6E-29 3.3 4.7E-20 
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SCO3592 Putative membrane protein vanJ Endonuclease/Exonuclease/Phosphatase 1.2 n/s 2.1 n/s 0.4 n/s 2.2 n/s 
SCO3607 Flotillin    Flottilin  63.1 2.6E-34 1.1 n/s 7 2.8E-13 3.1 3.4E-19 
SCO3725 putative conserved membrane protein 
 
Phosphatidic acid phosphatase enzyme 0.8 n/s 1 n/s 0.4 3.4E-05 1.2 n/s 
SCO3976 putative phosphodiesterase ugpQ3 Glycerophosphoryl diester 
phosphodiesterase 
0.5 n/s 0.8 n/s 0.9 n/s 0.5 n/s 
SCO4133 putative integral membrane protein 
 
Phosphatidic acid phosphatase enzyme 2.7 2.0E-11 0.6 n/s 0.8 n/s 2.1 n/s 
SCO4636 predicted 2-enoyl-CoA hydratase 2   Fatty acid biosynthesis 0.7 n/s 0.8 n/s 0.2 2.0E-19 2.3 2.7E-03 
SCO4637 Acyl dehydratase 
 
Fatty acid biosynthesis 0.7 n/s 0.9 n/s 0.2 5.2E-17 2.4 5.1E-04 
SCO4843 putative integral membrane protein   Phosphatidic acid phosphatase enzyme 2.2 n/s 0.9 n/s 14 1.7E-08 0 2.0E-07 
SCO5628 Phosphatidate cytidylyltransferase cdsA CDP-diacylglycerate biosynthesis  0.6 n/s 1.2 n/s 0.2 1.1E-24 3.1 1.1E-14 
SCO5661 putative phosphodiesterase ugpQ4 Glycerophosphoryl diester 
phosphodiesterase 
0.8 n/s 1.3 n/s 0.6 n/s 1.4 n/s 
SCO5753 CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase 
pgsA Cardiolipin biosynthesis 0.6 n/s 1 n/s 0.3 3.0E-14 1.9 n/s 
SCO6355 putative integral membrane protein   Phosphatidic acid phosphatase enzyme 3.6 2.2E-13 0.8 n/s 1.2 n/s 2.7 7.3E-08 
SCO6356 putative integral membrane protein 
 
Phosphatidic acid phosphatase enzyme 3.8 1.4E-16 0.8 n/s 1.1 n/s 3.2 6.4E-14 
SCO6378 putative membrane protein   Phosphatidic acid phosphatase enzyme 10.4 5.0E-13 0.6 n/s 2.8 1.3E-02 3.5 2.6E-09 
SCO6428 putative secreted protein 
 
Phosphatidic acid phosphatase enzyme 1.1 n/s 1.1 n/s 7.2 2.2E-14 0.1 7.9E-14 
SCO6467 putative phosphatidylserine synthase pssA Phosphatidylethanolamine biosynthesis 0.5 n/s 0.8 n/s 0.1 1.7E-25 3 1.7E-12 
SCO6468 Phosphatidylserine decarboxylase  psd Phosphatidylethanolamine biosynthesis 0.5 n/s 0.9 n/s 0.2 8.2E-26 3.2 3.1E-15 
SCO6511 Undecaprenyl pyrophosphatase   Phosphatidic acid phosphatase enzyme 10.1 1.2E-23 0.8 n/s 2.6 6.3E-05 3.3 4.7E-14 
SCO6759 putative phytoene synthase hpnC Hopanoid biosynthesis 0.8 n/s 1 n/s 0.3 4.4E-12 2 n/s 
SCO6760 putative phytoene synthase hpnD Hopanoid biosynthesis 0.8 n/s 1 n/s 0.3 2.7E-11 6.3 2.4E-22 
SCO6761 Uncharacterized protein 
 
Hopanoid biosynthesis 0.7 n/s 1 n/s 0.2 1.8E-08 2.4 n/s 
SCO6762 putative phytoene dehydrogenase hpnE Hopanoid biosynthesis 0.9 n/s 1 n/s 0.4 1.1E-06 2.3 5.9E-03 
SCO6763 putative polyprenyl synthatase fpps Hopanoid biosynthesis 0.7 n/s 1 n/s 0.3 2.5E-11 2 n/s 
SCO6764 putative squalene-hopene cyclase shc Hopanoid biosynthesis 1 n/s 0.8 n/s 0.5 n/s 1.6 n/s 
SCO6765 putative lipoprotein hpnG Hopanoid biosynthesis 1.1 n/s 0.8 n/s 1.1 n/s 0.9 n/s 
SCO6766 Hopanoid biosynthesis associated radical SAM protein 
HpnH 
hpnH Hopanoid biosynthesis 1 n/s 0.8 n/s 0.4 5.7E-03 2.5 5.7E-04 
SCO6767 GcpE protein homolog, conserved hypothetical protein ispG Hopanoid biosynthesis 1.3 n/s 1.1 n/s 0.6 n/s 2.2 n/s 
SCO6768 probable transketolase dxps1 Hopanoid biosynthesis 1.5 n/s 1.1 n/s 1.2 n/s 1.7 n/s 
SCO6769 probable aminotransferase hpnO Hopanoid biosynthesis 1.3 n/s 0.9 n/s 0.8 n/s 1.9 n/s 
SCO6770 putative DNA-binding protein   Hopanoid biosynthesis 0.6 n/s 1.1 n/s 0.3 4.1E-11 2.3 2.2E-03 
SCO7017 putative membrane protein 
 
Endonuclease/Exonuclease/Phosphatase 34.9 5.1E-23 0.8 n/s 7.4 2.1E-15 2.9 7.3E-11 
SCO7205 putative hydrolase 
 
Hydrolase 14.4 4.2E-23 0.9 n/s 5.7 2.3E-14 3.5 2.4E-15 
SCO7587 putative integral membrane protein   Phosphatidic acid phosphatase enzyme 0.4 2.7E-04 1 n/s 0.3 4.1E-13 1.3 n/s 
 
